Exempt Chemical Preparations Under the Controlled Substances Act, 16891-17040 [2016-06624]

Download as PDF Vol. 81 Friday, No. 58 March 25, 2016 Book 3 of 3 Books Pages 16891–17058 Part III Department of Justice ebenthall on DSK6SPTVN1PROD with NOTICES2 Drug Enforcement Administration Exempt Chemical Preparations Under the Controlled Substances Act; Notice VerDate Sep<11>2014 00:01 Mar 25, 2016 Jkt 238001 PO 00000 Frm 00001 Fmt 4717 Sfmt 4717 E:\FR\FM\25MRN2.SGM 25MRN2 16892 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Diversion Control, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 598–6812. SUPPLEMENTARY INFORMATION: DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–372] Exempt Chemical Preparations Under the Controlled Substances Act Drug Enforcement Administration, Department of Justice. ACTION: Notice of order with opportunity for comment. AGENCY: The applications for exempt chemical preparations received by the Drug Enforcement Administration (DEA) between April 1, 2013, and December 31, 2015, as listed below, were accepted for filing and have been approved or denied as indicated. DATES: Interested persons may file written comments on this order in accordance with 21 CFR 1308.23(e). Electronic comments must be submitted, and written comments must be postmarked, on or before May 24, 2016. Commenters should be aware that the electronic Federal Docket Management System will not accept comments after 11:59 p.m. Eastern Time on the last day of the comment period. ADDRESSES: To ensure proper handling of comments, please reference ‘‘Docket No. DEA–372’’ on all correspondence, including any attachments. The Drug Enforcement Administration (DEA) encourages that all comments be submitted through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the Web page or to attach a file for lengthier comments. Please go to https:// www.regulations.gov and follow the online instructions at that site for submitting comments. Upon completion of your submission you will receive a Comment Tracking Number for your comment. Please be aware that submitted comments are not instantaneously available for public view on Regulations.gov. If you have received a comment tracking number, your comment has been successfully submitted and there is no need to resubmit the same comment. Paper comments that duplicate the electronic submission are not necessary and are discouraged. Should you wish to mail a comment in lieu of an electronic comment, it should be sent via regular or express mail to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. ebenthall on DSK6SPTVN1PROD with NOTICES2 SUMMARY: FOR FURTHER INFORMATION CONTACT: Barbara J. Boockholdt, Office of VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 Posting of Public Comments Please note that all comments received are considered part of the public record and made available for public inspection online at https:// www.regulations.gov and in the DEA’s public docket. Such information includes personal identifying information (such as your name, address, etc.) voluntarily submitted by the commenter. If you want to submit personal identifying information (such as your name, address, etc.) as part of your comment, but do not want it to be posted online or made available in the public docket, you must include the phrase ‘‘PERSONAL IDENTIFYING INFORMATION’’ in the first paragraph of your comment. You must also place all the personal identifying information you do not want posted online or made available in the public docket in the first paragraph of your comment and identify what information you want redacted. If you want to submit confidential business information as part of your comment, but do not want it to be posted online or made available in the public docket, you must include the phrase ‘‘CONFIDENTIAL BUSINESS INFORMATION’’ in the first paragraph of your comment. You must also prominently identify confidential business information to be redacted within the comment. Comments containing personal identifying information and confidential business information identified as directed above will generally be made publicly available in redacted form. If a comment has so much confidential business information that it cannot be effectively redacted, all or part of that comment may not be made publicly available. Comments posted to https:// www.regulations.gov may include any personal identifying information (such as name, address, and phone number) included in the text of your electronic submission that is not identified as directed above as confidential. An electronic copy of this document is available at https:// www.regulations.gov for easy reference. Legal Authority The Drug Enforcement Administration (DEA) implements and enforces titles II and III of the Comprehensive Drug Abuse Prevention and Control Act of 1970, as amended. Titles II and III are referred to as the PO 00000 Frm 00002 Fmt 4701 Sfmt 4703 ‘‘Controlled Substances Act’’ and the ‘‘Controlled Substances Import and Export Act,’’ respectively, and are collectively referred to as the ‘‘Controlled Substances Act’’ or the ‘‘CSA’’ for purpose of this action. 21 U.S.C. 801–971. The DEA published the implementing regulations for these statutes in title 21 of the Code of Federal Regulations (CFR), chapter II. The CSA and its implementing regulations are designed to prevent, detect, and eliminate the diversion of controlled substances and listed chemicals into the illicit market while ensuring an adequate supply is available for the legitimate medical, scientific, research, and industrial needs of the United States. Controlled substances have the potential for abuse and dependence and are controlled to protect the public health and safety. Section 201 of the CSA (21 U.S.C. 811) authorizes the Attorney General, by regulation, to exempt from certain provisions of the CSA certain compounds, mixtures, or preparations containing a controlled substance, if she finds that such compounds, mixtures, or preparations meet the requirements detailed in 21 U.S.C. 811(g)(3)(B).1 DEA regulations 21 CFR 1308.23 and 1308.24 further detail the criteria by which the DEA Deputy Assistant Administrator may exempt a chemical preparation or mixture from certain provisions of the CSA. The Deputy Assistant Administrator may, pursuant to 21 CFR 1308.23(f), modify or revoke the criteria by which exemptions are granted and modify the scope of exemptions at any time. Exempt Chemical Preparation Applications Submitted Between April 1, 2013, and September 17, 2015 The Deputy Assistant Administrator received applications between April 1, 2013, and September 17, 2015, requesting exempt chemical preparation status detailed in 21 CFR 1308.23. Pursuant to the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23, the Deputy Assistant Administrator has found that each of the compounds, mixtures, and preparations described in Chart I below is intended for laboratory, industrial, educational, or special research purposes and not for general administration to a human being or animal and either: (1) Contains no narcotic controlled substance and is packaged in such a form or concentration that the packaged 1 This authority has been delegated from the Attorney General to the Administrator of the DEA by 28 CFR 0.100, and subsequently redelegated to the Deputy Assistant Administrator pursuant to section 7 of 28 CFR 0.104, appendix to subpart R. E:\FR\FM\25MRN2.SGM 25MRN2 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices ebenthall on DSK6SPTVN1PROD with NOTICES2 quantity does not present any significant potential for abuse; or (2) contains either a narcotic or nonnarcotic controlled substance and one or more adulterating or denaturing agents in such a manner, combination, quantity, proportion, or concentration that the preparation or mixture does not present any potential for abuse; if the preparation or mixture contains a narcotic controlled substance, it must be formulated in such a manner that it VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 incorporates methods of denaturing or other means so that the preparation or mixture is not liable to be abused or have ill effects if abused, and so that the narcotic substance cannot in practice be removed. Accordingly, pursuant to 21 U.S.C. 811(g)(3)(B), and in accordance with 21 CFR 1308.23 and 21 CFR 1308.24, the Deputy Assistant Administrator has determined that each of the chemical preparations or mixtures generally PO 00000 Frm 00003 Fmt 4701 Sfmt 4703 16893 described in Chart I below and specifically described in the application materials received by the DEA, are exempt, to the extent described in 21 CFR 1308.24, from application of sections 302, 303, 305, 306, 307, 308, 309, 1002, 1003, and 1004 (21 U.S.C. 822–823, 825–829, and 952–954) of the CSA, and 21 CFR 1301.74, as of the date that was provided in the approval letters to the individual requesters. BILLING CODE 4410–09–P E:\FR\FM\25MRN2.SGM 25MRN2 16894 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Chart I ebenthall on DSK6SPTVN1PROD with NOTICES2 Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. VerDate Sep<11>2014 18:45 Mar 24, 2016 Kit: 6 vials; 3 mLeach Control FD Immunoassay Kit: 6 vials; 5 mLeach Kit: 10 vials; 3 mL each Kit: 10 vials; 5 mLeach Control FD TDM Linearity FD Fertility Siemens Centaur Linearity FD Immunoassay Linearity FD Immunoassay Abbott Architect i Series K831M·5 Linearity FD Immunoassay Abbott Architect i Series K833M-5 Linearity FD TDM Linearity FD TDM Siemens Centaur (-)-11-Nor-~9-THC-carboxylic acid Suitable for immunoassay (100 Jlg/mL in Methanol) (- )-11-Nor-~9-THC-carboxyrlic acid Suitable for immunoassay (1000 Jlg/mL in Methanol) (-)-~8-THC (100 Jlg/mL in Methanol) (-)-~8-THC (1000 Jlg/mL in Methanol) (-)-~9-THC- Calibration Standard (1000 Jlg/mL in methanol) (-)-~9- THC- Performance Test HPLC-GC (500 Jlg/mL in methanol) (-)-~9-THC (100 Jlg/mL in Methanol) (-)-~9-THC (1 000 Jlg/mL in Methanol) (-)-~9-THC-D3 (100 ~tg/mL (-)-~9-THC-D3 (1000 Jlg/mL in Methanol) (-)-~9-THC-D3 (1000 Jlg/mL in methanol) in Methanol) (+/-)Amphetamine [(+/-)-1-Phenylpropan-2amine] (1000 Jlg/mL in Methanol) (+/-) Amphetamine-D5 (1000 Jlg/mL in Methanol) Jkt 238001 PO 00000 Frm 00004 Fmt 4701 Sfmt 4725 Kit: 10 vials; 5 mL each Kit: 5 vials; 5 mLeach Kit: 5 vials; 5 mLeach Kit: 5 vials; 5 mLeach Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL E:\FR\FM\25MRN2.SGM 25MRN2 10/22/2015 10/22/2015 10/22/2015 10/22/2015 11/23/2015 11/23/2015 10/22/2015 10/22/2015 7/11/2014 7/11/2014 7/11/2014 7/11/2014 11/20/2015 11/20/2015 7/11/2014 7/11/2014 7/11/2014 7/11/2014 11/20/2015 7/11/2014 7/11/2014 EN25MR16.179</GPH> Aalto Scientific, Ltd. 16895 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Absolute Standards, Inc. (+/-)-Amphetamine (100 Absolute Standards, Inc. (+/-)Amphetamine-D5 (100 Absolute Standards, Inc. Glass ampoule: 1 mL 7/11/2014 Glass ampoule: 1 mL 7/11/2014 (+/-)-Methamphetamine (100 MglmL in Methanol) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. (+/-)-Methamphetamine (1000 MglmL in Methanol) Absolute Standards, Inc. (+/-)-Methamphetamine as free base [dMethamphetantine] (1000 ~Lg/mL in Methanol) Glass ampoule: 1 mL Glass ampoule: 1 mL Absolute Standards, Inc. (+/-)Methamphetamine-D5 (100 MglmL in Methanol) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. (+/-)Methamphetamine-D5 (1000 MglmL in Methanol) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. (±)-11-nor-~9-THC Absolute Standards, Inc. (±)-11-nor-~9-THC Glass ampoule: 1 mL Glass ampoule: 1 mL Absolute Standards, Inc. (±)-MDA [3,4-MethylenedioA-'Yamphetamine] (1000 MglmL in Methanol) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. (±)-MDA 3,4-MethylenediOA-'Jatnphetamine (100 MglmL in Methanol) Glass ampoule: 1 mL 7/1112014 Absolute Stm1dards, Inc. (±)-MDA-D5 (1000 MglmL in Methanol) Glass ampoule: 1 mL 7/11/2014 Glass ampoule: 1 mL 7/1112014 Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Absolute Standards, Inc. ~Lg/mL in Methanol) ~Lg/mL in Methanol) carbOA.J'liC acid-D3 (100 MglmL in Methanol) ~Lg/mL carboxylic acid-D3 (1000 in Methanol) (±)-MDMA [d,l-3,4Methylenedioxymethamphetmnine; Ecstasy] (1000 MglmL in Methanol) (±)-MDMA 3,4Me thy lenedioxymethamphetantine(Ecstasy) (100 MglmL in Methanol) (±)-MDMA-D5 (100 Mg/mL in Methanol) Absolute Standards, Inc. (±)-MDMA-D5 (1000 MglmL in Methanol) Absolute Standards, Inc. 17a-Methyltestosterone (100 MglmL in Acetottitrile) Absolute Standards, Inc. 17 a-Methyltestosterone ( 1000 Acetottitrile) Absolute Stm1dards, Inc. Alprazolam (100 gg/mL in Methanol) Absolute Standards, Inc. Alprazolam-D5 (100 Absolute Standards, Inc. Glass ampoule: 1 mL Glass ampoule: 1 mL 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 Glass ampoule: 1 mL 7/1l/2014 Glass ampoule: 1 mL 711112014 Glass ampoule: 1 mL 7/ll/2014 Glass ampoule: 1 mL 7/ll/2014 Carisoprodol (100 MglmL in Methanol) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Carisoprodol ( 1000 MglmL in Acetonitrile) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Carisoprodol (1000 MglmL in Methanol) Glass ampoule: 1 mL 7/11/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~Lg/mL Frm 00005 ~Lg/mL in in Methanol) Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.180</GPH> ebenthall on DSK6SPTVN1PROD with NOTICES2 Absolute Standards, Inc. 7/11/2014 16896 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampoule: 1 mL 7/11/2014 Chloral hydrate (1000 11g/mL in MTBE) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Chloral hydrate Levell (5.0 11g/mL inMTBE) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Chloral hydrate Level2 (2.5 11g/mL in MTBE) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Chloral hydrate Level3 (1.0 11g/mL in MTBE) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Chloral hydrate Level4 (0.5 11g/mL in MTBE) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Chlordiazepoxide (100 11g/mL in Methanol) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Chlordiazepoxide (1000 11g/mL in Methanol) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. cis-Tramadol HCl (100 11g/mL in Methanol) Glass ampoule: 1 mL 7/1112014 Absolute Standards, Inc. Clonazepam (100 ~tg/mL Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Clonazepam (1000 11g/mL in Methanol) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Clonazepam-D4 (100 11g/mL in Methanol) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Clonazepam-D4 (1000 11g/mL in Methanol) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Cocaine (100 11g/mL in Acetonitrile) Glass an1poule: 1 mL 7/11/2014 Absolute Standards, Inc. Cocaine (1000 11g/mL in Acetonitrile) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Cocaine (1000 11g/mL in Methanol) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Cocaine-D3 (100 11g/mL in Acetonitrile) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Cocaine-D3 (1000 11g/mL in Acetonitrile) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Codeine [3-Methylmorphine] (100 11g/mL in Methanol) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Codeine [3-Methylmorphine] (1000 11g/mL in Methanol) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Codeine-6-~-D-glucuronide MeOH:H20 (80:20)) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Me0H:H20 (80:20)) Glass ampoule: 1 mL 7/11/2014 Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. VerDate Sep<11>2014 18:45 Mar 24, 2016 in Methanol) Codeine-6-~-D-glucuronide (100 11g/mL in (1000 ~tg/mL Codeine-D3 (100 11g/mL in Methanol) Jkt 238001 PO 00000 Frm 00006 Fmt 4701 Sfmt 4725 in E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.181</GPH> Chloral hydrate (100 11g/m.L) in MTBE Absolute Standards, Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Absolute Standards, Inc. 16897 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices ebenthall on DSK6SPTVN1PROD with NOTICES2 Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. VerDate Sep<11>2014 18:45 Mar 24, 2016 Codeine-D3 (1000 ~tg/mL ~tg/mL d-Cathine (100 Diazepam (100 in Methanol) ~g/mL d-Cathine (1000 in Methanol) ~g/mL in Methanol) in Methanol) Diazepam [Valium] (1000 Diazepam-DS (100 ~tg/mL ~g/mL Estazolam ( 1000 in Methanol) ~g/mL Flunitrazepam (1000 ~tg/mL Heroin (100 Heroin (1000 Methaqualone (100 PO 00000 in Acetonitrile) in Acetonitrile) ~g/mL Meprobamate (1000 Jkt 238001 in Acetonitrile) ~tg/mL Meprobamate (100 in Methanol) in Methanol) ~g/mL Lorazepam (1000 ~g/mL in Acetonitrile) ~g/mL Lorazepam (100 in Methanol) in Methanol) ~g/mL ~g/mL in Methanol) ~tg/mL Flunitrazepam-D7 (1000 GHB-D6 (1000 in Methanol) ~g/mL Flunitrazepam-D7 (100 GHB-D6 (1 00 in Methanol) ~g/mL Flunitrazepam ( 100 in Meth<mol) in Methanol) ~g/mL Fentanyl-DS (100 in Methanol) in Methanol) ~g/mL Diazepam-DS (1000 Estazolam (100 ~tg/mL in Methanol) ~tg/mL ~g/mL Frm 00007 in Methanol) in Methanol) Fmt 4701 Sfmt 4725 Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL E:\FR\FM\25MRN2.SGM 25MRN2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 7/11/2014 7111/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 EN25MR16.182</GPH> Absolute Standards, Inc. Absolute Standards, Inc. 16898 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. VerDate Sep<11>2014 18:45 Mar 24, 2016 Methaqualone (1000 Jlg/mL in Methanol) Methaqualone-D4 (100 ~tg/mL in Methanol) Methaqualone-D4 (1000 Jlg/mL in Methanol) Methcathinone (100 Jlg/mL in Acetonitrile) Methcathinone (1000 Jlg/mL in Acetonitrile) Midazolam (100 ~tg/mL in Methanol) Midazolam (1000 Jlg/mL in Methanol) Nordiazepam ( 1000 11g/mL in Methanol) Oxazepam (100 11g/mL in Methanol) Oxazepam ( 1000 Jlg/mL in Acetonitrile) Oxazepam-D5 (100 Jlg/mL in Methanol) ~tg/mL in Methanol) Pentobarbital.sodium salt (100 ~tg/mL in Methanol) Pentobarbital.sodimn salt (1000 ~tg/mL in Methanol) Pentobarbital-D5 (l 00 Jlg/mL in Methanol) Pentobarbital-D5 (1000 11g/mL in Methanol) Phenobarbital (100 11g/mL in Methanol) Phenobarbital (1000 Jlg/mL in Methanol) Phentemrine (100 ~tg/mL in Methanol) Phentermine [2-Methyl-1-phenylpropan-2amine] ( 1000 11g/mL in Methanol) Prazepam (100 ~tg/mL in Methanol) Prazepam (1000 Jlg/mL in Methanol) Jkt 238001 PO 00000 Frm 00008 Fmt 4701 Sfmt 4725 Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Nordiazepan1 (100 Jlg/mL in Methanol) Oxazepam-D5 (1000 Glass ampoule: 1 mL Glass ampoule: 1 mL 1 Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL Glass ampoule: mL 1 1 1 1 1 1 1 1 1 1 1 1 Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL E:\FR\FM\25MRN2.SGM 25MRN2 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 EN25MR16.183</GPH> Absolute Standards, Inc. Absolute Standards, Inc. 16899 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. R(-)-Amphetamine [!-Amphetamine] (1000 ~tg/mL in Methanol) R(-)-Amphetamine !-Amphetamine (100 ~g/mL in Methanol) R( -)-Methamphetamine [!-Methamphetamine] (1000 ~tg/mL in Methanol) R( -)-Methamphetamine hydrochloride 1Methamphetamine HCl (100 ~g/mL in Methanol) S(+)-Amphetamine [d-Amphetamine] ( 1000 ~g/mL in Methanol) S(+)-Amphetamine HCl d-Amphetan1ine HCl (100 ~g/nlL in Methanol) S(+)-Methamphetan1ine [d-Methamphetamine] (1000 ~g/mL in Methanol) S(+)-Methamphetamine d-Methamphetamine (100 ~g/mL in Methanol) Secobatbital (100 ~Lg/mL Absolute Standards, Inc. Secobatbital (1000 Absolute Standards, Inc. Secobatbital-D5 (100 Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. VerDate Sep<11>2014 18:45 Mar 24, 2016 in Methanol) ~g/mL Secobatbital-D5 (1000 in Methanol) ~g/mL in Methanol) Sodium g-hydro::\.'Ybutyrate (GHB) (100 in Methanol) ~g/mL Sodium g-hydroxybutyrate (GHB) (1000 in Methanol) Ternazepam (100 ~g/mL Temazepan1-DS (100 in Methanol) Testosterone (100 ~g/mL in Acetonitrile) Testosterone (1 00 ~tglmL in Methanol) Testosterone (1000 ~g/mL in Acetonitrile) Testosterone (1000 ~g/mL in Methanol) Testosterone-2,3,4-13C3 (100 Acet011itrile) Jkt 238001 PO 00000 Frm 00009 ~tg/mL Fmt 4701 Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL in Sfmt 4725 Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL 7/11/2014 7/11/20I4 7/11/20I4 7/1112014 7/11/2014 7/1112014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7111/2014 7/11/2014 7/11/2014 Glass ampoule: 1 mL in Methanol) ~g/mL Glass ampoule: 1 mL 7/11/2014 Glass ampoule: 1 mL in Methanol) ~g/mL Temazepam-D5 (1000 ~g/mL in Methanol) ~g/mL Temazepam (I 000 Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL in Methanol) ~g/mL Glass ampoule: 1 mL 7/11/2014 Glass ampoule: 1 mL Glass ampoule: 1 niL Glass ampoule: 1 niL Glass ampoule: 1 mL Glass ampoule: 1 niL Glass ampoule: 1 mL E:\FR\FM\25MRN2.SGM 25MRN2 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 EN25MR16.184</GPH> Absolute Standards, Inc. 16900 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Alltech Associates, Inc. VerDate Sep<11>2014 18:45 Mar 24, 2016 Testosterone-2,3,4-13C3 (1000 ng/mL in Methanol) Total1HC- Calibration Standard GC (100 J.tg/mL in methanol) Total1HC- Calibration Standard HPLC (100 J.tg/mL in methanol) Total1HC- Petformance Test GC (500 J.tg/mL in methanol) Total1HC- Petfom1ance Test HPLC (500 ~tg/mL in methanol) Tramadol (1000 ~tg/mL in Methanol) Triazolam (100 J.tg/mL in Methanol) Triazolam (1000 J.tg/mL in Methanol) Zolpidem (100 J.tg/mL in Methanol) Zolpidem (1000 J.tg/mL in Methanol) Custom Method 551 Standard, S-6861 G-R8 Custom Method 551 Standard, S-6861 G-R8lOX Custom Organic Standard, S-16085A Custom Standard, S-6861G-Rl0-5X Custom Volatile Standard, S-11728-R3-0.25X Korean Drinking Water Standard, KDWR-004 Forensic Toxicology Submix lOA Forensic Toxicology Submix lOB Forensic Toxicology Submix 9A Forensic Toxicology Submix 9B Forensic Toxicology Submix 9C Comprehensive MixComprehensive MixComprehensive MixComprehensive MixComprehensive Mix- 2C-C Quik-Chek, 1.0 mg/mL in Methanol Jkt 238001 PO 00000 Frm 00010 Fmt 4701 Sfmt 4725 Glass ampoule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL Glass ampoule: 1 mL Amber ampule: 1 mL Amber ampule: 1 mL Amber ampule: 1 mL Amber ampule: 1 mL Amber ampule: 1 mL Amber ampule: 1 mL Amber ampule: 1 mL Amber ampule: 1 mL Amber ampule: 1 mL Amber ampule: 1 mL Amber ampule: 1 mL Glass ampule: 1 mL E:\FR\FM\25MRN2.SGM 25MRN2 7/11/2014 11/20/2015 11/20/2015 11/20/2015 11/20/2015 7/11/2014 7/11/2014 7/11/2014 7/11/2014 7/11/2014 4/6/2015 5/6/2013 4/6/2015 5/27/2015 4/6/2015 5/6/2013 4/2/2013 4/2/2013 4/2/2013 4/2/2013 4/2/2013 5/14/2013 EN25MR16.185</GPH> ebenthall on DSK6SPTVN1PROD with NOTICES2 Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. Absolute Standards, Inc. AccuStandard, Inc. AccuStandard, Inc. AccuStandard, Inc. AccuStandard, Inc. AccuStandard, Inc. AccuStandard, Inc. Agilent Technologies Agilent Technologies Agilent Technologies Agilent Technologies Agilent Technologies 16901 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 1 mL 5/14/2013 2C-T-2, 1.0 mg/mL in Methanol Glass ampule: 1 mL 5/14/2013 Alltech Associates, Inc. 2C-T-4 Quik-Chek, 1.0 mg/mL in Methanol Glass ampule: 1 mL 9/12/2013 Alltech Associates, Inc. Allobarbital Quik-Chek, 1.0 mg/mL in Methanol Glass ampule: 1 mL 9/12/2013 Alltech Associates, Inc. Tramadol Quik-Chek, 1.0 mg/mL in Methanol Amber ampoule: 1 mL 8/19/2014 American Proficiency Institute (API) PCAPTT-QQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 American Proficiency Institute (API) PCCAPTT-AQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 American Proficiency Institute (API) PCJACT-AQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 American Proficiency Institute (API) PCJACT-NQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 American Proficiency Institute (API) PCJCPT-AQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 American Proficiency Institute (API) PCJCPT-NQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 American Proficiency Institute (API) PCJLR-AQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 American Proficiency Institute (API) PCJLR-NQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 American Proficiency Institute (API) PCJPT-AQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 American Proficiency Institute (API) PCJPT-NQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 American Proficiency Institute (API) PCPRO-AQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00011 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.186</GPH> 2C-I, 1.0 mg/mL in Methanol Alltech Associates, Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Alltech Associates, Inc. 16902 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Bag: 250-750 tubes; 0.5 mL each 9/12/2013 Detectabuse Custom Liquid Control Oral Fluid, OF26 Glass vials: 1 mL-100 mL 7/8/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Oral Fluid, OF27 Glass vials: 1 mL - 100 mL 8/20/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Plasma, PI Glass vials: 1 mL-200 mL 4/10/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine MC191 Glass vials: 1 mL-200 mL 6/19/2013 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine MC194 Glass vials: 1 mL-200mL 6/28/2013 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine MC195 Glass vials: 1 mL-200 mL 7/11/2013 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC182 Glass vials: 1 mL- 200 mL 4/22/2013 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC185 Glass vials: 1 mL-200 mL 9/3/2013 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC186 Glass vials: 1 mL-200 mL 9/3/2013 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC187 Glass vials: 1 mL- 200 mL 9/3/2013 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC188 Glass vials: 1 mL-200 mL 9/3/2013 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC189 Glass vials: 1 mL- 200 mL 4/16/2013 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC190 Glass vials: 1 mL-200 mL 5/10/2013 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC197 Glass vials: 1 mL-200 mL 8/28/2013 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC198 Glass vials: 1 mL-200 mL 9/5/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00012 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.187</GPH> PCPRO-NQ Biochemical Diagnostics, Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 American Proficiency Institute (API) 16903 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vials: 1 mL-200 mL 9/11/2013 Detectabuse Custom Liquid Control Urine, MC200 Glass vials: 1 mL-200 mL 9/17/2013 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC202 Glass vials: 1 mL-200 mL 10/28/2013 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC203 Glass vials: 1 mL-200 mL 11/21/2013 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC204 Glass vials: 1 mL-200 mL 11/21/2013 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC205 Glass vials: 1 mL-200 mL 12/6/2013 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC206 Glass vials: 1 mL-200 mL 12/30/2013 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC207 Glass vials: 1 mL-20 mL 5116/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC208 Glass vials: 1 mL-200mL 1/16/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC209 Glass vials: 1 mL-200mL 1/29/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC210 Glass vials: 1 mL- 200 mL 1/29/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC211 Glass vials: 1 mL-200 mL l/29/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC212 Glass vials: 1 mL-200mL 2/14/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC213 Glass vials: 1 mL- 200 mL 2/14/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC214 Glass vials: 1 mL-200mL 2/14/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC215 Glass vials: 1 mL- 200 mL 2/14/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00013 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.188</GPH> Detectabuse Custom Liquid Control Urine, MC199 Biochemical Diagnostics, Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Biochemical Diagnostics, Inc. 16904 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vials: 1 mL-200mL 4/11/2014 Detectabuse Custom Liquid Control Urine, MC217 Glass vial: 100 mL 10/30/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC218 Glass vials: 1 mL-200 mL 4/1112014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC219 Glass vials: 1 mL-200mL 4/11/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC220 Glass vials: 1 mL-200mL 4/11/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC221 Glass vials: 1 mL-200 mL 4/11/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC222 Glass vials: 1 mL-200 mL 4/11/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC223 Glass vials: 1 mL- 200 mL 4/11/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC224 Glass vials: 1 mL-200 mL 4/11/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC225 Glass vials: 1 mL-200 mL 4/11/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC226 Glass vials: 1 ml - 100 mL 4/11/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC227 Glass vials: 1 mL-200 mL 4/1112014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC228 Glass vials: 1 mL-200 mL 4/11/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC229 Glass vials: 1 mL- 200 mL 4/11/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC230 Glass vials: 1 ml - 100 mL 4/16/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC231 Glass vials: 1 mL-20 mL 5/16/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00014 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.189</GPH> Detectabuse Custom Liquid Control Urine, MC216 Biochemical Diagnostics, Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Biochemical Diagnostics, Inc. 16905 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vials: 1 mL-20 mL 5/16/2014 Detectabuse Custom Liquid Control Urine, MC233 Glass vials: 1 mL-25 mL 5/16/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC234 Glass vials: 1 ml - 100 mL 4/25/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC235 Glass vials: 1 mL-25 mL 5/16/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC236 Glass vials: 1 mL-20 mL 5/16/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC237 Glass vials: 1 mL-35 mL 5/16/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC238 Glass vials: 1 mL-35 mL 5/16/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC239 Glass vials: 1 mL - 100 mL 6/2/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC240 Glass vials: 1 mL-100 mL 7/8/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC241 Glass vials: 1 mL - 100 mL 8/14/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC242 Glass vials: 1 mL - 100 nlL 8/14/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC243 Glass vials: 1 nlL - 100 mL 8/20/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC244 Glass vials: 1ml - 100 nlL 9/9/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC245 Glass vials: 1ml - 100 mL 9/14/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC246 Glass vials: 1 ml - 100 mL 10/29/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC247 Glass vials: 1 ml - 100 nlL 12/3/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00015 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.190</GPH> Detectabuse Custom Liquid Control Urine, MC232 Biochemical Diagnostics, Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Biochemical Diagnostics, Inc. 16906 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC248 Glass vials: 1 ml - 100 mL 12/5/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC249 Glass vials: 1 ml - 100 mL 1128/2015 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, SC19 Glass vials: 1 mL-200mL 1l/21!2013 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, SD18 Glass vials: 1 mL-2L 4/11/2013 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, SD20 Glass vials: 1 mL-200mL 1/15/2014 Biochemical Diagnostics, Inc. Tapentadol Bulk Solution Bulk container: 1 mL-1L 8/27/2013 Bionostics, Inc. HEMOCHRON ACT Whole Blood Quality Control (QCACT) Box: 20 vials; 2.0 mL (dried) 4/11/2014 HEMOCHRON HiTTRx Whole Blood Quality Control (RQCHRT) HEMOCHRON HiTTRx Whole Blood Quality Control (RQCPRT) Box: 20 vials; 2.0 mL (dried) 4/11/2014 Box: 20 vials; 2.0 mL (dried) 4/11/2014 Bionostics, Inc. Bionostics, Inc. Ampule: 0.5 mL 9/12/2013 IN PROCESS MATERIAL DC Whole Blood Control Ampule: 0.5 mL 9/12/2013 Bionostics, Inc. IN PROCESS MATERIAL Whole Blood Control Glass vial: 2 mL lyophilized 4/11/2014 Bio-Rad Laboratories EQAS Immunoassay (Monthly) Program Box 12 vials; 5 mLeach 5/22/2013 Bio-Rad Laboratories Liquichek Innnunoassay Premium Control Levels 1-3 Box of 6 vials, 5 mLeach 9/25/2013 Bio-Rad Laboratories Liquichek Immunoassay Premium Control Trilevel Box of 6 vials, 5 mLeach 9/25/2013 Bio-Rad Laboratories Liquichek Immunoassay Premium Control Trilevel MiniPak Box of 3 vials, 5 mLeach 9/25/2013 Bio-Rad Laboratories Bio-Rad Laboratories Liqnichek Netherlands Unassayed Chemistry Plus Control, Levels 1 Liquichek Netherlands Unassayed Chemistry Plus Control, Levels 2 Box: 25 vials, 5 mLeach Box: 25 vials, 5 mLeach Bio-Rad Laboratories Liquichek Netherlands Unassayed Chemistry Plus Control, Levels 3 Box: 25 vials, 5 mLeach 6/30/2015 Cambridge Isotope Laboratories, Inc. LABELED STEROID CAH SET S NSK-SCAH-1 Plastic vial: 63 ng 2/7/2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00016 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 6/30/2015 6/30/2015 EN25MR16.191</GPH> VerDate Sep<11>2014 IN PROCESS MATERIAL DC PRO Whole Blood Control Bionostics, Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Bionostics, Inc. 16907 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Testosterone (3,4-13C2,99%; 17-180, 98%), 100 ug/mL in Methylene Chloride Glass vial: 1.2 mL 112112014 Cayman Chemical Company (-)-(S)-Cathinone (hydrochloride) CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company (-)-(S)-Cathinone (hydrochloride) CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company (-)-(S)-Cathinone (hydrochloride) CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company (-)-(S)-Cathinone (hydrochloride) CRM; 100 ~tg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company (-)-(S)-Cathinone (hydrochloride); 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company (-)-(S)-Cathinone (hydrochloride); 100 11g in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company (-)-(S)-Cathinone (hydrochloride); 500 11g in0.5 mL Methanol Glass vial: 3 mL 12/20/2013 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1127/2014 (-)-11-nor-9-carboxy-~9- THC CRM; 1 mg/mL in Methanol Glass ampule: 1 mL I/27/2014 (-)-11-nor-9-carboxy-~9-THC CRM; 100 11g/mL Glass ampule: 1 mL 1/27/2014 ~tg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company (-)-11-nor-9-carboxy-~9- THC-d3 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company (- )-11-nor-9-carboxy-~9- THC-d3 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 (-)-ll-nor-9-carboxy-~9-THC-d3 Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Cayman Chemical Company Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company Cayman Chemical Company VerDate Sep<11>2014 18:45 Mar 24, 2016 (-)-11-nor-9-carboxy-~9-THC in Methanol (-)-11-nor-9-carboxy-~9-THC CRM; 100 CRM; 100 11g/mL in Methanol Jkt 238001 PO 00000 Frm 00017 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.192</GPH> Cambridge Isotope Laboratories, Inc. 16908 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 1/27/2014 (+)- Propoxyphene; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company (+ )- Propoxyphene; 100 ~gin 0.1mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company (+)- Propo:>..yphene; 500 ~gin 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company (+)-ll-nor-Ll9-TIIC carboxylic acid CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company (+)-ll-nor-Ll9-TIIC carbox-ylic acid CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company (+)-ll-nor-Ll9-TIIC carboxylic acid CRM; 100 ~g/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company (+)-11-nor-Ll9-TIIC carboxylic acid CRM; 100 ~g/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company (+)-ll-nor-Ll9-TIIC carboxylic acid; lmg in 1 mLMethanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company (+)-ll-nor-Ll9-TIIC carboxylic acid; 100 0.1 mL Methanol ~gin Glass vial: 3 mL 12/20/2013 Cayman Chemical Company (+)-ll-nor-Ll9-TIIC carboxylic acid; 500 0.5 mL Methanol ~gin Glass vial: 3 mL 12/20/2013 Cayman Chemical Company (+)-Propoxyphene CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 mL 1127/2014 Cayman Chemical Company (+ )-Propoxyphene CRM; 1 mg/mL in Acetonitrile Glass ampule: 2 mL 1127/2014 Cayman Chemical Company (+ )-Propox-yphene CRM; 100 ~g/mL in Acetonitrile Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company (+ )-Propoxyphene CRM; 100 Acetonitrile Glass ampule: 2 mL 1127/2014 Cayman Chemical Company (±) Methcathinone CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00018 ~tg/mL Fmt 4701 in Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.193</GPH> (-)-ll-nor-9-carboxy-Ll9-TIIC-d3 CRM; 100 ~Lg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16909 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Cayman Chemical Company (±) Methcathinone CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company (±) Methcatltinone CRM; 100 flg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company (±) Methcathinone CRM; 100 flg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company (±)- Propoxyphene; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company (±)- Propoxyphene; 100 11g in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company (±)- Propoxyphene; 500 11g in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 (±)-11-nor-~9-THC carboxylic acid CRM; 1 Glass ampule: 1 mL 1/27/2014 carboxylic acid CRM; 1 Glass ampule: 2 mL 1127/2014 carboxylic acid CRM; 100 Glass ampule: 1 mL 1/27/2014 carbO-"J'liC acid CRM; 100 Glass ampule: 2 mL 1/27/2014 Glass vial: 3 mL 12/20/2013 Glass vial: 3 mL 12/20/2013 Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Cayman Chemical Company Cayman Chemical Company Cayman Chemical Company Cayman Chemical Company Cayman Chemical Company Cayman Chemical Company mg/mL in Methanol (±)-11-nor-~9-THC mg/mL in Methanol (±)-11-nor-~9-THC flg/mL in Methanol (±)-11-nor-~9-THC flg/mL in Methanol (±)-11-nor-~9-THC carbox--ylic acid; 1 mg in 1 mL Methanol (±)-11-nor-~9-THC carbox)'lic acid; 100 11g in 0.1mL Methanol (±)-11-nor-~9-THC carboxylic acid; 500 Jtg in 0.5 mL Methanol Glass vial: 1 mL 9/22/2014 (±)-Cannabichromene-d9 (exempt preparation); 100 flg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company (±)-Cannabichromene-d9 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00019 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.194</GPH> (±)-Cannabichromene-d9 (exempt preparation); 1 mg in 1 mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16910 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 1 mL 9/19/2014 (±)-Cannabichromene-d9 CRM; 100 11glmL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company (±)-Cannabichromene-d9 CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company (±)-CP 47,497 CRM; 1mg/mL in Acetonitrile Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company (±)-CP 47,497 CRM; 1mg/mL in Acetonitrile Glass ampule: 1 mL 1127/2014 Cayman Chemical Company (±)-CP 47,497 CRM; 100 flg/mL in Acetonitrile Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company (±)-CP 47,497 CRM; 100 Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company (±)-CP 47,497-CS-homolog CRM; 1mg/mL in Acetonitrile Glass ampule: 1 mL 1127/2014 Cayman Chemical Company (±)-CP 47,497-CS-homolog CRM; 1 mg/mL in Acetonitrile Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company (±)-CP 47,497-CS-homolog CRM; 100 flg/mL in Acetonitrile Glass ampule: 1 mL 1/27/2014 Cayman Chetnical Company (±)-CP 47,497-CS-homolog CRM; 100 Acetonitrile Glass ampule: 2 mL 1/27/2014 Cayman Chetnical Company (±)-Methadone CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company (±)-Methadone CRM; lmg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company (±)-Methadone CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company (±)-Methadone CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chetnical Company (±)-Methadone; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00020 ~Lg/mL Fmt 4701 in Acetonitrile ~Lg/mL Sfmt 4725 in E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.195</GPH> (±)-Oumabichromene-d9 CRM; 1mg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16911 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 3 mL 12/20/2013 (±)-Methadone; 500 ~tg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company (±)-Methadone-d3 (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company (±)-Methadone-d3 (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company (±)-Methadone-d3 (hydrochloride) CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company (±)-Methadone-d3 (hydrochloride) CRM; 100 ~tg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company (±)-Methamphetamine (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 CaytlL::'ln Chemical Company (±)-Methamphetamine (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company (±)-Methamphetamine (hydrochloride) CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company (±)-Methamphetamine (hydrochloride) CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company (±)-Methamphetamine (hydrochloride); 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company (±)-Methamphetamine (hydrochloride); 100 Jlg in0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company (±)-Methamphetamine (hydrochloride); 500 Jlg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company (±)-Methamphetamine-d5 (HCl) (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company (±)-Methamphetamine-d5 (HCl) (exempt preparation); 100 Jlg inl mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company (±)-Methamphetamine-d5 (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00021 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.196</GPH> (±)-Methadone; 100 Jlg in 0.1 mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16912 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 9/19/2014 (± )-Methamphetamine-d5 (hydrochloride) CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company (±)-Methamphetamine-d5 (hydrochloride) CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company (±)-Methcathinone; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company (±)-Methcathinone; 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company (±)-Methcathinone; 500 Jlg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company (±)-Propox)'phene CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 mL l/27/2014 Cayman Chemical Company (±)-Propoxyphene CRM; lmg/mL in Acetonitrile Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company (±)-Propoxyphene CRM; 100 Jlg/mL in Acetonitrile Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company (±)-Propoxyphene CRM; 100 Jlg/mL in Acetonitrile Glass ampule: 1 mL l/27/2014 Cayman Chemical Company 11-hydroxy-.6.9-THC CRM; lmg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 11-hydroxy-.6.9-THC CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 11-hydroxy -1'19-TH C CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL l/27/2014 Cayman Chemical Company 11-hydroxy-.6.9-THC CRM; 100 Methanol Glass ampule: 2 mL l/27/2014 Cayman Chemical Company 11-hydroxy-.6.9-THC; lmg in1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 11-hydroxy-.6.9-THC; 100 J1gin0.1 mL Methanol Glass vial: 3 mL 12/20/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00022 Fmt 4701 ~Lg/mL in Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.197</GPH> (±)-Methamphetamine-d5 (hydrochloride) CRM; 1 mg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16913 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 3 mL 12/20/2013 2,3-MDA-d3(HCI) (exempt preparation); 1mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayma11 Chemical Company 2,3-MDA-d3(HC1) (exempt preparation); 100 f.18 in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company 2,5-Dimethox)l-4-ethylamphetamine; lmg in 1 mLMethanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2,5-Dimethoxy-4-ethylamphetamine; lmg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2,5-Dimetho>..)l-4-ethylamphetamine; lmg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 2,5-Dimethoxy-4-ethylamphetamine; 100 f.18 in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2,5-Dimethoxy-4-ethylamphetamine; 100 in Methanol ~tg/mL Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2,5-Dimethox)l-4-ethylanlphetamine; 100 J.lg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 2,5-Dimethoxy-4-ethylamphetamine; 500 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2,5-Dimethox)lamphetamine CRM; lmg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2,5-Dimethoxyamphetamine CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 2,5-Dimethoxyamphetamine CRM; 100 J.lg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 2,5-Dimethoxyamphetamine CRM; 100 J.lg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company 2,5-Dimethox)lamphetamine; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2,5-Dimethoxyamphetamine; 100 f.18 in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00023 Fmt 4701 Sfmt 4725 ~tg in E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.198</GPH> 11-hydroxy -11.9-TH C; 500 f.18 in 0. 5 mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16914 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 3 mL 12/20/2013 25B-NBOMe (hydrochloride) CRM; 1 mg/mL in 10% H20/ACN Glass ampule: 1 mL 1127/2014 Cayman Chemical Company 25B-NBOMe (hydrochloride) CRM; 1 mg/mL in 10%H20/ACN Glass ampule: 2 mL 1127/2014 Cayman Chemical Company 25B-NBOMe 01ydrochloride) CRM; 100 J-tg/mL in10% H20/ACN Glass ampule: 1 mL 1127/2014 Cayman Chemical Company 25B-NBOMe (hydrochloride) CRM; 100 in 10% H20/ACN ~Lg/mL Glass ampule: 2 mL 1127/2014 Cayman Chemical Company 25B-NB0Me (hydrochloride); 1 mg in 1mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 25B-NB0Me (hydrochloride); 100 J-tg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 25B-NBOMe (hydrochloride); 500 J-tg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 25B-NBOMe CRM; 1 mg/mL Methanol Glass ampule: 2 mL 5/2/2014 Cayman Chemical Company 25B-NBOMe CRM; 1 mg/mL Methanol Glass ampule: 2 mL 5/2/2014 Cayman Chemical Company 25B-NB0Me CRM; 100 J-tg/mL Methanol Glass ampule: 1 mL 5/2/2014 Cayman Chemical Company 25B-NBOMe CRM; 100 Glass ampule: 2 mL 5/2/2014 Cayman Chemical Company 25C-NBOMe (hydrochloride) CRM; 1 mg/mL in 10% H20/ACN Glass ampule: 1 mL 1127/2014 Cayman Chemical Company 25C-NBOMe (hydrochloride) CRM; 1 mg/mL in10%H20/ACN Glass ampule: 2 mL 1127/2014 Cayman Chemical Company 25C-NBOMe (hydrochloride) CRM; 100 J-tg/mL in 10% H20/ACN Glass ampule: 1 mL 1127/2014 Cayman Chemical Company 25C-NBOMe (hydrochloride) CRM; 100 J-tg/mL in 10%H20/ACN Glass ampule: 2 mL 1/27/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00024 ~Lg/mL Fmt 4701 Methanol Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.199</GPH> 2,5-Dimethoxyamphetamine; 500 J-tg in 0.5 mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16915 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 3 mL 12/20/2013 25C-NBOMe Owdrochloride); 100 jlgin0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 25C-NBOMe (hydrochloride); 500 jlg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 25C-NBOMe CRM; 1 mg/mL Methanol Glass ampule: 2 mL 5/2/2014 Cayman Chemical Company 25C-NBOMe CRM; 1 mg/mL Methanol Glass ampule: 1 mL 5/2/2014 Cayman Chemical Company 25C-NBOMe CRM; 100 jlg/mL Methanol Glass ampule: 1 mL 5/2/2014 Cayman Chemical Company 25C-NBOMe CRM; 100 Glass ampule: 2 mL 5/2/2014 Cayman Chemical Company 251-NBOMe (hydrochloride) CRM; 1 mg/mL in 10%H20/ACN Glass ampule: 2 mL 1127/2014 Cayman Chemical Company 251-NBOMe (hydrochloride) CRM; 1mg/mL in 10%H20/ACN Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 251-NBOMe (hydrochloride) CRM; 100 jlg/mL in10%H20/ACN Glass ampule: 1 mL 1127/2014 Cayman Chemical Company 251-NBOMe (hydrochloride) CRM; 100 jlg/mL in10%H20/ACN Glass ampule: 2 mL 1127/2014 Cayman Chemical Company 251-NBOMe (hydrochloride); 1 mg in1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 251-NBOMe (hydrochloride); 100 gg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 251-NBOMe (hydrochloride); 500 jlg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 251-NBOMe CRM; 1 mg/mL Methanol Glass ampule: 1 mL 5/2/2014 Cayman Chemical Company 251-NBOMe CRM; lmg/mL Methanol Glass ampule: 2 mL 5/2/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00025 ~tg/mL Fmt 4701 Methanol Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.200</GPH> 25C-NB0Me (hydrochloride); 1 mg in 1 mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16916 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 5/2/2014 251-NBOMe CRM; 100 J.lg/mL Methanol Glass ampule: 1 mL 5/2/2014 Cayman Chemical Company 2C-B (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL l/27/2014 Cayman Chemical Company 2C-B (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 2C-B (hydrochloride) CRM; 100 J.Ig/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2C-B (hydrochloride) CRM; 100 J.Ig/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company 2C-B (hydrochloride); 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-B (hydrochloride); 100 Methanol ~tg in 0.1 mL Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-B (hydrochloride); 500 Methanol ~tg in 0.5 mL Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-C CRM; 1mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 2C-C CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2C-C CRM; 100 ~tg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company 2C-C CRM; 100 ~tg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 2C-C; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-C; 100 J.lg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-C; 500 Glass vial: 3 mL 12/20/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 ~tg in 0.5 mL Methanol PO 00000 Frm 00026 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.201</GPH> 251-NBOMe CRM; 100 J.Ig/mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16917 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 1/27/2014 2C-D CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2C-D CRM; 100 flg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company 2C-D CRM; 100 Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2C-D; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-D; 100 !l8 in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-D; 500 !l8 in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-E (hydrochloride) CRM; l mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2C-E (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 2C-E (hydrochloride) CRM; 100 flg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2C-E (hydrochloride) CRM; 100 flg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 2C-E (hydrochloride); 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-E (hydrochloride); 100 !l8 in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-E (hydrochloride); 500 !l8 in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-H CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2C-H CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~Lg/mL Frm 00027 in Methanol Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.202</GPH> 2C-D CRM; 1 mg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16918 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices ~tg/mL in Methanol Glass ampule: 1 mL 1/27/2014 2C-H CRM; 100 ~g/n1L in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company 2C-H; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-H; 100 ~gin 0.1 mL Methanol Glass vial: 3 n1L 12/20/2013 Cayman Chemical Company 2C-H; 500 ~tg in 0.5 mL Methanol Glass vial: 3 n1L 12/20/2013 Cayman Chemical Company 2C-I (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2C-I (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 2C-I (hydrochloride) CRM; 100 Methanol ~tg/mL in Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2C-I (hydrochloride) CRM; 100 Methanol ~tg/n1L in Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 2C-I (hydrochloride); 1 mg in1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-I(hydrochloride); 100 Methanol ~gin0.1 Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-I (hydrochloride); 500 Methanol ~gin Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-N CRM; 1 mg/mL in Methanol Glass ampule: 1 n1L 1/27/2014 Cayman Chemical Company 2C-N CRM; 1 mg/mL in Methanol Glass ampule: 2 n1L 1/27/2014 Cayman Chemical Company 2C-N CRM; 100 ~tg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2C-N CRM; 100 ~tg/mL in Methanol Glass ampule: 2 mL 1/27/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00028 Fmt 4701 mL 0.5 mL Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.203</GPH> 2C-H CRM; 100 Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16919 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 3 mL 12/20/2013 2C-N; 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Caytlk'lll Chemical Company 2C-N; 500 Jlg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-P CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2C-P CRM; 1mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 2C-P CRM; 100 in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2C-P CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 2C-P; 1mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-P; 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-P; 500 Jlg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-T-2 CRM; 1mg/mL in 10%H20/ACN Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 2C-T-2 CRM; 1 mg/mL in 10% H20/ACN Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2C-T-2 CRM; 100 Jlg/mL inlO% H20/ACN Glass ampule: 2 mL 1127/2014 Cayman Chemical Company 2C-T-2 CRM; 100 Jlg/mL in 10%H20/ACN Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2C-T-2; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-T-2; 100 11g in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~Lg/mL Frm 00029 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.204</GPH> 2C-N; 1 mg in 1 mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16920 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 3 mL 12/20/2013 2C-T-4 CRM; 1 mg/mL in 10%H20/ACN Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2C-T-4 CRM; lmg/mL in 10%H20/ACN Glass ampule: 2 mL 1127/2014 Cayman Chemical Company 2C-T-4 CRM; 100 in 10% H20/ACN Glass ampule: 2 mL 1127/2014 Cayman Chemical Company 2C-T-4 CRM; 100 J.lg/mL in 10% H20/ACN Glass ampule: 1 mL 1127/2014 Cayman Chemical Company 2C-T-4; I mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-T-4; 100 J.lg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-T-4; 500 J.lg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-T-7 CRM; lmg/mL inl0%H20/ACN Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2C-T-7 CRM; 1mg/mL in 10%H20/ACN Glass ampule: 2 mL 1127/2014 Cayman Chemical Company 2C-T-7 CRM; 100 J.lg/mL in10%H20/ACN Glass ampule: 2 mL 1127/2014 Cayman Chemical Company 2C-T-7 CRM; 100 J.lg/mL in10%H20/ACN Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 2C-T-7; 1 mg in 1mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-T-7; 100 J.lgin0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 2C-T-7; 500 J.lgin0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 3,4,5-Trimethox-yamphetamine (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~Lg/mL Frm 00030 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.205</GPH> 2C-T -2; 500 J.lg in 0.5 mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16921 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 1127/2014 3,4,5-Trimetho>..'}'amphetamine (hydrochloride) CRM; 100 ~g/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company 3,4,5-Trimetho>..'}'amphetamine (hydrochloride) CRM; 100 ~g/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 3,4,5-Trimetho>..'}'amphetanline (hydrochloride); 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 3,4,5-Trimethoxyamphetamine (hydrochloride); 100 ~gin 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 3,4,5-Trimetho>..'}'amphetamine (hydrochloride); 500 ~gin 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 3,4-MDEA (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company 3,4-MDEA (hydrochloride) CRM; lmg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 3,4-MDEA (hydrochloride) CRM; 100 Methanol ~g/mL in Glass ampule: 1 mL 1127/2014 Cayman Chemical Company 3,4-MDEA (hydrochloride) CRM; 100 Methanol ~g/mL in Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 3,4-MDEA (hydrochloride); 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 3,4-MDEA (hydrochloride); 100 Methanol ~gin 0.1 mL Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 3,4-MDEA (hydrochloride); 500 Methanol ~gin 0.5 mL Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 3,4-MDEA-d5 (HCl) (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company 3,4-MDEA-d5 (HCl) (exempt preparation); 100 ~g in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company 3,4-MDEA-d5 (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00031 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.206</GPH> 3,4 ,5-Trimetho>..'}'amphetamine (hydrochloride) CRM; 1 mg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16922 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 1 mL 9/19/2014 3,4-MDEA-d5 (hydrochloride) CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company 3,4-MDEA-d5 (hydrochloride) CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company 3,4-MDMA (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 3,4-MDMA (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 3,4-MDMA (hydrochloride) CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 3,4-MDMA (hydrochloride) CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 3,4-MDMA (hydrochloride); 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 3,4-MDMA (hydrochloride); 100 11g in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 3,4-MDMA (hydrochloride); 500 Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 3 4-MDMA-d3 (HCl) (exempt perparation); 1 ' mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company 3,4-MDMA-d3 (HCl) (exempt perparation); 100 11g in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company 3,4-MDMA-d5 (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company 3,4-MDMA-d5 (hydrochloride) CRM; 1mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company 3,4-MDMA-d5 (hydrochloride) CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company 3,4-MDMA-d5 (hydrochloride) CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00032 Fmt 4701 ~tg in 0.5 mL Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.207</GPH> 3,4-MDEA-d5 (hydrochloride) CRM; 1 mg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16923 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices 3-Fluoromethcathinone (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 3/21/2014 Cayman Chemical Company 3-Fluoromethcathinone (hydrochloride) CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 3/21/2014 Cayman Chemical Company 3-FMC (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 3/17/2014 Cayman Chemical Company 3-FMC (exempt preparation); 100 Jlg in 100 J1L Methanol Glass vial: 100 J!L 3/17/2014 Cayman Chemical Company 3-FMC (exempt preparation); 500 Methanol J1L Glass vial: 500 J!L 3/17/2014 Cayman Chemical Company 4-Bromo-2,5-DMA (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company 4-Bromo-2,5-DMA (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company 4-Bromo-2,5-DMA (hydrochloride) CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company 4-Bromo-2,5-DMA (hydrochloride) CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 4-Bromo-2,5-DMA (hydrochloride); 1 mg in1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 4-Bromo-2,5-DMA (hydrochloride); 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 4-Bromo-2,5-DMA (hydrochloride); 500 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 4-Fluoromethcathinone (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 3/21/2014 Cayman Chemical Company 4-Fluoromethcathinone (hydrochloride) CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 3/21/2014 Cayman Chemical Company 4-FMC (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 3/17/2014 Cayman Chemical Company 4-FMC (exempt preparation); 100 Jlg in 100 J1L Methanol Glass vial: 100 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00033 Fmt 4701 ~Lg in 500 Sfmt 4725 ~tg in ~LL E:\FR\FM\25MRN2.SGM 25MRN2 3/17/2014 EN25MR16.208</GPH> ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16924 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices 4-FMC (exempt preparation); 500 Methanol Cayman Chemical Company 4-MEC (exempt preparation); 1 mg in 1 mL Methanol Cayman Chemical Company 4-MEC (exempt preparation); 100 Methanol Cayman Chemical Company 4-MEC (exempt preparation); 500 gg in 500 Methanol Cayman Chemical Company 4-MePPP (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 3/17/2014 Cayman Chemical Company 4-MePPP (exempt preparation); 100 gg in 100 JlL Methanol Glass vial: 100 JlL 3/17/2014 Cayman Chemical Company 4-MePPP (exempt preparation); 500 gg in500 JlL Methanol Glass vial: 500 Cayman Chemical Compruzy 4-Methvl-2 ' 5-dimethoxyamphetamine CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Compru1y 4-Methyl-2,5-dimethoxyamphetamine CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 4-Methyl-2,5-dimethoxyrunphetamine CRM; 100 gg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company 4-Methyl-2,5-dimethoxyrunphetamine CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 4-Methyl-2,5-dimethox:yamphetamine; 1 mg in 1 mLMethanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 4-Methyl-2,5-dimethoxyamphetamine; 100 gg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 4-Methyl-2,5-dimethoxyrunphetamine; 500 in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Compmzy 4-Methylaminorex CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 4-Methylaminorex CRM; 1 mg/mL in Acetonitrile Glass ampule: 2 mL 1/27/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 ~Lg in 500 ~Lg ~ Glass vial: 500 JlL 3/17/2014 Glass vial: 1 mL 3/17/2014 in 100 JlL Glass vial: 100 JlL 3/17/2014 ~LL Glass vial: 500 . Jkt 238001 PO 00000 Frm 00034 Fmt 4701 Sfmt 4725 ~Lg ~LL ~ E:\FR\FM\25MRN2.SGM 25MRN2 3/17/2014 3/17/2014 EN25MR16.209</GPH> ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16925 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Cayman Chemical Company 4-Methylaminorex CRM; 100 Acetonitrile ~g/mL in Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 4-Methylaminorex CRM; 100 Acetonitrile ~g/mL in Glass ampule: 2 mL 1127/2014 Cayman Chemical Company 4-Methylaminorex; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 4-Methylaminorex; 100 ~tg Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 4-Methylaminorex; 500 ~gin 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chetnical Company 4-Methylethcathinone (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 3/21/2014 Cayman Chemical Company 4-Methylethcathinone (hydrochloride) CRM; 100 ~g/mL in Methanol Glass ampule: 2 mL 3/21/2014 Cayman Chemical Company 4'-Methyl-a-pyrrolidinopropiophenone (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 3/21/2014 Cayman Chemical Company 4'-Methyl-a-pyrrolidinopropiophenone (hydrochloride) CRM; 100 ~g/mL in Methanol Glass ampule: 2 mL 3/21/2014 Cayman Chemical Company 5-:fluoro PB-22 (exempt preparation); 1 mg in 1 mLMethanol Glass vial: 1 mL 3/17/2014 Cayman Chetnical Company 5-:fluoro PB-22 (exempt preparation); 100 100 ~tL Methanol ~gin Glass vial: 100 ~ 3/17/2014 Cayman Chemical Company 5-:fluoro PB-22 (exempt preparation); 500 500 ~L Methanol ~gin Glass vial: 500 Cayman Chemical Company 5-:fluoro PB-22 CRM; 100 Cayman Chemical Company in 0.1 mL Methanol ~L 3/17/2014 5-hydroxy DMT CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 5-hydrox')' DMT CRM; 1mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 5-hydroxy DMT CRM; 100 Glass ampule: 1 mL 1/27/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00035 in Acetonitrile ~g/mL Fmt 4701 in Methanol Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.210</GPH> 3/21/2014 Cayman Chetnical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Glass ampule: 2 mL ~g/mL 16926 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 1/27/2014 5-hydrox'Y DMT; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 5-hydroxy DMT; 100 11g in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 5-hydrox)' DMT; 500 Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 5-MethOXJ' DIPT CRM; 1mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 5-Methoxy DIPT CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 5-MetllOXJ' DIPT CRM; 100 Jlg/mL inMetl1anol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company 5-Methoxy DIPT CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company 5-Methoxy DiPT; 1 mg in 1 mL Met11anol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 5-Metlloxy DiPT; 100 in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 5-Methox'Y DiPT; 500 Jlg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 5-Methox)'-DMT CRM; 1mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company 5-Methoxy-DMT CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 5-Methoxy-DMT CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company 5-Methoxy-DMT CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company 5-Methox)'-DMT; lmg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~tg ~tg Frm 00036 in 0.5 mL Methanol Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.211</GPH> 5-hydrox'Y DMT CRM; 100 Jlg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16927 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices 5-Methoxy-DMT; 100 118 in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 5-Methoxy-DMT; 500 118 in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company AB-FUBINACA (exempt preparation); 1 m8 in l mL Methanol Glass vial: 1 mL 3/17/2014 Cayman Chemical Company AB-FUBINACA (exempt preparation); 100 in 100 ~IL Methanol Cayman Chemical Company AB-FUBINACA (exempt preparation); 500 118 in 500 ~ Methanol Glass vial: 500 IlL 3/17/2014 Cayman Chemical Company AB-FUBINACA CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 4/30/2015 Cayman Chemical Company AB-FUBINACA CRM; 100 !18/mL in Methanol Glass ampule: 1 mL 3/21/2014 Cayman Chemical Company AB-FUBINACA CRM; 100 118/mL in Methanol Glass ampule: 2 mL 3/21/2014 Cayman Chemical Company ADB-PINACA (exempt preparation); 1 m8 in 1 mL Methanol Glass vial: 1 mL 3/17/2014 Cayman Chemical Company ADB-PINACA (exempt preparation); 100 118 in 100 11L Methanol Glass vial: 100 Cayman Chemical Company ADB-PINACA (exempt preparation); 500 118 in 500 11L Methanol Glass vial: 500 Cayman Chemical Company ADB-PINACA CRM; 1 m8/mL in Methanol Glass ampule: 1 mL 4/30/2015 Cayman Chemical Company ADB-PINACA CRM; 100 118/mL in Methanol Glass ampule: 1 mL 3/21/2014 Cayman Chemical Company ADB-PINACA CRM; 100 Glass ampule: 2 mL 3/21/2014 Cayman Chemical Company AKB48 (exempt preparation); 1 m8 in 1 mL Methanol Glass vial: 1 mL 3/17/2014 Cayman Chemical Company AKB48 (exempt preparation); 100 118 in 100 Methanol VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00037 ~lg/mL Fmt 4701 ~L8 ~LL in Methanol Sfmt 4725 Glass vial: 100 ~ IlL ~IL Glass vial: 100 ~LL E:\FR\FM\25MRN2.SGM 25MRN2 3/17/2014 3/17/2014 3/17/2014 3/17/2014 EN25MR16.212</GPH> ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16928 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices AKB48 (exempt preparation); 500 Methanol Cayman Chemical Company AKB48 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL l/27/2014 Cayman Chemical Company AKB48 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company AKB48 CRM; 100 ~g/mL in Methanol Glass ampule: 1 mL l/27/2014 Cayman Chemical Company AKB48 CRM; 100 ~g/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Alprazolam CRM; 100 ~g/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Alprazolam CRM; 100 ~g/n1L in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Alprazolam-d5 (exempt preparation); 100 1 mL Methanol Glass vial: 1 n1L 9/22/2014 Cayman Chemical Company Alprazolam-d5 CRM; 100 gg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Alprazolam-d5 CRM; 100 Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company AM220 1 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL l/27/2014 Cayman Chemical Company AM220 1 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL l/27/2014 Cayman Chemical Company AM2201 CRM; 100 in Methanol Glass ampule: 1 n1L 1/27/2014 Cayman Chemical Company AM220 1 CRM; 100 gg/mL in Methanol Glass ampule: 2 n1L 1/27/2014 Cayman Chemical Company AM220 1; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company AM2201; 100 ~gin Glass vial: 3 mL 12/20/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~Lg/mL ~tg/mL ~gin 500 Fmt 4701 Glass vial: 500 ~L ~gin in Methanol 0.1 mL Methanol Frm 00038 ~L Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 3/17/2014 EN25MR16.213</GPH> ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16929 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 3 mL 12/20/2013 AM694 CRM; lmg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company AM694 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company AM694 CRM; 100 in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company AM694 CRM; 100 J.lg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company AM694; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company AM694; 100 J.lgin0.1 mLMethanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company AM694; 500 J.lg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Aminorex CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Aminorex CRM; 1 mg/mL in Acetonitrile Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Amino rex CRM; 100 J.lg/mL in Acetonitrile Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Aminorex CRM; 100 J.lg/mL in Acetonitrile Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Aminorex; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Aminorex; 100 J.lg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Aminorex; 500 J.lg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Amphetamine-d5 (HCl)(exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~tg/mL Frm 00039 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.214</GPH> AM2201; 500 J.lg in 0.5 mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16930 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 1 mL 9/22/2014 Amphetamine-d5 (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Amphetamine-d5 (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Amphetamine-d5 (hydrochloride) CRM; 100 gg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Amphetamine-d5 (hydrochloride) CRM; 100 gg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Androstenedione CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 6/13/2014 Cayman Chemical Company Androstenedione CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 6/13/2014 Cayman Chemical Company Androstenedione CRM; 100 ug/mL in Methanol Glass ampule: 1 mL 6/13/2014 Cayman Chemical Company Androstenedione CRM; 100 ug/mL in Methanol Glass ampule: 1 mL 6/13/2014 Cayman Chemical Company Benzoylecgonine CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Benzoylecgonine CRM; lmg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Benzoylecgonine CRM; 100 gg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Benzoylecgonine CRM; 100 gg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Benzoylecgonine-d3 CRM; 1mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Benzoylecgonine-d3 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Benzoylecgonine-d3 CRM; 100 Methanol Glass ampule: 2 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00040 Fmt 4701 ~tg/mL in Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.215</GPH> Amphetamine-d5 (HCl)(exempt preparation); 100 gg in 1 mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16931 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Benzoylecgonine-d3 CRM; 100 flg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Buprenorphine (hydrochloride) CRM; 1mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Caytmn Chemical Company Buprenorphine (hydrochloride) CRM; 100 flg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Buprenorphine (hydrochloride) CRM; 100 ~tg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Caytmn Chemical Company Buprenorphine-d4 (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Buprenorphine-d4 (exempt preparation); 100 in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Buprenorphine-d4 (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9119/2014 Cayman Chemical Company Buprenorphine-d4 (hydrochloride) CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Buprenorphine-d4 (hydrochloride) CRM; 100 flg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Butylone (exempt preparation); 1 mg in 1 mL Glass vial: 1 mL 3/17/2014 Caytmn Chemical Company Butylone (exempt preparation); 100 flg in 100 f.1L Methanol Glass vial: 100 Cayman Chemical Company Butylone (exempt preparation); 500 flL Methanol Cayman Chemical Company Butylone (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 3/21/2014 Cayman Chemical Company Butylone (hydrochloride) CRM; 100 flg/mL in Methanol Glass ampule: 2 mL 3/21/2014 Cayman Chemical Company BZP (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company BZP (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00041 Fmt 4701 ~tg ~tg in 500 Sfmt 4725 ~LL Glass vial: 500 J.1L E:\FR\FM\25MRN2.SGM 25MRN2 3/17/2014 3/17/2014 EN25MR16.216</GPH> ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16932 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices ~tg/mL in Glass ampule: 1 mL 1/27/2014 BZP (hydrochloride) CRM; 100 Methanol ~g/mL in Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company BZP (hydrochloride); 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company BZP (hydrochloride); 100 Methanol ~gin 0.1 mL Glass vial: 3 mL 12/20/2013 Cayman Chemical Company BZP (hydrochloride); 500 Methanol ~gin 0.5 mL Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Cmmabichromene CRM; 1 mg/mL Methanol Glass ampule: 1 mL 5/2/2014 Cayman Chemical CompatJY Cmmabichromene CRM; 1 mg/mL Methm10l Glass ampule: 2 mL 5/2/2014 Cayman Chemical Company Catlllabichromene CRM; 100 ~g/mL Methanol Glass ampule: 2 mL 5/2/2014 Cayman Chemical Company Cmmabichromene CRM; 100 ~g/mL Methanol Glass ampule: 1 mL 5/2/2014 Cayman Chemical Company Cmmabidiol CRM; 1 mg/mL in Methm10l Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Catlllabidiol CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Cmmabidiol CRM; 100 ~g/mL in Methm1ol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company Cmmabidiol CRM; 100 ~g/mL in Methm10l Glass ampule: 2 mL 1/27/2014 Cayman Chemical Compm1y Camlabidiol-d9 (exempt preparation); 1 mg in 1 mLMethanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Cmmabidiol-d9 (exempt preparation); 100 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Cmmabidiol-d9 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00042 Fmt 4701 Sfmt 4725 ~gin E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.217</GPH> BZP (hydrochloride) CRM; 100 Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16933 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 9/19/2014 Cmmabidiol-d9 CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cay mail Chemical Company Cannabidiol-d9 CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Caytll311 Chemical Company Cmmabidiolic acid CRM; 1 mg/mL in Acetonitrile Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Cannabidiolic acid CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Cannabidiolic acid CRM; 100 11g/mL in Acetonitrile Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Cmmabidiolic acid CRM; 100 Jlg/mL in Acetonitrile Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Cannabidiolic acid; lmg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chetnical Compm1y Cannabidiolic acid; 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Cmmabidiolic acid; 500 Glass vial: 3 mL 12/20/2013 Cayman Chetnical Compm1y Cannabidiolic acid-d3 (exempt preparation); 1 mg in 1 mL Acetonitrile Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Cannabidiolic acid-d3 (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Cannabidiolic acid-d3 (exempt preparation); 100 11g in 1 mL Acetonitrile Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Cannabidiolic acid-d3 (exempt preparation); 100 Jlg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cay mail Chetnical Company Cannabidiolic acid-d3 CRM; 1 mg/mL in Acetonitrile Glass ampule: 2 mL 9/19/2014 Cayman Chemical Compmw Cmmabidiolic acid-d3 CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00043 ~tg in 0.5 mL Methanol Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.218</GPH> Cannabidiol-d9 CRM; 1 mg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16934 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 1 mL 9/19/2014 Cannabidiolic acid-d3 CRM; 1 mg/rnL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Cannabidiolic acid-d3 CRM; 100 Jlg/rnL in Acetonitrile Glass ampule: 1 rnL 9/19/2014 Cayman Chemical Company Cannabidiolic acid-d3 CRM; 100 Jlg/mL in Acetonitrile Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Cannabidiolic acid-d3 CRM; 100 Jlg/rnL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chetnical Company Cannabidiolic acid-d3 CRM; 100 Jlg/rnL in Methanol Glass ampule: 2 rnL 9/19/2014 Cayman Chemical Company Cannabidiolic acid-d9 (exempt preparation); 1 mg in 1 mL Acetonitrile Glass vial: 1 rnL 9/22/2014 Cayman Chemical Company Cannabidiolic acid-d9 (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 rnL 9/22/2014 Cayman Chemical Company Cannabidiolic acid-d9 (exempt preparation); 100 Jlg in 1 rnL Acetonitrile Glass vial: 1 rnL 9/22/2014 Cayman Chemical Company Cmmabidiolic acid-d9 (exempt preparation); 100 Jlg in 1 rnL Methanol Glass vial: 1 rnL 9/22/2014 Cayman Chetnical Company Cannabidiolic acid-d9 CRM; 1 mg/mL in Acetonitrile Glass ampule: 2 rnL 9/19/2014 Cayman Chemical Company Cam1abidiolic acid-d9 CRM; l mg/mL in Acetonitrile Glass ampule: 1 rnL 9/19/2014 Cayman Chemical Company Cannabidiolic acid-d9 CRM; 1 mg/rnL in Methanol Glass ampule: 2 mL 9/19/2014 Cayn1an Chemical Company Cannabidiolic acid-d9 CRM; 1 mg/rnL in Methanol Glass ampule: 1 rnL 9/19/2014 Cayn1an Chemical Company Cannabidiolic acid-d9 CRM; 100 Jlg/mL in Acetonitrile Glass ampule: 1 rnL 9/19/2014 Cayman Chemical Company Cmmabidiolic acid-d9 CRM; 100 Jlg/rnL in Acetonitrile Glass ampule: 2 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00044 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.219</GPH> Cannabidiolic acid-d3 CRM; 1 mg/rnL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16935 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 1 mL 9/19/2014 Cannabidiolic acid-d9 CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Cannabigerol CRM; 1 mg/mL Methanol Glass ampule: 1 mL 5/2/2014 Cayman Chemical Company Cmmabigerol CRM; 1 mg/mL Methanol Glass ampule: 2 mL 5/2/2014 Cayman Chemical Company Cannabigerol CRM; 100 Jlg/mL Methanol Glass ampule: 1 mL 5/2/2014 Cayman Chemical Company Cannabigerol CRM; 100 Glass ampule: 2 mL 5/2/2014 Cayman Chemical Compm1y Cmmabigerol-d9 (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Cannabigerol-d9 (exempt preparation); 100 Jlg in 1 mL Methm10l Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Cannabigerol-d9 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Cannabigerol-d9 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Cannabigerol-d9 CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Camtabigerol-d9 CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Cam1abinol CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company Cmmabinol CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Camtabinol CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company Cannabinol CRM; 100 Glass ampule: 2 mL l/27/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~tg/mL ~tg/mL Frm 00045 Methm10l in Methanol Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.220</GPH> Cannabidiolic acid-d9 CRM; 100 Jlg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16936 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 3 mL 12/20/2013 Cammbinol; 100 11g in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Cannabinol; 500 11g in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Cannabinol-d3 (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Compm1y Cmmabinol-d3 (exempt preparation); 100 1 mL Methm1ol Glass vial: 1 mL 9/22/2014 Caynmn Chemical Company Cmmabinol-d3 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Cmmabinol-d3 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Cmmabinol-d3 CRM; 100 Jtg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Cmmabinol-d3 CRM; 100 11g/mL in Metlmnol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Compm1y Cmmabinol-d9 (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Cannabinol-d9 (exempt preparation); 100 11g in 1 mL Metl1ano1 Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Cammbinol-d9 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Compm1y Cmmabinol-d9 CRM; 1 mg/mL in Methm10l Glass ampule: 2 mL 9/19/2014 Caynmn Chemical Company Cannabinol-d9 CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical CompmlY Cmmabinol-d9 CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Carisoprodol CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00046 Fmt 4701 Sfmt 4725 ~tg in E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.221</GPH> Cannabinol; 1 mg in 1mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16937 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: I mL 9/19/2014 Carisoprodol CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Carisoprodol CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Carisoprodol-d7 (exempt preparation); 1mg in 1 mLMethanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Carisoprodol-d7 (exempt preparation); 100 11g in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Carisoprodol-d7 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Carisoprodo1-d7 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Carisoprodol-d7 CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Carisoprodol-d7 CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company cis-Tramadol (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company cis-Tramadol (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company cis-Tramadol (hydrochloride) CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company cis-Tran1adol (hydrochloride) CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company cis-Tramadol-d6 (HCI) (exempt preparation); I mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company cis-Tramadol-d6 (HCI) (exempt preparation); 100 11g in1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company cis-Tramadol-d6 (hydrochloride) CRM; I mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00047 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.222</GPH> Carisoprodol CRM; 1 mg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16938 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 9/19/2014 cis-Tramadol-d6 (hydrochloride) CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company cis-Tramadol-d6 (hydrochloride) CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Clonazepam CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Clonazepam-d4 (exempt preparation); 100 Jlg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Clonazepam-d4 CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Codeine CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company Codeine CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Codeine CRM; 100 in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Codeine CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Codeine; 1mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Codeine; 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Codeine; 500 Jlg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Codeine-d3 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 8/7/2015 Cayman Chemical Company Codeine-d6 (exempt preparation); 1 mg in1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Codeine-d6 (exempt preparation); 100 Jlg in 1 mLMethanol Glass vial: 1mL 9/22/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~tg/mL Frm 00048 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.223</GPH> cis-Tramadol-d6 (hydrochloride) CRM; 1 mg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16939 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 9/19/2014 Codeine-d6 CRM; l mg/rnL in Methanol Glass ampule: 1 rnL 9/19/2014 Cayman Chemical Company Codeine-d6 CRM; 100 11g/mL in Methanol Glass ampule: 2 rnL 9/19/2014 Cayman Chemical Company Codeine-d6 CRM; 100 Glass ampule: 1 rnL 9/19/2014 Cayman Chemical Company D-Amphetamine (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 rnL 1127/2014 Cayman Chemical Company D-Amphetamine (hydrochloride) CRM; 1 mg/rnL in Methanol Glass ampule: 2 rnL 1127/2014 Cayman Chemical Company D-Amphetamine (hydrochloride) CRM; 100 11g/mL in Methanol Glass ampule: 1 rnL 1127/2014 Cayman Chemical Company D-Amphetamine (hydrochloride) CRM; 100 11g/rnL in Methanol Glass ampule: 2 rnL 1127/2014 Cayman Chemical Company D-Amphetamine (hydrochloride); 1 mg in 1 mL Methanol Glass vial: 3 rnL 12/20/2013 Cayman Chemical Company D-Amphetamine (hydrochloride); 100 11g in 0.1 rnL Methanol Glass vial: 3 rnL 12/20/2013 Cayman Chemical Company D-Amphetamine (hydrochloride); 500 11g in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Desomorphine CRM; 1 mg/rnL in Acetonitrile Glass ampule: 1 mL 1127/2014 Cayllk'ln Chemical Company Desomorphine CRM; 1 mg/rnL in Acetonitrile Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Desomorphine CRM; 100 11g/mL in Acetonitrile Glass ampule: 1 rnL 1/27/2014 Cayman Chemical Company Desomorphine CRM; 100 Glass ampule: 2 rnL 1/27/2014 Cayman Chemical Company Desomorphine; 1 mg in 1 mL Methanol Glass vial: 3 rnL 12/20/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~lg/mL Frm 00049 in Methanol ~lg/rnL Fmt 4701 in Acetonitrile Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.224</GPH> Codeine-d6 CRM; 1 mg/rnL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16940 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 3 mL 12/20/2013 Desomorphine; 500 11g in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Diazepam CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Diazepam CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Diazepam CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Diazepam-d3 (exempt preparation); 1 mg in 1 mLMethanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Diazepam-d3 (exempt preparation); 100 Jlg in 1 mLMethanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Diazepam-d3 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Diazepam-d3 CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Diazepam-d3 CRM; 100 Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Diethyltryptamine CRM; 1mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Diethyltryptamine CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Diethyltryptamine CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Diethyltryptamine CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Diethyltryptamine; 1 mg inl mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Diethyltryptamine; 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00050 ~tg/mL Fmt 4701 in Methanol Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.225</GPH> Desomorphine; 100 11g in 0.1 mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16941 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Cayman Chemical Company Diethyltryptamine; 500 Cayman Chemical Company ~gin Dihydrocodeine (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Dihydrocodeine (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company Dihydrocodeine (hydrochloride) CRM; 100 ~tg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company Dihydrocodeine (hydrochloride) CRM; 100 ~g/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Dihydrocodeine (hydrochloride); 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Dihydrocodeine (hydrochloride); 100 mLMethanol ~g Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Dihydrocodeine (hydrochloride); 500 mLMethanol ~gin Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Dihydrocodeine-d6 (HCl) (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Dihydrocodeine-d6 (HCl) (exempt preparation); 100 ~g inl mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Dihydrocodeine-d6 (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Dihydrocodeine-d6 (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayll1::'ln Chemical Company Dihydrocodeine-d6 (hydrochloride) CRM; 100 ~g/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Dihydrocodeine-d6 (hydrochloride) CRM; 100 ~tg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Dihydrocodeine-d6 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Dihydrocodeine-d6 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00051 Fmt 4701 Sfmt 4725 in 0.1 0.5 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.226</GPH> 12/20/2013 Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Glass vial: 3 mL VerDate Sep<11>2014 0.5 mL Methanol 16942 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices ~g/mL in Glass ampule: 2 mL 9/19/2014 Dihydrocodeine-d6 CRM; 100 Methanol ~g/mL in Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Dihydromorphine CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company Dihydromorphine CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company Dihydromorphine CRM; 100 Methanol ~g/mL in Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Dihydromorphine CRM; 100 Methanol ~g/mL in Glass ampule: 2 mL 1127/2014 Cayman Chemical Company Dihydromorphine; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Dihydromorphine; 100 ~gin 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Dihydromorphine; 500 ~gin 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Dihydrotestosterone CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 6/13/2014 Cayman Chemical Company Dihydrotestosterone CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 6/13/2014 Cayman Chemical Company Dihydrotestosterone CRM; 100 ug/mL in Methanol Glass ampule: 1 mL 6/13/2014 Cayman Chemical Company Dihydrotestosterone CRM; 100 ug/mL in Methanol Glass ampule: 1 mL 6/13/2014 Cayman Chemical Company DL-Amphetamine (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company DL-Amphetamine (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company DL-Amphetan1ine (hydrochloride) CRM; 100 ~g/mL in Methanol Glass ampule: 1 mL 1/27/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00052 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.227</GPH> Dihydrocodeine-d6 CRM; 100 Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16943 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 1/27/2014 DL-Amphetamine (hydrochloride); 1 mg in 1 mLMethanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company DL-Amphetamine (hydrochloride); 100 0.1 mL Methanol ~gin Glass vial: 3 mL 12/20/2013 Cayman Chemical Company DL-Amphetamine (hydrochloride); 500 0.5 mL Methanol ~gin Glass vial: 3 mL 12/20/2013 Cayman Chemical Company DL-Cathinone (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company DL-Cathinone (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company DL-Cathinone (hydrochloride) CRM; 100 ~g/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company DL-Cathinone (hydrochloride) CRM; 100 ~g/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company DL-Cathinone (hydrochloride); 1 mg in1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company DL-Cathinone (hydrochloride); 100 mL Methanol ~tg Glass vial: 3 mL 12/20/2013 Cayman Chemical Company DL-Cathinone (hydrochloride); 500 mLMethanol ~gin 0.5 Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Fentanyl (hydrochloride) CRM; 100 Methanol ~g/mL Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Fentanyl-d3 (hydrochloride) CRM; 100 in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Flunitrazepam CRM; 100 ~g/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Flunitrazepam CRM; 100 ~g/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Flmntrazepam-d3 (exempt preparation); 100 in 1 mL Methanol Glass vial: 1 mL 9/22/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00053 Fmt 4701 in 0.1 in ~g/mL Sfmt 4725 ~g E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.228</GPH> DL-Amphetamine (hydrochloride) CRM; 100 ~tg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16944 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 1 mL 9/19/2014 Flunitrazepam-d3 CRM; 100 f..lg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayll1::'ln Chemical Company Flurazepam CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Flurazepam CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Flurazepam CRM; 100 f..lg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Flurazepam CRM; 100 f..lg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Flurazepam-d10 (exempt preparation); lmg in l mLMethanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Flurazepam-dlO (exempt preparation); 100 f..lg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Flurazepam-d10 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Flurazepam-dlO CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chetnical Company Flurazepam-dlO CRM; 100 f..lg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Flurazepam-d10 CRM; 100 f..lg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Heroin CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Heroin CRM; I mg/mL in Acetonitrile Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Heroin CRM; 100 f..lg/mL in Acetonitrile Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Heroin CRM; 100 f..lg/mL in Acetonitrile Glass ampule: 2 mL 1/27/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00054 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.229</GPH> Flunitrazepam-d3 CRM; 100 f..lg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16945 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Cayman Chemical Company Heroin; 1 mg in 1 mL Methanol Cayman Chemical Company Heroin; 100 ~gin Cayman Chemical Company Heroin; 500 ~gin Cayman Chemical Company Heroin-d3 (exempt preparation); 1 mg in 1 mL Acetonitrile Cayman Chemical Company Heroin-d3 (exempt preparation); 100 Acetonitrile Cayman Chemical Company 0.1 mL Methanol Glass via1: 3 mL 12/20/2013 0.5 mL Methanol Glass via1: 3 mL 12/20/2013 Glass via1: 1 mL 9/22/2014 Glass vial: 1 mL 9/22/2014 Heroin-d3 CRM; 1 mg/mL in Acetonitrile Glass ampule: 2 mL 9/19/2014 Heroin-d3 CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Heroin-d3 CRM; 100 ~g/mL in Acetonitrile Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Heroin-d3 CRM; 100 ~g/mL in Acetonitrile Glass ampule: 1 mL 9/19/2014 Cayman Chetnical Company HU-210 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company HU-210 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company HU-210 CRM; 100 ~g/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company HU-210 CRM; 100 ~g/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Hydrocodone CRM; 1mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chetnical Company Hydrocodone CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemica1 Company Hydrocodone CRM; 100 Glass ampule: 2 mL 1/27/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00055 ~Lg/mL Fmt 4701 ~gin 1 mL in Methanol Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.230</GPH> 12/20/2013 Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Glass via1: 3 mL 16946 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 1 mL 1/27/2014 Hydrocodone; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Hydrocodone; 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Hydrocodone; 500 Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Hydrocodone-d6 (exempt preparation); 1 mg in l mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Hydrocodone-d6 (exempt preparation); 100 in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Hydrocodone-d6 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Hydrocodone-d6 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Hydrocodone-d6 CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Hydrocodone-d6 CRM; 100 Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Hydromorphone CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Hydromorphone CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Hydromorphone CRM; 100 ~tg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Hydromorphone CRM; 100 ~tglmL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company Hydromorphone; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Hydromorphone; 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~tg in 0.5 mL Methanol Frm 00056 ~tg/mL Fmt 4701 ~tg in Methanol Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.231</GPH> Hydrocodone CRM; 100 11g/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16947 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Cayman Chemical Company Hydromorphone; 500 Cayman Chemical Company ~gin Hydromorphone-d3 (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Hydromorphone-d3 (exempt preparation); 100 ~g in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Hydromorphone-d3 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Hydromorphone-d3 CRM; 100 Methanol ~g/mL in Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Hydromorphone-d3 CRM; 100 Methanol ~g/mL in Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company JWH 018 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company JWH 018 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company JWH 018 CRM; 100 ~g/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company JWH 018 CRM; 100 ~Lg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company JWH 019 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company JWH 019 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company JWH 019 CRM; 100 ~g/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company JWH 019 CRM; 100 ~g/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company JWH 019; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company JWH 019; 100 Glass vial: 3 mL 12/20/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 in 0.1 mL Methanol Frm 00057 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.232</GPH> 12/20/2013 Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Glass vial: 3 mL ~Lg 0.5 mL Methanol 16948 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 3 mL 12/20/2013 JWH 073 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company JWH 073 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company JWH 073 CRM; 100 in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company JWH 073 CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company JWH 081 CRM; 1mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company JWH 081 CRM; 1mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company JWH 081 CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company JWH 081 CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company JWH 081; 1mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company JWH 081; 100 11g in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company JWH 081; 500 11g in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company JWH 122 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company JWH 122 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company JWH 122 CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company J\VH 122 CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 1127/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~Lg/mL Frm 00058 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.233</GPH> JWH 019; 500 11g in 0.5 mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16949 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 3 mL 12/20/2013 JWH 122; 100 11gin0.1 mLMethanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company JWH 122; 500 11g in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company JWH 200 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company JWH 200 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company JWH 200 CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company JWH 200 CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company JWH 203 CRM; lmg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company JWH 203 CRM; lmg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company JWH 203 CRM; 100 in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company JWH 203 CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company JWH 203; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company JWH 203; 100 11g in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company JWH 203; 500 11g in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company JWH 250 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company JWH 250 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~Lg/mL Frm 00059 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.234</GPH> JWH 122; 1 mg in 1 mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16950 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 1 mL 1/27/2014 JWH 250 CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company JWH 250; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company JWH 250; 100 in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company JWH 250; 500 !lg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company JWH 398 CRM; lmg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company JWH 398 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company JWH 398 CRM; 100 !lg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company JWH 398 CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company JWH 398; 1 mg in 1mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company JWH 398; 100 !lg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company JWH 398; 500 !lg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company L-Amphetamine (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company L-Amphetamine (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company L-Amphetamine (hydrochloride) CRM; 100 ~tg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company L-Amphetamine (hydrochloride) CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 1/27/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~tg Frm 00060 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.235</GPH> JWH 250 CRM; 100 11g/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16951 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 3 mL 12/20/2013 L-Amphetamine (hydrochloride); 100 118 in 0.1 mLMethanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company L-Amphetamine (hydrochloride); 500 mLMethanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Levomethorphan CRM; 1 m8/mL in Acetonitrile Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Levomethorphan CRM; 1 m8/mL in Acetonitrile Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Levomethorphan CRM; 100 118/mL in Acetonitrile Glass ampule: 1 mL 1127/2014 Cayman Chemical Company Levomethorphan CRM; 100 Acetonitrile Glass ampule: 2 mL 1127/2014 Cayman Chemical Company Levomethorphan; 1 m8 in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Levomethorphan; 100 118 in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Levomethorphan; 500 Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Lisdexamfetmnine (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company Lisdexamfetamine (hydrochloride) CRM; 1 ll18/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Lisdexamfetamine (hydrochloride) CRM; 100 118/mL in Methm1ol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Lisdexamfetamine (hydrochloride) CRM; 100 118/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Lisdexmnfetmnine (hydrochloride); 1 m8 in 1 mLMethanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Compm1y Lisdexanlfetamine (hydrochloride); 100 118 in 0.1 mL Methm1ol Glass vial: 3 mL 12/20/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~t8 Frm 00061 ~tg/mL ~t8 in 0.5 in in 0.5 mL Methanol Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.236</GPH> L-Amphetamine (hydrochloride); 1 m8 in 1 mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16952 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 3 mL 12/20/2013 Lorazepam CRM; 100 gg/mL in Acetonitrile Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Lorazepam CRM; 100 gg/mL in Acetonitrile Glass ampule: 2 mL 9/19/2014 Cayman Chetnical Company Lorazepam-d4 (exempt preparation); 100 gg in 1 mL Acetonitrile Glass vial: 1 mL 9/22/2014 Cayman Che1nical Company Lorazepam-d4 (exempt preparation); 100 gg in 1 mLMethanol Glass vial: 1 mL 9/22/2014 Cayman Chetnical Company Lorazepam-d4 CRM; 100 gg/mL in Acetonitrile Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Lorazepani-d4 CRM; 100 gg/mL in Acetonitrile Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company MDA (hydrochloride) CRM; 1mg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company MDA (hydrochloride) CRM; 1mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company MDA (hydrochloride) CRM; 100 gg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company MDA (hydrochloride) CRM; 100 gg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company MDA (hydrochloride); 1mg inl mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chetnical Company MD A (hydrochloride); 100 gg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company MDA (hydrochloride); 500 gg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company MDA-d3 (hydrochloride) CRM; lmg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company MDA-d3 (hydrochloride) CRM; lmg/mL in Methanol Glass ampule: 2 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00062 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.237</GPH> Lisdexamfetamine (hydrochloride); 500 gg in 0.5 mL Methanol Cayll1::'1n Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16953 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices ~g/mL in Glass ampule: 1 mL 9/19/2014 MDA-d3 (hydrochloride) CRM; 100 Methanol ~g/mL in Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Meperidine CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayll1:'Ul Chemical Company Meperidine CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Meperidine CRM; 100 gg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Meperidine CRM; 100 Glass ampule: 1 mL 1/27/2014 Cayll1:'ln Chemical Company Meperidine; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Meperidine; 100 gg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Meperidine; 500 gg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Meperidine-d4 (exempt preparation); 1 mg in 1 mLMethanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Meperidine-d4 (exempt preparation); 100 gg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Meperidine-d4 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Meperidine-d4 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Meperidine-d4 CRM; 100 gg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Meperidine-d4 CRM; 100 Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Mephedrone (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~g/mL Frm 00063 in Methanol ~Lg/mL Fmt 4701 in Methanol Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.238</GPH> MDA-d3 (hydrochloride) CRM; 100 Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16954 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 1 mL 1/27/2014 Mephedrone (hydrochloride) CRM; 100 J.tg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Mephedrone (hydrochloride) CRM; 100 J.tg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Mephedrone (hydrochloride); 1 mg in lmL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Mephedrone (hydrochloride); 100 J.tg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Mephedrone (hydrochloride); 500 Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Meprobanmte CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Meprobamate CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Meprobamate CRM; 100 J.tg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Meprobamate CRM; 100 J.tg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Meprobamate-d7 (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Meprobamate-d7 (exempt preparation); 100 in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Meprobamate-d7 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Meprobamate-d7 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Meprobamate-d7 CRM; 100 J.tg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Meprobamate-d7 CRM; 100 J.tg/mL in Methanol Glass ampule: 1 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00064 Fmt 4701 ~tg in 0.5 mL Sfmt 4725 ~tg E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.239</GPH> Mephedrone (hydrochloride) CRM; 1 mg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16955 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 1/27/2014 Mescaline (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Mescaline (hydrochloride) CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company Mescaline (hydrochloride) CRM; 100 Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Mescaline (hydrochloride); 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Mescaline (hydrochloride); 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Mescaline (hydrochloride); 500 11g in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Methadone-d3 (exempt preparation); 1mg in 1 mLMethanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Methadone-d3 (exempt preparation); 100 Jlg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Methylenedioxy Pyrovalerone (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Me thy lenedioxy Pyrovalerone (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Methylenedioxy Pyrovalerone (hydrochloride) CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company Methy lenedioxy Pyrovalerone (hydrochloride) CRM; 100 ~Lg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Methylenedioxy Pyrovalerone (hydrochloride); 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Me thy lenediO}.'Y Pyrovalerone (hydrochloride); 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Me thy lenedioxy Pyrovalerone (hydrochloride); 500 ~~gin 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00065 Fmt 4701 ~Lg/mL Sfmt 4725 in E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.240</GPH> Mescaline (hydrochloride) CRM; 1 mg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16956 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 1 mL 1/27/2014 Methylone (hydrochloride) CRM; 1 mg/mL in 10%H20/ACN Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Methylone (hydrochloride) CRM; 100 Jlg/mL in l0%H20/ACN Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Methylone (hydrochloride) CRM; 100 10%H20/ACN Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Methylone (hydrochloride); 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Methylone (hydrochloride); 100 Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Methylone (hydrochloride); 500 Jlg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Midazolam CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Midazolam CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Midazolam CRM; 100 in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Midazolam CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Midazolam-d5 (exempt preparation); 1 mg in 1 mLMethanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Midazolam-d5 (exempt preparation); 100 Jlg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Midazolam-d5 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Midazolam-d5 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Midazolam-d5 CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~tg/mL Frm 00066 Fmt 4701 ~tg ~tg/mL in in 0.1 mL Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.241</GPH> Methylone (hydrochloride) CRM; 1 mg/mL in 10%H20/ACN Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16957 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Cayman Chemical Company Midazolam-d5 CRM; 100 Cayman Chemical Company MMDA (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 MMDA (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company MMDA (hydrochloride) CRM; 100 Methanol ~tglmL in Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company MMDA (hydrochloride) CRM; 100 Methanol ~g/mL in Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company MMDA (hydrochloride); 1 mgin 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company MMDA (hydrochloride); 100 ~g in0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company MMDA (hydrochloride); 500 Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Morphine CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Morphine CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company Morphine CRM; 100 ~g/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Morphine CRM; 100 ~g/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Morphine; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Morphine; 100 ~gin 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Morphine; 500 ~gin 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Morphine-d3 (exempt preparation); 1 mg in 1 mLMethanol Glass vial: 1 mL 9/22/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00067 in Methanol ~gin 0.5 Fmt 4701 mL Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.242</GPH> 9/19/2014 Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Glass ampule: 2 mL ~tg!mL 16958 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 1 mL 9/22/2014 Morphine-d3 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Morphine-d3 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Morphine-d3 CRM; 100 gg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Morphine-d3 CRM; 100 gg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Morphine-N-oxide CRM; 1mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Morphine-N-oxide CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Morphine-N-oxide CRM; 100 gg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Morphine-N-oxide CRM; 100 Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Morphine-N-oxide; 1 mg in 1mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Morphine-N-oxide; 100 gg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Morphine-N-oxide; 500 gg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company N,N-Dimethyltcyptamine CRM; 1mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company N,N-Dimethyltcyptamine CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company N,N-Dimethyltcyptamine CRM; 100 Methanol in Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company N,N-Dimethyltcyptamine CRM; 100 gg/mL in Methanol Glass ampule: 1 mL 1/27/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00068 ~tg/mL Fmt 4701 in ~tg/mL Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.243</GPH> Morphine-d3 (exempt preparation); 100 gg in 1 mLMethanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16959 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 3 mL 12/20/2013 N,N-Dimethyltryptamine; 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company N,N-Dimethyltryptamine; 500 Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company N,N-DMA (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company N,N-DMA (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company N,N-DMA (hydrochloride) CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company N,N-DMA (hydrochloride) CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company N,N-DMA (hydrochloride); 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company N,N-DMA (hydrochloride); 100 Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company N,N-DMA (hydrochloride); 500 Jlg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Naphyrone (exempt preparation); 1 mg in 1 mL Glass vial: 1 mL 3/17/2014 Cayman Chemical Company Naphyrone (exempt preparation); 100 Jlg in100 JlL Methanol Glass vial: 100 JlL 3/17/2014 Cayman Chemical Company Naphyrone (exempt preparation); 500 JlL Methanol Glass vial: 500 JlL 3/17/2014 Cayman Chemical Company Naphyrone (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 3/21/2014 Cayman Chemical Company Naphyrone (hydrochloride) CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 3/21/2014 Cayman Chemical Company N-Ethylamphetamine (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00069 ~Lg Fmt 4701 in 0.5 mL ~Lg in 0.1 mL ~Lg Sfmt 4725 in500 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.244</GPH> N,N-Dimethyltryptamine; 1 mg in 1 mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16960 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 1/27/2014 N-Ethylamphetamine (hydrochloride) CRM; 100 ~tg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company N-Ethylamphetamine (hydrochloride) CRM; 100 ~g/mL in Methanol Glass ampule: 2 mL l/27/2014 Cayiik'ln Chemical Company N-Ethylamphetamine (hydrochloride); 1mg in 1 mLMethanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company N-Ethylamphetamine (hydrochloride); 100 0.1 mL Methanol ~gin Glass vial: 3 mL 12/20/2013 Cayman Chemical Company N-Ethylamphetamine (hydrochloride); 500 0.5 mL Methanol ~gin Glass vial: 3 mL 12/20/2013 Cayman Chemical Company N-hydroxy l'viDA (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company N-hydrox}' l'viDA (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company N-hydro:x.'Y l'viDA (hydrochloride) CRM; 100 ~g/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company N-hydroxy l'viDA (hydrochloride) CRM; 100 ~tg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company N-Hydrox]'-l'viDA (hydrochloride); 1mg in1 mLMethanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company N-Hydroxy-l'viDA (hydrochloride); 100 0.1 mL Methanol ~gin Glass vial: 3 mL 12/20/2013 Cayman Chemical Company N-Hvdroxy-l'viDA (hydrochloride); 500 0.5 mL Methanol ~gin Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Nitrazepam CRM; 1 mg/mL in Acetonitrile Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Nitrazepam CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Nitrazepam CRM; 100 Glass ampule: 1 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~g/mL Frm 00070 in Acetonitrile Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.245</GPH> N-Ethylamphetamine (hydrochloride) CRM; 1 mg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16961 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 9/19/2014 Nitrazepam-d4 (exempt preparation); 1 mg in 1 mL Acetonitrile Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Nitrazepam-d4 (exempt preparation); 100 Jlg in 1 mL Acetonitrile Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Nitrazepam-d5 CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Nitrazepam-d5 CRM; 1 mg/mL in Acetonitrile Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Nitrazepam-d5 CRM; 100 11g/mL in Acetonitrile Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Nitrazepam-d5 CRM; 100 Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Nordiazepam CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Nordiazepam CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Nordiazepam CRM; 100 in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Nordiazepam CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Nordiazepam-d3 (exempt preparation); 1 mg in l mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Nordiazepam-d3 (exempt preparation); 100 Jlg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Nordiazepam-d3 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Nordiazepam-d3 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Nordiazepam-d3 CRM; 100 Glass ampule: 1 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00071 ~tg/mL ~tg/mL in Acetonitrile ~tg/mL Fmt 4701 in Methanol Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.246</GPH> Nitrazepam CRM; 100 Jlg/mL in Acetonitrile Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16962 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 9/19/2014 Normeperidine CRM; l mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Nonneperidine CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Nonneperidine CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Nom1eperidine CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Normeperidine CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Nonneperidine CRM; 100 f1g/mL in Methanol Glass ampule: 1 mL 9/19/2014 Caytmn Chemical Company Normeperidine CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company Normeperidine CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Normeperidine; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Caytmn Chemical Company Normeperidine; 100 11g in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Nonneperidine; 500 ~tg Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Nonneperidine-d4 (exempt preparation); 1mg in 1 mL Methanol Glass vial: 1mL 9/22/2014 Cayman Chemical Company Normeperidine-d4 (exempt preparation); 100 11g in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Normeperidine-d4 CRM; 1mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Nonneperidine-d4 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00072 in 0.5 mL Methanol Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.247</GPH> Nordiazepam-d3 CRM; 100 11g/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16963 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 9/19/2014 Normeperidine-d4 CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Normorphine CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Normorphine CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Normorphine CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Normorphine CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company Nom10rphine; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Normorphine; 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Normorphine; 500 Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Opiate Mixture CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical v Compan.. Opiate Mixture CRM; 100 Jlg/mL in Methanol Glass ampule: lmL 1/27/2014 Cayman Chemical Company Opiate Mixture CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company Oxazepam CRM; 1 mg/mL in Acetonitrile Glass vial: 1 mL 12/2/2014 Cayman Chemical Company Oxazepam CRM; 1 mg/mL in Acetonitrile Glass vial: 2 mL 12/2/2014 Cayman Chemical Company Oxazepam CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Oxazepam CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~tg in 0.5 mL Methanol Frm 00073 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.248</GPH> Nomleperidine-d4 CRM; 100 Jlg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16964 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 1 mL 9/19/2014 Oxazepam CRM; 100 f!g/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Oxazepam-d5 (exempt prepamtion); 1 mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Oxazepam-d5 (exempt prepamtion); 100 11g in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Oxazepam-d5 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Oxazepam-d5 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Oxazepam-d5 CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Oxazepan1-d5 CRM; 100 f!g/mL in Methanol Glass ampule: I mL 9/19/2014 Cayman Chemical Company Oxycodone CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Oxycodone CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Ox;rcodone CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Ox;rcodone CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayllk'1n Chemical Company Oxycodone; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Oxycodone; 100 11g in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Oxycodone; 500 Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Oxycodone-d3 (exempt preparation); 1mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~tg in 0.5 mL Methanol Frm 00074 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.249</GPH> Oxazepam CRM; 100 f!g/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16965 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: lmL 9/22/2014 Oxycodone-d3 CRM; 1 tn8/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Oxycodone-d3 CRM; 1 m8/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Oxycodone-d3 CRM; 100 118/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Oxycodone-d3 CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Oxymmphone CRM; 1 tn8/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company Ox.)'motphone CRM; 100 118/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company Ox.)'motphone CRM; 100 118/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company Oxymotphone; 1 m8 in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company 0>..J'l110tphone; 100 in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Oxymotphone; 500 118 in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Oxymotphone-d3 (exempt preparation); 100 118 in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Oxymotphone-d3 CRM; 100 118/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Oxymotphone-d3 CRM; 100 118/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company para-Methoxyamphetanline (hydrochloride) CRM; 1 m8/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company para-Methoxyamphetamine (hydrochloride) CRM; 1m8/mL in Methanol Glass ampule: 2 mL 1/27/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~L8 Frm 00075 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.250</GPH> Oxycodone-d3 (exempt preparation); 100 118 in 1 mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16966 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices para-MethO:\)Iamphetamine (hydrochloride) CRM; 100 ~tg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company para-MethO:\)Iamphetamine (hydrochloride) CRM; 100 ~g/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company para-MethO:\)Iamphetamine (hydrochloride); 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company para-MethO:\)Iamphetamine (hydrochloride); 100 ~Lg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company para-Methoxyamphetamine (hydrochloride); 500 ~gin 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company PB-22 (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 3/17/2014 Cayman Chemical Company PB-22 (exempt preparation); 100 Methanol ~g Cayll1::'ln Chemical Company PB-22 (exempt preparation); 500 Methanol ~tg Cayman Chetnical Company PB-22 CRM; 1 mg/mL in Acetonitrile Cayman Chetnical Company PB-22 CRM; 100 Cayman Chemical Company PCP-d5 (exempt preparation); lmg in 1 mL Methanol Cayll1::'ln Chetnical Company PCP-d5 (exempt preparation); 100 Methanol Cayman Chemical Company Pentedrone (exempt preparation); 1 mg in 1 mL Methanol Cayman Chemical Company Pentedrone (exempt preparation); 100 ~L Methanol ~Lg Cayman Chemical Company Pentedrone (exempt preparation); 500 ~L Methanol ~tg Cayman Chemical Company Pentedrone (hydrochloride) CRM; 1mg/mL in Methanol VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~g/mL Frm 00076 in100 ~tL ~tL in 500 ~ Glass vial: 500 ~L 3/17/2014 3/17/2014 Glass ampule: 1 mL ~gin 1mL in 100 8/7/2015 Glass ampule: 2 mL in Acetonitrile Fmt 4701 Glass vial: 100 3/21/2014 Glass vial: 1 mL 9/22/2014 Glass vial: 1 mL 9/22/2014 Glass vial: 1mL 3/17/2014 Glass vial: 100 ~L Sfmt 4725 in 500 Glass vial: 500 ~L Glass ampule: 2 mL E:\FR\FM\25MRN2.SGM 25MRN2 3/17/2014 3/17/2014 3/21/2014 EN25MR16.251</GPH> ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16967 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Pentedrone (hydrochloride) CRM; 100 )lg/mL in Methanol Glass ampule: 2 mL 3/21/2014 Cayman Chemical Company Pentobarbital CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company Pentobarbital CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Pentobarbital CRM; 100 in Methanol Glass ampule: 2 mL l/27/2014 Cayman Chemical Company Pentobarbit:'ll CRM; 100 )lg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Pentobarbital; 1 mg in 1mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Pentobarbital; 100 )lg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Pentobarbital; 500 )lg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Pentylone (exempt preparation); 1mg inlmL Methanol Cayman Chemical Company Pentylone (exempt preparation); 100 )lg in 100 IlL Methanol Glass vial: 100 IlL Cayman Chemical Company Pentylone (exempt preparation); 500 )lg in500 11L Methanol Glass vial: 500 Cayman Chemical Company Pentylone (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 3/21/2014 Cayman Chemical Company Pentylone (hydrochloride) CRM; 100 )lg/mL in Methanol Glass ampule: 2 mL 3/21/2014 Cayman Chemical Company Phencyclidine (hydrochloride) CRM; 1mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Phencyclidine (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Phencyclidine (hydrochloride) CRM; 100 ~tg/mL in Methanol Glass ampule: 2 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00077 ~tg/mL Fmt 4701 Sfmt 4725 3/17/2014 ~tL E:\FR\FM\25MRN2.SGM 25MRN2 3/17/2014 3/17/2014 EN25MR16.252</GPH> ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16968 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 1 mL 9/19/2014 Phencyclidine CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Phencyclidine CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Phencyclidine CRM; 100 gg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Phencyclidine CRM; 100 gg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Phencyclidine-d5 (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Phencyclidine-d5 (hydrochloride) CRM; 1 mglmL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Phencyclidine-d5 (hydrochloride) CRM; 100 ~tg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Phencyclidine-d5 (hydrochloride) CRM; 100 ~tg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Phencyclidine-d5 CRM; 1 mglmL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Phencyclidine-d5 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Phencyclidine-d5 CRM; 100 gg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Phencyclidine-d5 CRM; 100 gg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Phentermine (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9119/2014 Cayman Chemical Company Phentermine (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Phentennine (hydrochloride) CRM; 100 gg/mL in Methanol Glass ampule: 1 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00078 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.253</GPH> Phencyclidine (hydrochloride) CRM; 100 11glmL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16969 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 9/19/2014 Phentermine-d5 (HCl) (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Phentennine-d5 (HCl) (exempt preparation); 100 ~tg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Phentennine-d5 (hydrochloride) CRM; lmg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Phentennine-d5 (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Phentennine-d5 (hydrochloride) CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Phentermine-d5 (hydrochloride) CRM; 100 ~tg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Phenylacetone CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company Phenylacetone CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company Phenylacetone CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Phenylacetone CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Phenylacetone; lmg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Phenylacetone; 100 Jlg in O.lmL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Phenylacetone; 500 Jlg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Propoxyphene-d5 (exempt preparation); 1 mg in 1 mL Acetonitrile Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Propoxyphene-d5 (exempt preparation); 100 Jlg in 1 mL Acetonitrile Glass vial: 1mL 9/22/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00079 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.254</GPH> Phentennine (hydrochloride) CRM; 100 Jlg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16970 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 9/19/2014 PropOA.'}'phene-d5 (hydrochloride) CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 rnL 9/19/2014 Cayman Chemical Company PropOA.]'Phene-d5 (hydrochloride) CRM; 100 11glmL in Acetonitrile Glass ampule: 1 rnL 9/19/2014 Cayman Chemical Company PropOA.'}'phene-d5 (hydrochloride) CRM; 100 ~tg/mL in Acetonitrile Glass ampule: 2 rnL 9/19/2014 Cayman Chemical Company Psilocin CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Psilocin CRM; 1 mg/rnL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Psilocin CRM; 100 Jlg/mL in Methanol Glass ampule: 2 rnL 1127/2014 Cayman Chemical Company Psilocin CRM; 100 Jlg/rnL in Methanol Glass ampule: 1 rnL 1/27/2014 Cayman Che1nical Company Psilocin; 1 mg in 1 rnL Methanol Glass vial: 3 rnL 12/20/2013 Cayman Chemical Company Psilocin; 100 in 0.1mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Psilocin; 500 11g in 0.5 rnL Methanol Glass vial: 3 rnL 12/20/2013 Cayman Chemical Company Psilocybin CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Che1nical Company Psilocybin CRM; 1 mg/rnL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Psilocybin CRM; 100 in Methanol Glass ampule: 2 rnL 1127/2014 Cayman Chemical Company Psilocybin CRM; 100 Jlg/rnL in Methanol Glass ampule: 1 rnL 1/27/2014 Cayman Chemical Company Psilocybin; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 ~tg PO 00000 ~tg/rnL Frm 00080 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.255</GPH> PropOA.'}'phene-d5 (hydrochloride) CRM; 1 mg/rnL in Acetonitrile Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16971 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 3 mL 12/20/2013 Psilocybin; 500 11g in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company RCS-4 CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company RCS-4 CRM; 1 mg/mL in Acetonitrile Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company RCS-4 CRM; 100 Jlg/mL in Acetonitrile Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company RCS-4 CRM; 100 Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company RCS-4; 1mg in 1mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company RCS-4; 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chetnical Company RCS-4; 500 Jlg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chetnical Company RCS-8 CRM; 1mg/mL in Acetonitrile Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company RCS-8 CRM; 1 mg/mL in Acetonitrile Glass ampule: 2 mL 1/27/2014 Cayman Chetnical Company RCS-8 CRM; 100 Jlg/mL in Acetonitrile Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company RCS-8 CRM; 100 Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company RCS-8; 1mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company RCS-8; 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company RCS-8; 500 Jlg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~Lg/mL ~Lg/mL Frm 00081 in Acetonitrile in Acetonitrile Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.256</GPH> Psilocybin; 100 Jlg in 0.1 mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16972 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 1 mL 12/2/2014 Temazepam CRM; I mg/mL in Acetonitrile Glass vial: 2 mL 12/2/2014 Cayman Chemical Company Temazepam CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Temazepam CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Temazepam CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chetnical Company Temazepam CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Temazepam-d5 (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Temazepam-d5 (exempt preparation); 100 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Temazepam-d5 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Temazepam-d5 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Temazepam-d5 CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Temazepam-d5 CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Testosterone CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 6/13/2014 Cayman Chemical Company Testosterone CRM; 1mg/mL in Methanol Glass ampule: 2 mL 6/13/2014 Cayman Chemical Company Testosterone CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 6/13/2014 Cayman Chetnical Company Testosterone CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 6/13/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00082 Fmt 4701 Sfmt 4725 ~tg in E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.257</GPH> Temazepam CRM; 1 mg/mL in Acetonitrile Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16973 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 5/2/2014 Tetrahydrocaimabivarin CRM; 1 mg/mL Methanol Glass ampule: 1 mL 5/2/2014 Cayman Chemical Company Tetrahydrocmmabivarin CRM; 100 Jlg/mL Methanol Glass ampule: 2 mL 5/2/2014 Cayman Chemical Company Tetrahydrocaimabivarin CRM; 100 Methanol ~tg/mL Glass ampule: 1 mL 5/2/2014 Cayman Chemical Company THCA-A CRM; 1 mg/mL in Acetonitrile Glass vial: 2 mL 12/2/2014 CaytUail Chetnical Company THCA-A CRM; 1 mg/mL in Acetonitrile Glass vial: 1 mL 12/2/2014 Cayman Chemical Compm1y THCA-A CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company THCA-A CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Compm1y THCA-A CRM; 100 Jlg/mL in Acetonitrile Glass vial: 1 mL 12/2/2014 Cayman Chemical Compm1y THCA-A CRM; 100 Glass vial: 2 mL 12/2/2014 Cayman Chemical Company THCA-A CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chetnical Company THCA-A CRM; 100 Jlg/mL in Methm1ol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company THCA-A; 1 mg in 1 mL Methm1ol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company THCA-A; 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Caylllail Chemical Company THCA-A; 500 Jlg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company THCA-A-d3 (exempt preparation); 1mg in 1 mL Acetonitrile Glass vial: 1 mL 9/22/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~Lg/mL Frm 00083 in Acetonitrile Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.258</GPH> Tetrahydrocmmabivarin CRM; 1 mg/mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16974 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Cayman Chemical Company THCA-A-d3 (exempt preparation); 1mg in 1 mLMethanol Cayman Chemical Company THCA-A-d3 (exempt preparation); 100 mL Acetonitrile ~tg Cayman Chemical Company THCA-A-d3 (exempt preparation); 100 mLMethanol ~gin Cayman Chemical Company Glass vial: 1 mL 9/22/2014 Glass vial: 1 mL 9/22/2014 THCA-A-d3 CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 mL 9/19/2014 THCA-A-d3 CRM; 1 mg/mL in Acetonitrile Glass ampule: 2 mL 9/19/2014 Cayman Che1nical Company THCA-A-d3 CRM; 100 ~g/mL in Acetonitrile Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company THCA-A-d3 CRM; 100 ~g/mL in Acetonitrile Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company THCA-A-d3 CRM; 100 ~g/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company THCA-A-d3 CRM; 100 ~g/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company THCA-A-d9 (exempt preparation); 1 mg in 1 mL Acetonitrile Glass vial: 1 mL 9/22/2014 Cayman Chetnical Company THCA-A-d9 (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company THCA-A-d9 (exempt preparation); 100 mL Acetonitrile ~gin 1 Glass vial: 1mL 9/22/2014 Cayman Chemical Company THCA-A-d9 (exempt preparation); 100 mL Methanol ~gin 1 Glass vial: lmL 9/22/2014 Cayman Chemical Company THCA-A-d9 CRM; 1 mg/mL in Acetonitrile Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company THCA-A-d9 CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company THCA-A-d9 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00084 Fmt 4701 Sfmt 4725 in 1 1 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.259</GPH> 9/22/2014 Cayman Chetnical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Glass vial: 1mL 16975 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 9/19/2014 THCA-A-d9 CRM; 100 11g/mL in Acetonitrile Glass ampule: 1 mL 9/19/2014 Cayman Chetnical Company THCA-A-d9 CRM; 100 11g/mL in Acetonitrile Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company THCA-A-d9 CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company THCA-A-d9 CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Thebaine CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Thebaine CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company Thebaine CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Thebaine CRM; 100 Glass ampule: 1 mL 1/27/2014 Cayman Chetnical Company Thebaine; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chetnical Company Thebaine; 100 11g in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Thebaine; 500 11g in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Tilidine (hydrochloride) CRM CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company Tilidine (hydrochloride) CRM CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Tilidine (hydrochloride) CRM CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Tilidine (hydrochloride) CRM CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 1/27/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~lg/mL Frm 00085 in Methanol Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.260</GPH> THCA-A-d9 CRM; 1 mg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16976 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 3 mL 12/20/2013 Tilidine (hydrochloride); 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Tilidine (hydrochloride); 500 Jlg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company UR-144 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company UR-144 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company UR-144 CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company UR-144 CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company UR-144; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company UR-144; 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company UR-144; 500 gg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company XLR11 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company XLR11 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company XLRll CRM; 100 Jlg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company XLR11 CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company XLRll; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company XLRll; 100 Glass vial: 3 mL 12/20/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 ~tg PO 00000 in 0.1 mL Methanol Frm 00086 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.261</GPH> Tilidine (hydrochloride); 1 mg in 1 mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16977 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 3 mL 12/20/2013 u-Ethyltryptamine CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company u-Ethyltryptamine CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company u-Ethyltryptamine CRM; 100 Methanol in Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company u-Ethyltryptamine CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company u-Ethyltryptamine; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company u-Ethyltryptamine; 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company u-Ethyltryptamine; 500 Jlg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company u-Methyltryptamine (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company u-Methyltryptamine (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company u-Methyltryptamine (hydrochloride) CRM; 100 ~tg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company u-Methyltryptan1ine (hydrochloride) CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company u-Methyltryptamine (hydrochloride); 1mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company u-Methyltryptamine (hydrochloride); 100 0.1 mL Methanol ~Lg in Glass vial: 3 mL 12/20/2013 Cayman Chemical Company u-Methyltryptamine (hydrochloride); 500 0.5 mL Methanol ~tg in Glass vial: 3 mL 12/20/2013 Cayman Chemical Company a-PBP (exempt preparation); lmg in 1 mL Glass vial: 1 mL 3/17/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00087 ~tg/mL Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.262</GPH> XLRll; 500 11g in 0.5 mL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16978 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices a-PBP (exempt preparation); 100 Methanol ~tg Cayman Chemical Company a-PBP (exempt preparation); 500 Methanol ~gin Cayman Chemical Company a-PVP (exempt preparation); 1 mg in 1 mL Cayman Chemical Company a-PVP (exempt preparation); 100 ~gin 100 Methanol Cayman Chemical Company a-PVP (exempt preparation); 500 Methanol Cayman Chemical Company a-Pyrrolidinopentiophenone (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 3/21/2014 Cayman Chemical Company a-Pyrrolidinopentiophenone (hydrochloride) CRM; 100 ~g/mL in Methanol Glass ampule: 2 mL 3/21/2014 Cayman Chemical Company y-Hydroxybutyric acid (sodium salt) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company y-Hydroxybutyric acid (sodium salt) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company y-Hydrox}'butyric acid (sodimn salt) CRM; 100 ~g/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company y-Hydroxybutyric acid (sodium salt) CRM; 100 ~g/mL in Methanol Glass ampule: 2 mL l/27/2014 Cayman Chemical Company y-Hydroxybutyric acid (sodium salt); 1 mg in 1 mLMethanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company y-Hydroxybutyric acid (sodium salt); 100 0.1 mL Methanol ~g Glass vial: 3 mL 12/20/2013 Cayman Chemical Company y-Hydroxybutyric acid (sodium salt); 500 0.5 mL Methanol ~gin Glass vial: 3 mL 12/20/2013 Cayman Chemical Company AS-THC CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company A8-THC CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00088 Fmt 4701 in 100 ~L Glass vial: 100 ~LL 500 ~ Glass vial: 500 ~L ~gin 500 Glass vial: 1 mL ~tL Glass vial: 100 ~L ~L Glass vial: 500 ~tL Sfmt 4725 in E:\FR\FM\25MRN2.SGM 25MRN2 3/17/2014 3/17/2014 3/17/2014 3/17/2014 3/17/2014 EN25MR16.263</GPH> ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 16979 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Cayman Chemical Company ~8-THC CRM; 100 ~Lg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company ~8-THC CRM; 100 ~g/mL in Methanol Glass ampule: 1 mL 1127/2014 Cayman Chemical Company ~8-THC; 1 mg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company ~8-THC; 100 ~gin0.1 mLMethanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company ~8- THC; 500 Glass vial: 3 mL 12/20/2013 Glass vial: 1 mL 9/22/2014 Cayman Chemical Company ~8-THC-d9 ~gin 0.1 mL Methanol (exempt preparation); 1 mg in 1 mL Methanol Cayman Chemical Company ~8-THC-d9 (exempt preparation); 100 ~g in1 mLMethanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company ~8- THC-d9 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company ~8-THC-d9 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company ~8-THC-d9 CRM; 100 ~g/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company ~8-THC-d9 CRM; 100 ~g/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company ~9-TetrahydrocalUlabinol CRM; 1mg/mL Methanol Glass ampule: 2 mL 5/2/2014 Cayman Chemical Company ~9-Tetrahydroca1TI1abinol CRM; 1mg/mL Methanol Glass ampule: 1 mL 5/2/2014 ~9-TetrahydrocalUlabinol ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company Cayman Chemical Company VerDate Sep<11>2014 18:45 Mar 24, 2016 CRM; 100 ~g/mL Glass ampule: 2 mL 5/2/2014 CRM; 100 ~g/mL Glass ampule: 1 mL 5/2/2014 Glass ampule: 1 mL 1/27/2014 Methanol ~9-TetrahydrocalUlabinol Methanol ~9-THC Jkt 238001 CRM; 1 mg/mL in Methanol PO 00000 Frm 00089 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.264</GPH> Cayman Chemical Company 16980 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Cayman Chemical Company ~9-THC CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company ~9-THC CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company ~9-THC CRM; 100 Glass ampule: 2 mL 1127/2014 Cayman Chemical Company ~9-THC; 1 mg in1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company ~9-THC; 100 11g in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company ~9-THC; 500 11g in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Glass vial: 1 mL 9/22/2014 (exempt preparation); 100 11g in 1 mLMethanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company ~9-THC-d9 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company ~9-THC-d9 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company ~9-THC-d9 CRM; 100 11g/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company ~9-THC-d9 CRM; 100 11g/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cerilliant Corporation (±)-2,5-Dimethoxy-4-bromoamphetamine HCl (1.0 mg/mL) Glass ampule: 1 mL 6/21/2013 Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation (±)-2,5-Dimethoxy-4-bromoamphetamine-D5 HCl (0.1mg/mL) Glass an1pule: 1 mL Glass an1pule: 1 mL Glass ampule: 1 mL ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company Cerilliant Corporation Cerilliant Corporation VerDate Sep<11>2014 18:45 Mar 24, 2016 ~9-THC-d9 in Methanol (exempt preparation); lmg in 1 mL Methanol ~9-THC-d9 (±)-Cathinone-D5 HCl (0.1 mg/mL) (±)-Methcathinone-D3 HCl (0.1 mg/mL) (±)-threo-Methylphenidate-D4 HCl (0.1mg/mL) 17alpha-Methyltestosterone (1.0 mg/mL) Jkt 238001 PO 00000 Frm 00090 Fmt 4701 Sfmt 4725 Glass ampule: 1 mL Glass ampule: 1 mL E:\FR\FM\25MRN2.SGM 25MRN2 6/9/2015 11/17/2015 11/19/2014 2/13/2015 4/21/2014 EN25MR16.265</GPH> Cayman Chemical Company ~Lg/mL 16981 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 1 mL 9/9/2013 2,5-Dimethoxy-4-(n)-propylthiophenethylamine HCI (1.0 mg/mL) Glass ampule: 1 mL 10/21/2013 Cerilliant Corporation 2,5-Dimethoxy-4-ethylphenethylamine HCl (1.0 mg/mL) Glass ampule: 1 mL 9/9/2013 Cerilliant Corporation 2,5-Dimethm,"")'-4-ethylphenethylamine-13C,D3 HCl (0.1 mg/mL) Glass ampule: 1 mL 4/3/2014 Cerilliant Corporation 2,5 -Dimetho>-"Y -4-ethy lthiophenethy lamine HCl (1.0 mg/mL) Glass ampule: 1 mL 12/11/2013 Cerilliant Corporation 2,5 -Dimethoxy -4-ethy lthiophenethy!amine13C,D3 HCl (0.1 mg/mL) Glass ampule: 1 mL 4/3/2014 Cerilliant Corporation 2,5 -Dimethoxy -4-isopropy lthiophenethylamine13C, D3 HCl (0.1 mg/mL) Glass ampule: 1 mL 12/11/2013 Cerilliant Corporation 2,5 -Dimetho>-"Y -4-isopropy lthiophenethyIamine HCl (1.0 mg/mL) Glass ampule: 1 mL 12/11/2013 Cerilliant Corporation 2,5 -Dimethoxy -4-methy lphenethy lamine H Cl (1.0 mg/mL) Glass ampule: 1 mL 9/9/2013 Cerilliant Corporation 2,5 -Dimetho>-"Y -4-methy lphenethy lamine13C,D3 HCl (0.1mg/mL) Glass ampule: 1 mL 4/3/2014 Cerilliant Corporation 2,5-Dimethoxy-4-nitrophenethylamine- 13C, D3 HCl (0.1mg/mL as free base) Glass ampule: 1 mL 6/16/2014 Cerilliant Corporation 2,5-Dimethoxy-4-nitrophenethylamine HCl (1.0 mg/mL) Glass ampule: 1 mL 10/21/2013 Cerilliant Corporation 25B-NB0Me HCl (1.0 mg/mL) Glass ampule: 1 mL 12/11/2013 Cerilliant Corporation 25B-NB0Me-D3 HCl (0.1 mg/mL) Glass ampule: 1 mL 12/11/2013 Cerilliant Corporation 25C-NBOMe HCl (1.0 mg/mL) Glass ampule: 1 mL 12/11/2013 Cerilliant Corporation 25C-NB0Me-D3 HCl (0.1 mg/mL) Glass ampule: 1 mL 12/11/2013 Cerilliant Corporation 25I-NBOMe HCl (1.0 mg/mL) Glass ampule: 1 mL 12/11/2013 Cerilliant Corporation 25I-NBOMe-D3 HCl (0.1 mg/mL) Glass ampule: 1 mL 12/11/2013 Cerilliant Corporation 3,4-Dimethylmethcathinone HCI (1.0 mg/mL) Glass ampule: 1 mL 2/25/2014 Cerilliant Corporation 3-Fluoromethcathinone HCl (1.0 mg/mL) Glass ampule: 1 mL 2/25/2014 Cerilliant Corporation 4-Chloro-2, 5-Dimethoxymethy lphenethy lamine HCl (1.0 mg/mL) Glass ampule: 1 mL 10/21/2013 Cerilliant Corporation 4-Ethylmethcathinone (1.0 mg/mL) Glass ampule: 1 mL 2/25/2014 Cerilliant Corporation 4-Fluoromethcathinone HCl (1.0 mg/mL) Glass ampule: 1 mL 2/25/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00091 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.266</GPH> 2,5 -Dimethoxy -4-(n)-propy lphenethylamine HCl (1.0 mg/mL) Cerilliant Corporation ebenthall on DSK6SPTVN1PROD with NOTICES2 Cerilliant Corporation 16982 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation ebenthall on DSK6SPTVN1PROD with NOTICES2 Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation VerDate Sep<11>2014 18:45 Mar 24, 2016 4-Iodo-2,5-Dimethoxymethy lphenethy lamine HCl (1.0 mg/mL) 4-Iodo-2,5-dimethoxyphenethylamine- 13C, D3 HCl (0.1 mg/mL) Glass ampule: 1 mL Glass ampule: 1 mL 4-Methylethcathinone (1.0 mg/mL) Glass ampule: 1 mL 2/25/2014 5-Fluoro PB-22 (0.1 mg/mL) Ampule: 1 mL 2/11/2014 6-beta-Naltrexol-3-beta-D-glucuronide (1 mg/mL) Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL AB-FUBINACA (0.1 mg/mL) Ampule: 1 mL 5-MeO-DiPT (1.0 mg/mL) 5-MeO-DMT (1.0 mg/mL) 6alpha-Naloxol (1.0 mg/mL) Acetyl fentanyl (0.05 mg/mL) Acetyl fentanyl-13C6 (0.05 mg/mL) AKB48 (0.1 mg/mL) alpha-PVP HCl (alphaPyrrolidinovalerophenone HCl) (1.0 mg/mL) alpha-Pyrrolidinovalerophenone-D8 HCl (0.1 mg/mL) APINACA (0.1 mg/mL) Bromazepam-D4 (0.1 mg/mL) Buphedrone HCl (1.0 mg/mL) Buprenorphine-3-beta-D-glucuronide (0.1 mg/mL) Buprenorphine-D4-3-beta-D-glucuronide (0 .1 mg/mL) Butylone HCl (1.0 mg/mL) Butylone-D3 HCl (0.1 mg/mL) Frm 00092 Fmt 4701 1 1 Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: 1mL Glass ampule: mL Glass ampule: mL Sfmt 4725 E:\FR\FM\25MRN2.SGM 12/11/2013 8/6/2015 10/7/2014 3/30/2015 6/1/2015 2111/2014 1 1 1 1 1 1 8/6/2015 10/8/2015 10/8/2015 5/16/2013 2/25/2014 2/25/2014 10/8/2015 12/23/2014 5/8/2013 1 1 Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Butabarbital-D5 (0.1 mg/mL) PO 00000 1 Glass ampule: 1 mL Glass ampule: 1 mL AB-PINACA (0.1 mg/mL) Jkt 238001 1 10/2112013 25MRN2 6/9/2015 8/13/2015 8/6/2015 2/25/2014 2/25/2014 EN25MR16.267</GPH> Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation 16983 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerillia11t Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation ebenthall on DSK6SPTVN1PROD with NOTICES2 Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation VerDate Sep<11>2014 18:45 Mar 24, 2016 Cmmabichromene [CBC] (1.0 mg/mL Glass vial: 1 mL 6/3/2014 Cannabidiolic acid [CBDA] (1.0 mg/mL) Glass vial: 1 mL 6/3/2014 Cannabidivarin [CBDV] (1.0 mg/mL) Glass vial: 1 mL 6/3/2014 Ca1mabidivarinic acid (1.0 mg/mL) Glass ampule: 1 mL 9/15/2015 Cam1abigerol [CBG] (1.0 mg/mL) Glass vial: 1 mL 6/3/2014 Ca1mabigerolic acid [CBGA] (1.0 mg/mL) Glass vial: 1 mL 6/3/2014 Carisoprodol-13C3 (O.lmg/mL) cis-Trmnado1 HCl (1.0 mg/mL) Clobazam-13C6 (0.1mg/mL) Codeine-6-beta-D-glucuronide-D3 (0.1 mg/mL) Delorazepmn (0.1 mg/mL) Desomorphine-D3 (0 .1 mg/mL) Dihydrocodeine-6-beta-D-glucuronide ( 1.0 mg/mL) Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL 1 1 1 1 1 Glass ampule: 1 mL Glass ampule: 1 mL 6/16/2014 7/7/2014 8/9/2013 4/3/2014 12/11/2015 7/19/2013 3/16/2015 Dihydrocodeine-6-beta-D-glucuronide (0.1 mg/mL) Ampule: 1 mL 2/1112014 Dihydromorphine-3-beta-D-glucuronide (1.0 mg/mL) Glass ampule: 1 mL 2/13/2015 Dihydromorphine-6-beta-D-glucuronide (0.1 mg/mL) Ampule: 1 mL 2/11/2014 Glass ampule: 1 mL Glass ampule: 1 mL Ethylone HCl (1.0 mg/mL) Ethylone-D5 HCl (0.1 mg/mL) Glass ampule: 1 mL Glass ampule: 1 mL Eutylone HCl (1.0 mg/mL) Eutylone-D5 HCI (0.1mg/mL) Flunitrazepam-13 C6 (0 .1 mg/mL) Flurazepam-D4 (0 .1 mg/mL) GHB Sodium Salt (1.0 mg/mL) Jkt 238001 PO 00000 Frm 00093 Fmt 4701 Sfmt 4725 Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL E:\FR\FM\25MRN2.SGM 25MRN2 2/25/2014 2/25/2014 2/25/2014 2/25/2014 8/6/2015 12/11/2015 4/29/2014 EN25MR16.268</GPH> Cerilliant Corporation Cerilliant Corporation 16984 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation ebenthall on DSK6SPTVN1PROD with NOTICES2 Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation VerDate Sep<11>2014 18:45 Mar 24, 2016 Glass ampule: 1 mL Glass ampule: 1 mL GHB Sodium Salt-D6 (0.1 mg/mL) GHB Sodium Salt-D6 (1.0 mg/mL) Interference Mix 1 (100-1000 Interference Mix 2 (100 ~g/mL) Interference Mix 3 (50-1000 Interference Mix 4 (5-100 Interference Mix 5 (100 Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL ~tg/mL) ~g/mL) ~g/mL) ~g/mL) Ketamine-D4 HCl (1 mg/mL) Levorphanol tartrate (1mg/mL) MBDB-D5 HCl (0.1mg/mL) Mephobamital (1.0 mg/mL) Meprobamate-13C3 (0.1mg/mL) Meprobamate-D3 (0.1mg/mL) Methy1phenidate-D9 HCl N,N-Dimethyltryptmnine (1.0 mg/mL) Naloxone-3-beta-D-glucuronide (0.1 mg/mL) 1 1 1 1 1 1 1 1 1 1 1 1 1 Ampule: l mL Glass ampule: 1 mL Glass ampule: 1 mL Naphyrone HCl (1.0 mg/mL) Naphyrone-D5 HC1 (1.0 mg/mL) 4/29/2014 4/29/2014 1/29/2015 1/29/2015 1/29/2015 1/29/2015 1/29/2015 4/14/2015 11/17/2015 6/16/2014 12/11/2015 4/3/2014 7/19/2013 12/23/2013 10/7/2014 2/1112014 2/25/2014 2/25/2014 N-Ethylcathinone HCl (1.0 mg/mL) Glass ampule: 1mL 5/8/2013 Norbuprenorphine glucuronide-D3 (0.1 mg/mL) Glass vial: 1 mL 6/3/2014 Nonneperidine (1.0 mg/mL) Oxycodone-D3 (N-methyl-D3) (0.1 mg/mL) Oxycodone-D3 (N-methyl-D3) (1.0 mg/mL) Jkt 238001 PO 00000 Frm 00094 Fmt 4701 Sfmt 4725 Glass ampule: 1mL Glass ampule: 1 mL Glass ampule: 1 mL E:\FR\FM\25MRN2.SGM 25MRN2 4/2/2013 9/9/2013 9/9/2013 EN25MR16.269</GPH> Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation 16985 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation ebenthall on DSK6SPTVN1PROD with NOTICES2 Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation VerDate Sep<11>2014 18:45 Mar 24, 2016 Pain Management Multi-component Opiate Mixture-13 (0.01 -0.1 mg/mL) Glass ampule: 1 mL 8/26/2014 PB-22 (0.1 mg/mL) Ampule: 1 mL 2/11/2014 Pentedrone HCl (1.0 mg/mL) Pentylone HCl (1.0 mg/mL) Pentylone-D3 HCl (0.1 mg/mL) Pregabalin-13-C3 (0.1 mg/mL) Psilocybin-D3 (0.1 mg/mL) Testosterone Calibrator Level 1 (2 ng/dL) Testosterone Calibrator LevellO (2000 ng/dL) Testosterone Calibrator Level2 (4 ng/dL) Testosterone Calibrator Level 3 (9 ng/dL) Testosterone CalibratorLevel4 (17.5 ng/dL) Testosterone Calibrator Level5 (35 ng/dL) Testosterone Calibrator Level6 (52.5 ng/dL) Testosterone Calibrator Level 7 ( 150 ng/dL) Testosterone Calibrator Level8 (500 ng/dL) Testosterone Calibrator Level 9 (7 50 ng/dL) Testosterone-2,3,4-13C3 ( 10 !lg/mL) Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL 1 1 1 1 1 1 1 1 1 1 1 1 1 1 Glass ampule: 1 mL Glass ampule: 1 mL 2/25/2014 2/25/2014 2/25/2014 9/9/2013 12/23/2014 8/7/2014 8/7/2014 8/7/2014 817/2014 8/7/2014 8/7/2014 8/7/2014 8/7/2014 8/7/2014 8/7/2014 8/7/2014 Tetrahydrocannabinolic acid [THCA-A] (1.0 mg/mL) Glass vial: 1 mL 6/3/2014 Tetral1ydrocannabivarin [THCV] (1.0 mg/mL) Glass vial: 1 mL 6/3/2014 THC Cannabinoids Mixture-3 (0.5 mg/mL each analyte) Glass ampule: 1 mL Glass ampule: 0.5mL THC Camtabinoids Mixture-3 (1.0 mg/mL) Tramadol-13C, D3 HCl (0.1 mg/mL) Jkt 238001 PO 00000 Frm 00095 Fmt 4701 Sfmt 4725 Glass ampule: 1 mL E:\FR\FM\25MRN2.SGM 25MRN2 6/9/2015 8/13/2015 717/2014 EN25MR16.270</GPH> Cerilliant Corporation Cerilliant Corporation 16986 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cliniqa Corporation Cliniqa Corporation Cliniqa Corporation Cliniqa Corporation Cliniqa Corporation Cliniqa Corporation Cliniqa Corporation Tramadol-13C, D3 HCl (1.0 mg/mL) UR-144 (0.1 mg/mL) XLR-11 (0.1 mg/mL) TDM Control Level 1 TDM Control Levell Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Plastic bottle: 1 Gallon Plastic bottle: 500ml 7/7/2014 5/16/2013 5/16/2013 4/15/2014 4/15/2014 12/15/2014 TDM Control Level 2 Plastic bottle: 500 ml 4/15/2014 TDM Control Level2, Part: 82810-M Bottle: 5 mL 12/15/2014 TDM Control Level 3 Plastic bottle: 500ml 4/15/2014 TDM Control Level3, Part: 82811-M Bottle: 5 mL 12/15/2014 PCAPTT-QQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 College of American Pathologists PCCAPTT-AQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 College of American Pathologists PCJACT-AQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 College of American Pathologists PCJACT-NQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 College of American Pathologists PCJCPT-AQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 College of American Pathologists PCJCPT-NQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 College of American Pathologists PCJLR-AQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 College of American Pathologists PCJLR-NQ Bag:250-750 tubes; 0.5 mL each 9/12/2013 College of American Pathologists PCJPT-AQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00096 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.271</GPH> Bottle: 5 mL College of American Pathologists ebenthall on DSK6SPTVN1PROD with NOTICES2 TDM Control Levell, Part: 82809-M 16987 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices PCJPT-NQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 College of American Pathologists PCPRO-AQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 College of American Pathologists PCPRO-NQ Bag: 250- 750 tubes; 0.5 mL each 9/12/2013 Eli Lilly and Company Testosterone Reference Standard Glass ampule: 1 mL 11/26/2013 Honeywell Specialty Materials LUMILUX Red CD 325 Plastic bottle: 5 g 9/16/2015 Immunalysis Corporation 6-Acetylmorphine Calibrator Glass vial: 5 mL 7/16/2014 Immunalysis Corporation 6-Acetylmorphine High Control Glass vial: 5 mL 7/16/2014 6-Acetylmorphine Low Control Glass vial: 5 mL 7/16/2014 Amphetamine Calibrator Level 1 Glass vial: 5 mL 7/16/2014 Amphetamine Calibrator Level 2 Glass vial: 5 mL 7/16/2014 Amphetamine Calibrator Level 3 Glass vial: 5 mL 7/16/2014 Amphetamine Calibrator Level 4 Glass vial: 5 mL 7/16/2014 Amphetamine High Control-A Glass vial: 5 mL 7/16/2014 Amphetamine High Control-B Glass vial: 5 mL 7/16/2014 Amphetamine Low Control-A Glass vial: 5 mL 7/16/2014 Amphetamine Low Control-B Glass vial: 5 mL 7/16/2014 Carisoprodol Calibrator Level 1 Glass vial: 10 mL 8/25/2014 Carisoprodol Calibrator Level 2 Glass vial: 10 mL 8/25/2014 Carisoprodol Calibrator Level 3 Glass vial: 10 mL 8/25/2014 Immunalysis Corporation Carisoprodol Calibrator Level 4 Glass vial: 10 mL 8/25/2014 Immunalysis Corporation Carisoprodol High Control- I Glass vial: 10 mL 8/25/2014 Immunalysis Corporation Immunalysis Corporation Immunalysis Corporation Immunalysis Corporation Immunalysis Corporation Immunalysis Corporation Immunalysis Corporation Immunalysis Corporation Inununalysis Corporation ebenthall on DSK6SPTVN1PROD with NOTICES2 Immunalysis Corporation Inmmnalysis Corporation Ilnmunalysis Corporation VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00097 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.272</GPH> College of American Pathologists 16988 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Immunalysis Corporation Immunalysis Corporation ebenthall on DSK6SPTVN1PROD with NOTICES2 Immunalysis Corporation Inmmnalysis Corporation hmnunalysis Corporation Innnunalysis Corporation Immunalysis Corporation Innnunalysis Corporation Immunalysis Corporation Innnunalysis Corporation Innnunalysis Corporation Itmnunalysis Corporation Innnunalysis Corporation Immunalysis Corporation Immunalysis Corporation Immunalysis Corporation Ilmnunalysis Corporation Immunalysis Corporation Immunalysis Corporation Immunalysis Corporation Immunalysis Corporation VerDate Sep<11>2014 18:45 Mar 24, 2016 Carisoprodol High Control-2 Glass vial: 10 mL 8/25/2014 Carisoprodol Low Control-1 Glass vial: 10 mL 8/25/2014 Carisoprodol Low Control-2 Glass vial: 10 mL 8/25/2014 Carisoprodol Positive Reference Control- I Glass vial: 2 mL 8/25/2014 Carisoprodol Positive Reference Control-2 Glass vial: 5 mL 8/25/2014 cTHC Calibrator High Control Glass vial: 5 mL 7/16/2014 cTHC Calibrator Level 1 Glass vial: 5 mL 7/16/2014 cTHC Calibrator Level 2 Glass vial: 5 mL 7/16/2014 cTHC Calibrator Level 3 Glass vial: 5 mL 7/16/2014 cTHC Calibrator Level 4 Glass vial: 5 mL 7/16/2014 cTHC Calibrator Low Control Glass vial: 5 mL 7/16/2014 Glass vial: mL Glass vial: mL Glass vial: mL Glass vial: mL Glass vial: mL Glass vial: mL Fentanyl Calibrator High Control Fentanyl Calibrator Level 1 Fentanyl Calibrator Level2 Fentanyl Calibrator Level 3 Fentanyl Calibrator Level4 Fentanyl Calibrator Low Control 10 10 10 10 10 10 7/16/2014 7/16/2014 7/16/2014 7/16/2014 7/16/2014 7/16/2014 Morphine Calibrator Level 1 Glass vial: 5 mL 7/16/2014 Morphine Calibrator Level 2 Glass vial: 5 mL 7/16/2014 Morphine Calibrator Level 3 Glass vial: 5 mL 7/16/2014 Morphine Calibrator Level 4 Glass vial: 5 mL 7/16/2014 Oxazepam Calibrator Level 1 Glass vial: 5 mL 7/16/2014 Oxazepam Calibrator Level 2 Glass vial: 5 mL 7/16/2014 Jkt 238001 PO 00000 Frm 00098 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.273</GPH> Immunalysis Corporation Immunalysis Corporation 16989 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Inununalysis Corporation Immunalysis Corporation Immunalysis Corporation Immunalysis Corporation Immunalysis Corporation Inununalysis Corporation Innnunalysis Corporation Immtmalysis Corporation Immmmlysis Corporation Immunalysis Corporation Inununalysis Corporation Oxazepam Calibrator Level 3 Glass vial: 5 mL 7/16/2014 Oxazepam Calibrator Level 4 Glass vial: 5 mL 7/16/2014 Oxazepam High Control Glass vial: 5 mL 7/16/2014 Oxazepam Low Control Glass vial: 5 mL 7/16/2014 Tramadol Calibrator Level 1 Glass vial: 10 mL Glass vial: mL Glass vial: mL Glass vial: mL Glass vial: mL Glass vial: mL Tramadol Calibrator Level 2 Tramadol Calibrator Level 3 Tramadol Calibrator Level 4 Tramadol High Control Tramadol Low Control 10 10 10 10 10 7/8/2014 7/8/2014 7/8/2014 7/8/2014 7/8/2014 7/8/2014 Tramadol Posititve Reference Control Glass vial: 5 mL 7/8/2014 Immunalysis Corporation Tramadol Positive Reference Control Glass vial: 2 mL 7/8/2014 Instrumentation Laboratory GEM Check Coag Abnonnal (6260060100) Box: 15 vials; 0.5 mL each 9/12/2013 Instrumentation Laboratory GEM Check Coag Abnormal (6260060200) Box: 15 vials; 0.5 mL each 9/12/2013 Instrumentation Laboratory GEM Check Coag Abnonnal (6260060300) Box: 15 vials; 0.5 mL each 9/12/2013 Instrmnentation Laboratory GEM Check Coag Abnormal (6260061400) Box: 15 vials; 0.5 mL each 9/12/2013 GEM Check Coag Citrate PT Abnonnal (6260061600) Box: 15 vials; 0.5 mL each 9/12/2013 GEM Check Coag Citrate PTNorutal (6260061100) Box: 15 vials; 0.5 mL each 9/12/2013 ebenthall on DSK6SPTVN1PROD with NOTICES2 Instrumentation Laboratory Irvine Scientific Irvine Scientific Irvine Scientific VerDate Sep<11>2014 18:45 Mar 24, 2016 Box: 15 vials; 0.5 mL each Box: 15 vials; 0.5 mL each Box: 15 vials; 0.5 mL each GEM Check Coag Nonnal (6260060400) GEM Check Coag Nonnal (6260060500) GEM Check Coag Nonnal (6260060600) GEM Check Coag Nonnal (6260061700) Chang Atmtio Ref: 994 73 Chang Medium C Frozen Supplement Ref: C106 Chang Medium C Frozen Supplement Ref: Jkt 238001 PO 00000 Frm 00099 Fmt 4701 Sfmt 4725 Box: 15 vials; 0.5 mL each 100 mL; 500 mL 9/12/2013 9/12/2013 9/12/2013 9/12/2013 1/29/2015 14 mL 1/29/2015 10mL 1/29/2015 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.274</GPH> Instrumentation Laboratory Instrumentation Laboratory Instrumentation Laboratory Instrumentation Laboratory Instnunentation Laboratory 16990 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Irvine Scientific IS 293 Catalog# 91101 Irvine Scientific IS 293-V Catalog# 91107 Irvine Scientific IS GRO Catalog# 91105 Irvine Scientific IS PRO Catalog# 91103 Irvine Scientific Prime VX ASFC Catalog# 91133 Irvine Scientific Irvine Scientific · Irvine Scientific Irvine Scientific Irvine Scientific . Irvine Scientific I so Sciences, LLC !so Sciences, LLC IsoSciences, LLC !so Sciences, LLC !so Sciences, LLC 11~-Hydroxytestosterone, 11 ~-HydrO:\.)Itestosterone, 1000 methanol ~tg /mL in 100 Jlg /mL in methanol in !so Sciences, LLC methanol Iso Sciences, LLC ebenthall on DSK6SPTVN1PROD with NOTICES2 1000 ~tg /mL methanol 5a-Androstan-3,17-dione, 100 Jlg /mL in methanol I so Sciences, LLC I so Sciences, LLC 5a-Androstan-3,17-dione, 1000 11g /mL in methanol 5a-Androstan-3a,17~-diol, 100 Jlg/mL in methanol !so Sciences, LLC methanol 18:45 Mar 24, 2016 methanol 5-Androsten-3~,17~-diol-[2H3], 5-Androsten-3~,17~-diol-[2H3], 5a-Androstan-3a,l7~-diol, Jkt 238001 PO 00000 Frm 00100 1/29/2015 100mL 500mL 1129/2015 l/29/2015 100 mL; 500 mL 1/29/2015 100 mL; 500 mL 100 mL; 500 mL 100 mL; 500 mL Plastic bottle: 1 L l/29/2015 l/29/2015 1/29/2015 1000 Fmt 4701 100 11g /mL in 1000 ~tg /mL in ~tg Amber Ampule: 1mL Amber Ampule: 1 mL Amber Ampule: 1 mL Amber Ampule: 1 mL l/29/2015 1/29/2015 1129/2015 1/29/2015 9/30/2014 1129/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 Amber Ampule: 1 mL Amber Ampule: 1 mL Amber Ampule: 1 mL /mL in Sfmt 4725 Plastic bottle: 250mL 1L Amber Ampule: 1 mL Amber Ampule: 1 mL Amber Ampule: 1 mL Amber Ampule: 1mL 100 11g /mL in I so Sciences, LLC IsoSciences, , LLC VerDate Sep<11>2014 50mL Plastic bottle: 1 L Plastic bottle: 1 L methanol 5-Androsten-3~,17~-diol, l/29/2015 Plastic bottle: 1 L W.I.P. Catalog#: CC.IP 1,4-Androstadiene-3,17-dione (Boldione), 100 11g /mL in methanol 1,4-Androstadiene-3,17-dione (Boldione), 1000 Jlg /mL in methanol 5-Androsten-3~,17~-diol, 70mL 9/17/2015 Amber Ampule: lmL 9/17/2015 E:\FR\FM\25MRN2.SGM 25MRN2 9/17/2015 9/17/2015 EN25MR16.275</GPH> Irvine Scientific Irvine Scientific Irvine Scientific C107 Chang Medium C Frozen Supplement Ref: Cl08 Chang Medium C Frozen Supplement Ref: Cl09 Chang Medium C Lyophilized Ref: TlOl-019 Chang Medium C Lyophilized Ref: TlOl-059 Chang Medium C Lyophilized with Gentamicin Ref: 99419 Chang Medium D Ref: 99404 Chang Medium D Ref: Tl05 Chang Medium In Situ Ref: T1 04 16991 IsoSciences, LLC !so Sciences, LLC 1soSciences, LLC !so Sciences, LLC IsoSciences, LLC IsoSciences, LLC IsoSciences, LLC Iso Sciences, LLC IsoSciences, LLC IsoSciences, LLC !so Sciences, LLC IsoSciences, LLC !so Sciences, LLC IsoSciences, LLC IsoSciences, LLC IsoSciences, LLC !so Sciences, LLC Iso Sciences, LLC !so Sciences, LLC !so Sciences, LLC IsoSciences, LLC !so Sciences, LLC IsoSciences, LLC VerDate Sep<11>2014 18:45 Mar 24, 2016 5a-Androstan-3a,l7~-diol-[2H3], 100 ~g /mL in methanol 5a-Androstan-3a, 17~-diol-[2H3], 1000 ~g /mL in methanol 5a-Androstan-3~,17~-diol, 100 ~g /mL in methanol 5a-Androstan-3~, 17~-diol, 1000 ~g /mL in methanol 5a-Androstan-3~, 17~-diol-[2H3], 100 ~g /mL in methanol 5a-Androstan-3~,17~-diol-[2H3], 1000 ~g /mL in methanol 5a-Androstan-3~,17~-diol-[2H4], 100 ~tg /mL in methanol 5a-Androstan-3~,17~-diol-[2H4], 1000 ~g /mL in methanol 5a-Androstan-3~, 17~-diol-[2H4]-17-sulfate, 100 ~g /mL in methanol 5a-Androstan-3~, 17~-diol-[2H4]-17-sulfate, 1000 ~g /mL in methanol 5a-Androstan-3~, 17~-diol-[2H4]-3-sulfate, ~tg 100 /mL in methanol 5a-Androstan-3~, 17~-diol-[2H4 ]-3-sulfate, 1000 /mL in methanol Androst-4-ene-3,17 -diane, 100 ~g /mL in methanol Androst-4-ene-3,17-dione, 1000 ~g/mL in methanol Androst-4-ene-3,17-dione-[13C3], 100 ~g /mL in methanol Androst-4-ene-3,17-dione-[13C3], 1000 ~tg /mL in methanol Androst-4-ene-3,17-dione-[2H7], 100 ~g /mL in methanol Androst-4-ene-3,17-dione-[2H7], 1000 ~g /mL in methanol ~tg Boldenone sulfate, 100 ~tg /mL Boldenone sulfate, 1000 Boldenone, 100 ~g Boldenone, 1000 ~tg PO 00000 /mL in methanol /mL in methanol ~tg /mL in methanol Dihydrotestosterone, 100 Jkt 238001 in methanol Frm 00101 ~g/mL Fmt 4701 in methanol Sfmt 4725 Amber Ampule: 1 mL Amber Ampule: 1 mL Amber Ampule: 1 mL Amber Ampule: 1 mL Amber Ampule: 1 mL Amber Ampule: 1 mL Amber Ampule: 1 mL Amber Ampule: 1mL Amber Ampule: 1 mL Amber Ampule: 1mL Amber Ampule: lmL Amber Ampule: 1 mL Amber Ampule: 1 mL Amber Ampule: 1 mL Amber Ampule: 1mL Amber Ampule: lmL Amber Ampule: 1 mL Amber Ampule: 1 mL Amber Ampule: lmL Amber Ampule: 1 mL Amber Ampule: 1 mL Amber Ampule: lmL Amber Ampule: lmL E:\FR\FM\25MRN2.SGM 25MRN2 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 EN25MR16.276</GPH> ebenthall on DSK6SPTVN1PROD with NOTICES2 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices 16992 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices ebenthall on DSK6SPTVN1PROD with NOTICES2 1soSciences, LLC !so Sciences, LLC !so Sciences, LLC !so Sciences, LLC !so Sciences, LLC IsoSciences, LLC !so Sciences, LLC IsoSciences, LLC !so Sciences, LLC !so Sciences, LLC IsoSciences, LLC Iso Sciences, LLC Iso Sciences, LLC Iso Sciences, LLC Iso Sciences, LLC Iso Sciences, LLC !so Sciences, LLC IsoSciences, LLC IsoSciences, LLC IsoSciences, LLC IsoSciences, LLC VerDate Sep<11>2014 18:45 Mar 24, 2016 Dihydrotestosterone, 1000 ~tg/mL Dihydrotestosterone-[l3C3], 100 methanol in methanol ~g Dihydrotestosterone-[l3C3], 1000 methanol Methandriol, 100 ~g Methandriol, 1000 ~g Nandrolone Laurate, 100 ~tg /mL in methanol ~g ~g Nandrolone Laurate, 1000 Stanozolo1, 1000 /mL in /mL in methanol Methandrostenolone, 1000 ~g ~g /mL in methanol Methandrostenolone, 100 Stanozolol, 100 /mL in /mL in methanol /mL in methanol ~g /mL in methanol /mL in methanol ~g /mL in methanol Testosterone Decanoate, 100 ~tg /mL in 1,2dimethoxyethane Testosterone Decanoate, 1000 ~tg /mL in 1,2dimethoxyethane Testosterone Glucuronide, 100 ~g /mL in methanol Testosterone Glucuronide, 1000 ~tg /mL in methanol Testosterone Heptanoate, 100 ~g /mL in 1,2dimethoxyethane Testosterone Heptanoate, 1000 ~g /mL in 1,2dimethoxyethane Testosterone Isocaproate, 100 ~g /mL in methanol Testosterone Isocaproate, 1000 ~g /mL in methanol Testosterone Phenylpropionate, 100 ~g /mL in methanol Testosterone Phenylpropionate, 1000 ~g /mL in methanol Testosterone Propionate, 100 ~g /mL in 1,2dimethox'Y ethane Testosterone Propionate, 1000 ~g /mL in 1,2dimethox)'ethane Jkt 238001 PO 00000 Frm 00102 Fmt 4701 Sfmt 4725 Amber Ampule: 1 mL Amber Ampule: 1mL Amber Ampule: 1 mL Amber Ampule: 1mL Amber Ampule: 1 mL Amber Ampule: 1 mL Amber Ampule: lmL Amber Ampule: 1 mL Amber Ampule: 1 mL Amber Ampule: 1 mL Amber Ampule: 1mL Amber Ampule: 1 mL Amber Ampule: 1mL Amber Ampule: 1 mL Amber Ampule: 1 mL Amber Ampule: 1mL Amber Ampule: 1 mL Amber Ampule: 1mL Amber Ampule: 1 mL Amber Ampule: 1 mL Amber Ampule: 1mL Amber Ampule: 1 mL Amber Ampule: 1 mL E:\FR\FM\25MRN2.SGM 25MRN2 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9!17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 9/17/2015 EN25MR16.277</GPH> !so Sciences, LLC !so Sciences, LLC 16993 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Amber Ampule: 1 mL 9/17/2015 Testosterone Undecanoate, 1000 J.tg /mL in methanol Amber Ampule: 1mL 9/17/2015 IsoSciences, LLC Testosterone, 100 J.tg/mL in methanol Amber Ampule: 1mL 9/17/2015 IsoSciences, LLC Testosterone, 1000 J.tg/mL in methanol Amber Ampule: lmL 9/17/2015 IsoSciences, LLC Testosterone-[13C3], 100 J.tg/mL in methanol Amber Ampule: 1 mL 9/17/2015 IsoSciences, LLC Testosterone-[13C3], 1000 J.tg/mL in methanol Amber Ampule: 1mL 9/17/2015 IsoSciences, LLC Testosterone-[2H3] Decanoate, 100 J.tg /mL in 1,2 -dimethoxyethane Amber Ampule: 1 mL 9/17/2015 IsoSciences, LLC Testosterone-[2H3] Decanoate, 1000 J.tg /mL in 1,2-dimethoA'}'ethane Amber Ampule: 1mL 9/17/2015 IsoSciences, LLC Testosterone-[2H3] Glucuronide, 100 methanol Amber Ampule: 1 mL 9/17/2015 IsoSciences, LLC Testosterone-[2H3] Glucuronide, 1000 J.tg /mL in methanol Amber Ampule: 1 mL 9/17/2015 IsoSciences, LLC Testosterone-[2H3] Heptanoate, 100 J.tg /mL in 1,2-dimethOA'}'ethane Amber Ampule: 1mL 9/17/2015 IsoSciences, LLC Testosterone-[2H3] Heptanoate, 1000 J.tg /mL in 1,2-dimethOA'}'ethane Amber Ampule: 1mL 9/17/2015 IsoSciences, LLC Testosterone-[2H3] Isocaproate, 100 methanol Amber Ampule: 1mL 9/17/2015 IsoSciences, LLC Testosterone-[2H3] Isocaproate, 1000 J.tg /mL in methanol Amber Ampule: 1 mL 9/17/2015 IsoSciences, LLC Testosterone-[2H3] Phenylpropionate, 100 J.tg /mL in methanol Amber Ampule: 1 mL 9/17/2015 IsoSciences, LLC Testosterone-[2H3] Phenylpropionate, 1000 J.tg /mL in methanol Amber Ampule: 1mL 9/17/2015 !so Sciences, LLC Testosterone-[2H3] Propionate, 100 J.tg /mL in 1,2 -dimethoxyethane Amber Ampule: 1 mL 9/17/2015 !so Sciences, LLC Testosterone-[2H3] Propionate, 1000 J.tg /mL in 1,2-dimethoxyethane Amber Ampule: 1 mL 9/17/2015 IsoSciences, LLC Testosterone-[2H3] Undecanoate, 100 J.tg /mL in methanol Amber Ampule: 1 mL 9/17/2015 !so Sciences, LLC Testosterone-[2H3] Undecanoate, 1000 J.tg /mL in methanol Amber Ampule: 1mL 9/17/2015 !so Sciences, LLC Testosterone-[2H3], 100 J.tg/mL in methanol Amber Ampule: 1 mL 9/17/2015 !so Sciences, LLC Testosterone-[2H3], 1000 J.tg/mL in methanol Amber Ampule: 1 mL 9/17/2015 Iso Sciences, LLC Testosterone-[2H5], 100 Amber Ampule: 1mL 9/17/2015 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00103 ~tg/mL Fmt 4701 ~tg ~tg /mL in /mL in in methanol Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.278</GPH> Testosterone Undecanoate, 100 J.tg /mL in methanol IsoSciences, LLC ebenthall on DSK6SPTVN1PROD with NOTICES2 IsoSciences, LLC 16994 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Testosterone-[2H5], 1000 Jlg/rnL in methanol Unlabeled Steroid Standard Mix SMUOOl, methanol Unlabeled Steroid Standard Mix SMU002, methanol ITC directCHECK Whole Blood Control (DCJACTA) ITC directCHECK Whole Blood Control (DCJACTN) ITC directCHECK Whole Blood Control (DCJAPTT -A) ITC directCHECK Whole Blood Control (DCJAPTT-N) ITC directCHECK Whole Blood Control (DCJCAPTT-A CITRATE) ITC directCHECK Whole Blood Control (DCJCPTA CITRATE) ITC directCHECK Whole Blood Control (DCJCPTNCITRATE) ITC directCHECK Whole Blood Control (DCJLR-A) ITC directCHECK Whole Blood Control (DCJLR-N) ITC directCHECK Whole Blood Control (DCJPT-A) ITC directCHECK Whole Blood Control (DCJPT-N) TTC directCHECK Whole Blood Control (DCPROA) ITC directCHECK Whole Blood Control (DCPRON) ITC directCHECK Whole Blood Control (DCRHYLl) ITC directCHECK Whole Blood Control (DCRHYL2) ITC HepCheck Whole Blood Control (DCP214-A) ITC HepCheck Whole Blood Control (DCP214-N) Amber Ampule: 1 mL Amber Ampule: 1 rnL Amber Ampule: 1 mL Box: 15 vials; 0.5 rnL each Box: 15 vials; 0.5 rnL each Box: 15 vials; 0.5 rnL each Box: 15 vials; 0.5 mL each Box: 15 vials; 0.5 rnL each Box: 15 vials; 0.5 mL each Box: 15 vials; 0.5 rnL each Box: 15 vials; 0.5 mL each Box: 15 vials; 0.5 rnL each Box: 15 vials; 0.5 mL each Box: 15 vials; 0.5 mL each Box: 15 vials; 0.5 rnL each Box: 15 vials; 0.5 rnL each Box: 15 vials; 0.5 rnL each Box: 15 vials; 0.5 rnL each Box: 15 vials; 0.5 rnL each Box: 15 vials; 0.5 rnL each ebenthall on DSK6SPTVN1PROD with NOTICES2 ITC PCAPTT-QQ Bag: 250-750 tubes; 0.5 mL each ITC PCCAPTT-AQ Bag: 250-750 tubes; 0.5 rnL each VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00104 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 9/17/2015 9/17/2015 9/17/2015 9/12/2013 9/12/2013 9/12/2013 9/12/2013 9/12/2013 9/12/2013 9/12/2013 9/12/2013 9/12/2013 9/12/2013 9/12/2013 9/12/2013 9112/2013 9/12/2013 9/12/2013 9/12/2013 9/12/2013 9/12/2013 9/12/2013 EN25MR16.279</GPH> IsoSciences, LLC IsoSciences, LLC IsoSciences, LLC 16995 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices 9/12/2013 PCJACT-NQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 PCJCPT-AQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 ITC PCJCPT-NQ Bag: 250- 7 50 tubes; 0.5 mL each 9/12/2013 lTC PCJLR-AQ Bag:250-750 tubes; 0.5 mL each 9/12/2013 lTC PCJLR-NQ Bag: 250- 750 tubes; 0.5 mL each 9/12/2013 ITC PCJPT-AQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 ITC PCJPT-NQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 ITC PCPRO-AQ Bag: 250- 750 tubes; 0.5 mL each 9/12/2013 ITC PCPRO-NQ Bag: 250-750 tubes; 0.5 mL each 9/12/2013 LGCLimited (S)-(+)-Amphetamine (De:'l.iroamphetamine) 0.1 mg/ml in Methanol Glass vial: 1 mL 6/23/2014 LGCLimited Alprazolam 0.1 mg/ml in Methanol Glass vial: 1 mL 6/23/2014 LGCLimited Amobarbital 0.1 mg/ml in Methanol Glass vial: 1 mL 6/23/2014 LGCLimited Chlordiazepoxide 0.1 mg/ml in Acetonitrile Glass vial: 1 mL 6/23/2014 LGCLimited Chlordiazepoxide 0.1 mg/ml in Methanol Glass vial: 1 mL 6/23/2014 LGC Litnited Chlordiazepoxide 1.0 mg/ml in Acetonitrile Glass vial: 1 mL 6/23/2014 LGCLimited Chlordiazepoxide-D5 0.1 mg/ml in Acetonitrile Glass vial: 1 mL 6/23/2014 LGCLimited Clobazam 0.1 mg/ml in Methanol Glass vial: 1 mL 6/23/2014 LGCLimited Clonazepam 0.1 mg/ml in Methanol Glass vial: 1 mL 6/23/2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00105 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.280</GPH> Bag: 250- 750 tubes; 0.5 mL each lTC VerDate Sep<11>2014 PCJACT-AQ ITC ebenthall on DSK6SPTVN1PROD with NOTICES2 lTC 16996 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices LGCLimited Ecgonine Ethyl Ester 0.1 mg/ml in Acetonitrile Glass vial: 1 mL 6/23/2014 LGCLimited Estazolam 0.1 mg/ml in Methanol Glass vial: 1 mL 6/23/2014 LGC Limited Fluoxymesterone 1.0 mg/ml in 1,2Dimethoxyethane Glass vial: 1 mL 6/23/2014 LGCLimited Lonnetazepam 0.1mg/ml in Methanol Glass vial: 1mL 6/23/2014 LGCLimited Meprobamate 0.1 mg/ml in Methanol Glass vial: 1 mL 6/23/2014 Glass vial: 1 mL 6/23/2014 Glass vial: 1 mL 6/23/2014 Glass vial: 1 mL 6/23/2014 LGCLimited LGCLimited LGCLimited Meprobamate-D7 (2-methyl-1,3-propanediolD7) 0.1mg/mL in Methanol Methamphetamine ((S)-( +)-Methamphetamine) O.lmg/mL in Methanol Methandieone 1.0 mg/tnl in 1,2Dimethoxyethane LGCLimited Methaqualone 0.1 mg!Inl in Methanol Glass vial: 1 mL 6/23/2014 LGCLimited Methenolone 1.0 mg/ml in Acetonitrile Glass vial: 1 mL 6/23/2014 Glass vial: 1 mL 6/23/2014 Glass vial: 1 mL 6/23/2014 LGCLimited LGCLimited Methyltestosterone (17alphaMethyltestosterone) 1.0 mg/ml in1,2Dimethoxyethane Norethandrolone 1.0 mg/ml in 1,2Dimetho>..yrethane Glass vial: 1 mL 6/23/2014 Pentobarbital 0.1 mg/mL in Methanol Glass vial: 1 mL 6/23/2014 LGCLimited Phencyclidine (PCP) 0.01 mg/ml in Methanol Glass vial: 1 mL 6/23/2014 LGCLimited Phenobarbital 0.1 mg/ml in Methanol Glass vial: 1 mL 6/23/2014 LGCLimited Phentennine 0.1 mg/ml in Methanol Glass vial: 1 mL 6/23/2014 LGC Litnited Pipradrol Hydrochloride O.Olmg/ml in Methanol Glass vial: 1 mL 6/23/2014 LGCLimited Prazepam 0.1 mg/ml in Methanol Glass vial: 1 mL 6/23/2014 LGCLimited rac-Amphetamine-D10 0.1mg/ml in Methanol Glass vial: 1 mL 6/23/2014 LGC Limited Secobarbital 0.1 mg/ml in Methanol Glass vial: 1 mL 6/23/2014 LGC Limited Secobarbital-D5 O.lmg/ml in Methanol Glass vial: 1 mL 6/23/2014 LGCLimited Stanozolol-D3 1.0 mg/ml in 1,2Dimetho>..yrethane Glass vial: 1 mL 6/23/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00106 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.281</GPH> Oxazepam 0.1 mg/ml in Methanol LGCLimited ebenthall on DSK6SPTVN1PROD with NOTICES2 LGCLimited 16997 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices LGC Limited LGC Standards LGC Standards LGC Standards LGC Standards LGC Standards LGC Standards Glass vial: 1 mL Triazolam 0.1 mg/ml in Methanol 1-Naphyrone Hydrochloride ( 1-Naphthalen-1yl-2-pyrrolidin-1-ylpentan-1-one Hydrochloride) 1.0 mg/ml in Methanol (as free base) 2-Fluoromethcathinone Hydrochloride (1-(2Fluorophenyl)-2-(methylarnino )propan-1-one Hydrochloride) 1.0 mg/ml in Methanol (as free base) 2-MMC HCl (2-Methylmethcathinone Hydrochloride) 1.0 mg/ml in Methanol (as free base) 3,4-Dichloromethylphenidate Hydrochloride (3,4-CTMP HCl; Methyl (2RS)-3,4Dichlorophenyl[(2RS)-piperidin-2-yl]acetate Hydrochloride) 1.0 mg/ml in Methanol (as free base) 3',4'-Methylenedioxy-alphapyrrolidinobutiophenone Hydrochloride (MDPBP HCl) 1.0 mg/ml in Methanol (as free base) 3,4-Methylenedioxycathinone Hydrochloride (MDC HCl, bk-MDA HCl) 1.0 mg/ml in Methanol (as free base) 6/23/2014 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 3-Acetylmorphine 0.1 mg/ml in Acetonitrile Glass ampule: 1 mL 6/8/2015 LGC Standards 3-Acetylmorphine 1.0 mg/ml in Acetonitrile Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 LGC Standards LGC Standards LGC Standards LGC Standards LGC Stat1dards ebenthall on DSK6SPTVN1PROD with NOTICES2 LGC Standards LGC Standards VerDate Sep<11>2014 18:45 Mar 24, 2016 3-Fluoromethcathinone Hydrochloride ( 1-(3Fluorophenyl)-2-(methylamino )propan-1-one Hydrochloride) 1.0 mg/ml in Dimethyl Sulfoxide (as free base) 4-EMC HCl (4-Ethylmethcathinone Hydrochloride) 1.0 mg/ml in Methanol (as free base) 4-MePPP HCl (4-Methyl-alphapyrrolidinopropiophenone Hydrochloride) 1.0 mg/ml in Methanol (as free base) 5-F-AKB-48 (5-F-APINACA; N-(1Adamantyl)-1-(5-fluoropentyl)-1H -indazole-3carboxatnide) 0.1 mg/ml in Acetonitrile 5-F-AKB-48 (5-F-APINACA; N-(1Adamatltyl)-1-(5-fluoropentyl)-lH-indazole-3carboxarnide) 1.0 mg/ml in Acetonitrile AKB-48 (APINACA; N-(1-Adamantyl)-1pentyl-1H-indazole-3-carboxamide) 0.1 mg/ml in Acetonitrile AKB-48 (APINACA; N-(1-Adamantyl)-1pentyl-1H-indazole-3-carboxamide) 1.0 mg/ml in Acetonitrile Jkt 238001 PO 00000 Frm 00107 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.282</GPH> LGC Standards 16998 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices LGC Standards Allobatbital 0.1 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 LGC Standards Allobatbital 1.0 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 LGC Standards LGC Stat1dards LGC Standards AM-220 1 ((l-(5-Fluoropentyl)indol-3yl)(naphthalen-1-yl)methanone) 0.1 mg/ml in Acetonitrile AM-2201 ((1-(5-Fluoropentyl)indol-3yl)(naphthalen-1-yl)methanone) 1.0 mg/ml in Acetonitrile AM-694 (1-(5-Fluoropentyl)-3-(2iodobenzoyl)indole) 0.1 mg/ml in Acetonitrile LGC Standards Anhydroecgonine Hydrochloride 1.0 mg/ml in Water (as free base) Glass ampule: 1 mL 6/8/2015 LGC Standards Benzoylecgonine 1.0 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 Glass atnpule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 LGC Standards LGC Standards LGC Standards Benzylpiperazine Dihydrochloride (BZP Dihydrochloride) 1.0 mg/ml in Methanol (as free base) beta-Ethylmethcathinone Hydrochloride (Pentedrone Hydrochloride)l.O mg/ml in Methanol (as free base) bk-2C-B HCl (2-Amino-l-(4..:bromo-2,5dimethoxypheny l)ethanone Hydrochloride) 1. 0 mg/ml in Methanol (as free base) Buprenorphine 1.0 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 LGC Standards Buprenorphine 3-beta-D-Glucuronide 0.1 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 LGC Standards Butylone Hydrochloride 1.0 mg/ml in Methanol (as free base) LGC Standards Cocaethylene (Benzoylethylecgonine) 0.1 mg/ml in Acetonitrile Glass ampule: 1 mL Glass ampule: 1 mL LGC Standards Cocaine 0.1 mg/ml in Acetonitrile Glass ampule: 1 mL 6/8/2015 LGC Standards Cocaine-D8 0.1 mg/ml in Acetonitrile Glass an1pule: 1 mL 6/8/2015 LGC Standards Cocaine-D8 1.0 mg/ml in Acetonitrile Glass ampule: 1 mL 6/8/2015 LGC Stat1dards Desomorphine (Dihydrodesox-ymorphine, Krokodil) 0.01 mgltul in Methanol Glass ampule: 1 mL 6/8/2015 LGC Stat1dards Desomorphine (Dihydrodesoxymorphine, Krokodil) 1.0 mg/ml in Methanol Glass atnpule: 1 mL 6/8/2015 LGC Stat1dards Dibutylone Hydrochloride (bk-MMBDB HCl) 1.0 mg/ml in Methanol (as free base) Glass ampule: 1 mL 6/8/2015 LGC Standards Dihydromorphine 0.1 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 LGC Stat1dards Embutramide 1.0 mg/ml in Acetonitrile Glass atnpule: 1 mL 6/8/2015 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00108 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 6/8/2015 6/8/2015 EN25MR16.283</GPH> ebenthall on DSK6SPTVN1PROD with NOTICES2 LGC Standards 16999 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices LGC Standards Epitestosterone 1.0 mg/ml in Acetonitrile Glass ampule: 1 mL 6/8/2015 LGC Standards Ethcathinone Hydrochloride (N-Ethylcathinone Hydrochloride) 1.0 mg/ml in Methanol (as free base) Glass ampule: 1 mL 6/8/2015 LGC Standards Ethylmorphine 0.1 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 LGC Standards Ethylmorphine 1.0 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 LGC Standards Ethylmorphine-D5 0.1 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 LGC Standards Ethylmorphine-D5 1.0 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 LGC Standards Ethylone Hydrochloride 1.0 mg/ml in Methanol (as free base) Glass ampule: 1 mL 6/8/2015 Ethylone-D5 Hydrochloride 0.1 mg/ml in Methanol (as free base) Euty lone Hydrochloride (1-(3 ,4Me thy lenedioxypheny1)-2-ethylamino-butan-1one Hydrochloride) 1.0 mg/ml in Methanol (as free base) Flephedrone Hydrochloride (4Fluoromethcathinone Hydrochloride) 1.0 mg/ml in Dimethy I Sulfoxide (as free base) Flephedrone Hydrochloride (4Fluoromethcathinone Hydrochloride) 1.0 mg/ml in Methanol (as free base) Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 LGC Standards LGC Standards LGC Standards LGC Standards LGC Standards FluoAymesterone 1.0 mg/ml in Acetonitrile Glass ampule: 1 mL 6/8/2015 LGC Standards Heroin (Diacetylmorphine) 0.01 mg/ml in Acetonitrile Glass ampule: 1 mL 6/8/2015 Heroin-D3 (Diacetylmorphine-D3) 0.1 mg/ml in Acetonitrile Heroin-D3 (Diacetylmorphine-D3) 1.0 mg/ml in Acetonitrile Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 LGC Standards LGC Standards Hexobarbital 1.0 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 LGC Standards Hydrocodone 0.1 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 LGC Standards Hydromorphone 0.1 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 LGC Standards ebenthall on DSK6SPTVN1PROD with NOTICES2 LGC Standards LGC Standards VerDate Sep<11>2014 18:45 Mar 24, 2016 Isomethadone ((5RS)-6-(Dimethylamino)-5methyl-4,4-diphenylhexan-3-one) 0.1 mg/ml in Methanol JWH-0 18 ((Naphthalen-l-yl)(1-pentylindol-3yl)methanone) 1.0 mg/ml in Acetonitrile JWH -081 ((4-Methoxynaphthalen-1-y I)( 1pentylindol-3-yl)methanone) 0.1 mg/ml in Acetonitrile Jkt 238001 PO 00000 Frm 00109 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.284</GPH> LGC Standards 17000 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices LGC Standards LGC Standards LGC Standards LGC Standards LGC Standards LGC Standards LGC Standards LGC Standards LGC Standards JWH-122 ((4-Methylnaphthalen-1-yl)(1pentylindol-3-yl)methanone) 0.1 mg/ml in Acetonitrile JWH-203 (2-(2-Chlorophenyl)-1-(l-pentylindol3-yl)ethanone) 0.1mg/ml in Acetonitrile JWH-250 (2-(2-Methoxyphenyl)-1-(lpentylindol-3-yl)ethanone) 0.1mg/ml in Acetonitrile JWH-250 (2-(2-Methoxyphenyl)-1-(1pentylindol-3-yl)ethanone) 1.0 mg/ml in Acetonitrile JWH-398 ((4-Chloronaphthalen-1-yl)(1pentylindol-3-yl)methanone) 1.0 mg/ml in Acetonitrile Mephedrone Hydrochloride (4-MMC HCl, 4Me thy lmethcathinone Hydrochloride) 1. 0 mg/ml in Methanol (as free base) Mephedrone-D3 Hydrochloride (4-MMC-D3 HCl, 4-Methylmethcathinone-D3 Hydrochloride) 0.1 mg/ml in Methanol (as free base) Methamphetamine Hydrochloride ((S)-(+)Methamphetamine Hydrochloride) 0.1 mg/ml in Methanol (as free base) 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL Lorazepam-D4 0.1 mg/ml in Acetonitrile Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Methamphetamine Hydrochloride ((S)-(+)Methamphetamine Hydrochloride) 1.0 mg/ml in Methanol (as free base) Methylenedioxypyrovalerone Hydrochloride (MDPV HCl) 1.0 mg/ml in Methanol (as free base) Methylethcathinone Hydrochloride (4-MethylN-ethylcathinone Hydrochloride, 4-J\.1EC HCl) 1.0 mg/ml in Methanol (as free base) Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 LGC Standards Midazolam 0.1 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 LGC Standards Moda:finill.O mg/ml in Acetonitrile Glass ampule: 1 mL 6/8/2015 LGC Standards Morphine N-Oxide 0.1mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 LGC Standards LGC Standards LGC Standards LGC Standards LGC Standards Morphine-D6 0.1mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 LGC Standards Morphine-D6 1.0 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00110 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.285</GPH> ebenthall on DSK6SPTVN1PROD with NOTICES2 LGC Standards Morphine-D3 3-beta-D-Glucuronide O.lmg/ml in Methanol with 0.05 percent Sodium Hydroxide (w/v) Morphine-D3 6-beta-Glucuronide 0.1 mg/ml in Methanol/Water (l/1) 17001 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices LGC Standards Nalorphine Hydrochloride 1.0 mg/ml in Methanol (as free base) Glass ampule: 1 mL 6/8/2015 LGC Standards Naphyrone Hydrochloride (1-Naphtha1en-2-yl2-pyrrolidin-1-ylpentan-1-one Hydrochloride) 1.0 mg/ml in Methanol (as free base) Glass ampule: 1 mL 6/8/2015 LGC Standards N -Desmethy ldextromethorphan Hydrochloride (ent-3-Methoxymorphinan Hydrochloride) 1.0 mg/ml in Methanol (as free base) Glass ampule: 1 mL 6/8/2015 LGC Standards N-Ethylbuphedrone Hydrochloride (NEB HCI, alpha-Ethylaminobutyrophenone Hydrochloride) 1.0 mg/ml in Methanol (as free base) Glass ampule: 1 mL 6/8/2015 LGC Standards Norrnorphine 0.01mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 LGC Standards Noroxymorphone Hydrochloride 1.0 mg/ml in Dimethyl Sulfoxide (as free base) Glass ampule: 1 mL 6/8/2015 LGC Standards Norpethidine (Nonneperidine) 0.1 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 LGC Standards Norpethidine-D4 (Norrneperidine-D4) 0.1 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 LGC Standards Oripavine 0.1 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 LGC Standards Oxycodone 0.1 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 LGC Standards Oxymorphone 0.1 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 LGC Standards Pentylone Hydrochloride 1.0 mg!tul in Methanol (as free base) Glass ampule: 1 mL 6/8/2015 LGC Standards Pethidine (Meperidine) 0.1 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 LGC Standards LGC Standards Pethidine Acid (Meperidine Acid, 1-Methyl-4phenylpiperidine-4-carbox-ylic Acid) 0.1 mg/ml in Methanol Pethidine Acid Methyl Ester (Meperidine Acid Methyl Ester, Methyl1-Methyl-4phenylpiperidine-4-carboxylate) 0.1 mg/ml in Methanol Pholcodine-D3 0.1 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 LGC Standards Pholcodine-D3 1.0 mg/ml in Methanol Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 mL 6/8/2015 LGC Standards ebenthall on DSK6SPTVN1PROD with NOTICES2 LGC Standards LGC Standards VerDate Sep<11>2014 18:45 Mar 24, 2016 PMEA HCl (p-Methox-yethylan1phetamine Hydrochloride) 1.0 mg/ml in Methanol (as free base) PPP HCl (alpha-Pyrrolidinopropiophenone Hydrochloride) 1. 0 mg/ml in Methanol (as free base) Properidine ( 1-Methylethyl1-Methyl-4-phenylpiperidine-4-carbox)' late) 0. 01 mg/ml in Methanol Jkt 238001 PO 00000 Frm 00111 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.286</GPH> LGC Standards 17002 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices LGC Standards LGC Standards Properidine (1-Methylethyl1-Methyl-4-phenylpiperidine-4-carboxylate) 1. 0 mg/rnl in Methanol rac-Amphetamine-D 11 Hydrochloride 0.1 mg/rnl in Methanol (as free base) Glass ampule: 1 rnL 6/8/2015 Glass ampule: 1 rnL 6/8/2015 LGC Standards rac-Amphetamine-D ll Hydrochloride 1.0 mg/rnl in Methanol (as free base) Glass ampule: 1 rnL 6/8/2015 LGC Standards rac-Amphetamine-D6 Hydrochloride 0.1 mg/ml in Methanol (as free base) Glass ampule: 1 rnL 6/8/2015 rac-Amphetamine-D6 Hydrochloride 1.0 mg/rnl in Methanol (as free base) rac-Amphetamine-D8 Hydrochloride 0.1 mg/rnl in Methanol (as free base) rac-Amphetamine-D8 Hydrochloride 1.0 mg/ml in Methanol (as free base) Glass ampule: 1 rnL 6/8/2015 Glass ampule: 1 rnL 6/8/2015 Glass ampule: 1 rnL 6/8/2015 rac-Cathinone Hydrochloride 1.0 mg/rnl in Methanol (as free base) rac-MDA (rac-3,4Methylenedioxyamphetan1ine) 0.01mg/rnl in Methanol rac-MDEA (rac-3,4-Methylenedioxy-Nethy!amphetamine) 0. 01 mg/ml in Methanol rac-MDEA-D6 (rac-3,4-Methylenedioxy-Nethylamphetamine-D6) O.lmg/ml in Methanol rac-MDMA (rac-3,4Me thy 1enedioxymethamphetamine) 0. 01 mg/rnl in Methanol rac-Methamphetamine-D 11 Hydrochloride 1.0 mg/rnl in Methanol (as free base) Glass ampule: 1 rnL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 rnL 6/8/2015 Glass ampule: 1 rnL 6/8/2015 Glass ampule: 1 mL 6/8/2015 Glass ampule: 1 rnL 6/8/2015 rac-Methamphetamine-D14 Hydrochloride 0.1 mg/rnl in Methanol (as free base) rac-Methamphetamine-D14 Hydrochloride 1.0 mg/ml in Methanol (as free base) RCS-4 (DD-001, (4-Methoxyphenyl)(1pentylindol-3-yl)methanone) 0.1 mg/rnl in Acetonitrile RCS-8 (1-(1-(2-Cyclohex;rlethyl)indol-3-yl)-2(2-methoxyphenyl)ethanone) 1.0 mg/rnl in Acetonitrile Glass ampule: 1 mL Glass ampule: 1 rnL LGC Standards LGC Standards LGC Standards LGC Standards LGC Standards LGC Standards LGC Standards LGC Standards LGC Standards LGC Standards LGC Standards LGC Standards LGC Standards 6/8/2015 6/8/2015 Glass ampule: 1 rnL 6/8/2015 Glass ampule: 1 rnL 6/8/2015 Glass ampule: 1 rnL 6/8/2015 Tilidine Hydrochloride Hemihydrate 1.0 mg/rnl in Methanol (as anhydrous free base) Glass ampule: 1 rnL 6/8/2015 Tramadol Hydrochloride 1.0 mg/rnl in Methanol (as free base) Tramadol-13C-D3 Hydrochloride 0.1 mg/rnl in Methanol (as free base) Glass ampule: 1 rnL 6/8/2015 Glass ampule: 1 rnL 6/8/2015 LGC Standards LGC Standards VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00112 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.287</GPH> Thebaine 0.1 mg/ml in Methanol LGC Standards ebenthall on DSK6SPTVN1PROD with NOTICES2 LGC Standards 17003 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices UR-144 ((1-Pentylindol-3-yl)(2,2,3,3tetramethylcyclopropyl)methanone, KM X-1) 0.1 mg/ml in Acetonitrile Glass ampule: 1 mL 6/8/2015 LGC Standards UR-144 ((1-Pentylindol-3-yl)(2,2,3,3tetramethylcyclopropyl)methanone, KM X-1) 1.0 mg/rnl in Acetonitrile Glass ampule: 1 mL 6/8/2015 Lipomed Inc. 1-Benzylpiperazine.2HC1 (1 mg/1 mL Methanol) Glass ampule: 1 mL 4/8/2013 Lipomed Inc. 2C-B-D6-HC1 (0.1 mg/1 mL Methanol) Glass ampule: 1 mL 1/5/2015 Lipomed Inc. 2C-B-D6-HC1 (1 mg/1 mL Methanol) Glass ampule: 1 mL 1/5/2015 Lipomed Inc. 2C-C.HC1 (1 mg/1 mL Methanol) Glass ampule: 1 mL 1/5/2015 Lipomed Inc. 2C-C-D6.HC1 (0.1 mg/1 mL Methanol) Glass ampule: 1 mL 1/5/2015 Lipomed Inc. 2C-C-D6.HC1 (1mg/1 mL Methanol) Glass ampule: 1 mL 115/2015 Lipomed Inc. 2C-D.HC1 (1 mg/1 mL Methanol) Lipomed Inc. 2C-E.HCl (1 mg/1 mL Methanol) Lipomed Inc. 2C-H.HC1(1 mg/1 mL Methanol) Lipomed Inc. 2C-I.HCl (1 mg/1 mL Methanol) Lipomed Inc. 2C-I-D6-HC1 (0.1 mg/1 mL Methanol) Lipomed Inc. 2C-I-D6-HC1 (1 mg/1 mL Methanol) Lipomed Inc. 2C-N.HC1 (1 mg/1 mL Methanol) Lipomed Inc. 2C-P.HC1 (1mg/l mL Methanol) Lipomed Inc. 2C-T-2.HCl (1 mg/1 mL Methanol) Lipomed Inc. 2C-T-4.HC1 (1 mg/1 mL Methanol) Glass ampule: 1 mL 4/8/2013 Lipomed Inc. 3,4-Methylendioxypyrovalerone.HCl (1 mg/1 mL Methanol) Glass ampule: 1 mL 4/8/2013 Lipomed Inc. 4-Methy lmethcathinone.HCl; Mephedrone.HCl (lmg/1 mL Methanol) Glass ampule: 1 mL 4/8/2013 Lipomed Inc. 6-Acetylmorphine-D6.HCl (0.1 mg/1 mL Methanol) Glass ampule: 1 mL 4/8/2013 Lipomed Inc. AM-2201 (0.1 mg/1 mL Methanol) Glass ampule: 1 mL 1/5/2015 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00113 Fmt 4701 Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Sfmt 4725 Glass ampule: 1 mL Glass ampule: 1 mL E:\FR\FM\25MRN2.SGM 25MRN2 1/5/2015 4/8/2013 4/8/2013 4/8/2013 1/5/2015 115/2015 1/5/2015 1/5/2015 4/8/2013 EN25MR16.288</GPH> ebenthall on DSK6SPTVN1PROD with NOTICES2 LGC Standards 17004 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices AM-2201 (1 mg/1 mL Methanol) Lipomed Inc. Amfepramone.HCl (1 mg/1 mL ethanol) Lipomed Inc. Benzodiazepines mixture 8 (0.25 mg/1 mL acetronitrile) Lipomed Inc. Boldenone (1 mg/1 mL Acetonitrile) Lipomed Inc. Bromazepam-D4 (0.1 mg/1 mL Methanol) Lipomed Inc. Bromazepam-D4 (1 mg/1 mL Methanol) Lipomed Inc. Lipomed Inc. Bufotenine.oxalate.monohydrate (1 mg/1 mL Methanol) Buphedrone.HCl (MABP.HC1)(1mg/1 mL Methanol) Lipomed Inc. Butabarbital(1 mg/1 mL Methanol) Lipomed Inc. Butalbital( 1 mg/1 mL Methanol) Lipomed Inc. Carisoprodol(! mg/1 mL Methanol) Lipomed Inc. Clonazepam-D4 (0.1 mg/1 mL Methanol) Lipomed Inc. Codeine-D6(0.1 mg/1 mL Methanol) Lipomed Inc. Codeine-D6(1 mg/1 mL Methanol) Lipomed Inc. d,l-2,5-DMA.HCl (1 mg/1 mL Methanol) Lipomed Inc. d,l-3,4,5-TMA.HCl (1mg/1 mL Methanol) Lipomed Inc. Lipomed Inc. Lipomed Inc. Lipomed Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Lipomed Inc. Lipomed Inc. Lipomed Inc. VerDate Sep<11>2014 18:45 Mar 24, 2016 d,l-3,4-Dimethoxyamphetamine.HCl d,l-3,4DMA.HCl (1 mg/1 mL Methanol) d,l-4-Methylmethcathinone-D3.HC1; Mephedrone-D3.HC1 (0.1 mg/1 mL Methanol) d,l-4-Methylmethcathinone-D3 .HCl; Mephedrone-D3.HC1 (1 mg/1 mL Methanol) d,l-Amphetamine-D ll.HCl (1 mg/1 mL Methanol) d,l-Amphetamine-D3.HCl (0.1 mg/1 mL Methanol) d,l-Amphetamine-D3.HCl (1 mg/1mL Methanol) d,l-Amphetamine-D5.HC1 (side chain) (0.1 mg/1 mL Methanol) Jkt 238001 PO 00000 Frm 00114 Fmt 4701 Sfmt 4725 Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 Glass ampule: 1 mL Glass an1pule: 1 mL Glass ampule: 1 mL E:\FR\FM\25MRN2.SGM 25MRN2 1/5/2015 4/8/2013 4/8/2013 115/2015 1/5/2015 115/2015 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 1/5/2015 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 EN25MR16.289</GPH> Glass ampule: 1 mL Glass ampule: 1 mL Lipomed Inc. 17005 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Lipomed Inc. d,l-Amphetamine-D5.HC1 (side chain) (1 mg/1 mL Methanol) Glass ampule: 1 mL 4/8/2013 Lipomed Inc. d,l-Cathinone.HC1(1 mg/lmL Acetonitri1e)/water (l/1) Glass ampule: 1 mL 4/8/2013 Lipomed Inc. d,l-Fenfluramine.HCl (1 mg/1 mL Methanol) Lipomed Inc. d,l-HMMA.HCl ( 1 mg/1 mL Methanol) Lipomed Inc. d,l-Metamfepramone.HCl (1 mg/1 mL Methanol) Lipomed Inc. d,l-Methylphenidate.HCl (1 mg/1 mL Methanol) Lipomed Inc. d,l-N,N-Dimethylamphetamine.HCl (1 mg/1 mL Methanol) Lipomed Inc. d,l-Pentobarbital-D5 (0.1 mg/1 mL Methanol) Lipomed Inc. d,l-Pentobarbital-D5 (1 mg/1 mL Methanol) Lipomed Inc. d,l-trans-Tilidine.HCI (1 mg/1 mL Methanol) Lipomed Inc. d,l-trans-Tilidine.HCl (1 mg/1 mL Methanol) Lipomed Inc. Desmethyldiazepam(1 mg/1 mL Methanol) Lipomed Inc. Desmethyldiazepam-D5 (Nordazepam-D5) (0.1 mg/1 mL Methanol) Desmethyldiazepam-D5 (Nordazepam-D5) (1 mg/1 mL Methanol) Desomorphine (1 mg/1 mL Acetonitrile) Lipomed Inc. Dihydrocodeine-D6.HC1 (0.1 mg/1 mL Methanol) Lipomed Inc. Dihydrocodeine-D6.HC1 (1 mg/1mL Methanol) Lipomed Inc. Estazolam(1 mg/1 mL Methanol) Lipomed Inc. Ethcathinone.HCl (1 mg/1 mL Methanol) Lipomed Inc. Fenethylline.HCl (1 mg/1mL Methanol) Lipomed Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Lipomed Inc. Fenethylline-D3.HC1 (0.1 mg/1 mL Methanol)) Lipomed Inc. Fenethylline-D3.HC1 (1 mg/1mL Methanol) Lipomed Inc. Heroin-D9 (1 mg/1 mL Acetonitrile) VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00115 Fmt 4701 Sfmt 4725 1 1 1 1 1 1 1 1 1 Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL 1 Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL 1 1 1 1 1 1 1 1 Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL E:\FR\FM\25MRN2.SGM 25MRN2 4/8/2013 4/8/2013 l/5/2015 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 1/5/2015 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 l/5/2015 4/8/2013 4/8/2013 4/8/2013 4/8/2013 EN25MR16.290</GPH> Lipomed Inc. Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL 17006 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Heroin-D9(0.1 mg/1 mL Acetonitrile) Glass ampule: 1 mL 4/8/2013 Lipomed Inc. Hexobarbital(! mg/1 mL Methanol) Glass ampule: 1 mL 4/8/2013 Lipomed Inc. Hydrocodone-D6(0.1 mg/1 mL Methanol) Lipomed Inc. Hydrocodone-D6(1 mg/1 mL Methanol) Lipomed Inc. JWH-018 (0.1 mg/1 mL Methanol) Lipomed Inc. JWH-018 (1 mg/1 mL Methanol) Lipomed Inc. JWH-018-Dll (0.1 mg/1 mL Methanol) Lipomed Inc. JWH-018-Dll (1 mg/1 mL Methanol) Lipomed Inc. JWH-019 (0.1 mg/1 mL Methanol) Lipomed Inc. JWH-019 (1 mg/1 mL Methanol) Lipomed Inc. JWH-073 (0.1 mg/1 mL Methanol) Lipomed Inc. JWH-073 (1 mg/1 mL Methanol) Lipomed Inc. JWH-081 (0.1 mg/1 mL Methanol) Lipomed Inc. JWH-081 (1 mg/1 mL Methanol) Lipomed Inc. JWH-122 (0.1 mg/1 mL Methanol) Lipomed Inc. JWH-122 (1 mg/1 mL Methanol) Lipomed Inc. JWH-200 (0.1mg/1 mL Methanol) Lipomed Inc. JWH-200 (1mg/l mL Methanol) Lipomed Inc. JWH-250 (0.1mg/lm.L Methanol) Lipomed Inc. JWH-250 (1mg/l mL Methanol) Lipomed Inc. 1-Metham.phetam.ine.HCl (1 m.g/1 m.L Methanol) Lipomed Inc. Loprazolam (lmg/1 mL Methanol) Lipomed Inc. Lorazepam-D4 (0.1 mg/1 mL Acetonitrile) VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00116 Fmt 4701 Sfmt 4725 Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: m.L Glass an1pule: m.L Glass ampule: mL Glass ampule: mL Glass ampule: mL 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 Glass ampule: 1 m.L Glass ampule: 1 mL Glass ampule: 1 mL E:\FR\FM\25MRN2.SGM 25MRN2 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 EN25MR16.291</GPH> ebenthall on DSK6SPTVN1PROD with NOTICES2 Lipomed Inc. 17007 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 1 mL Glass ampule: 1 mL Lipomed Inc. Lorazepam-D4 (1 mg/1 mL Acetonitrile) Lipomed Inc. Mazindol (1 mg/1 mL dimethylfonnamide) Lipomed Inc. Mazindol (l mg/1 mL Methanol) Lipomed Inc. Meperidine-D4.HC1 (0.1 mg/1 mL Methanol) Lipomed Inc. Meperidine-D4.HC1 (0.1 mg/1 mL Methanol) Glass ampule: 1 mL 1/5/2015 Lipomed Inc. Meperidine-D4.HC1 (1 mg/1 mL Methanol) Glass ampule: 1 mL l/5/2015 Lipomed Inc. Meperidine-D4.HC1 (1 mg/1 mL Methanol) Lipomed Inc. Meprobamate (1 mg/1 mL Methanol) Lipomed Inc. Meprobamate-D7 (0.1 mg/1 mL Methanol) Lipomed Inc. Lipomed Inc. Lipomed Inc. Lipomed Inc. Lipomed Inc. Lipomed Inc. Meprobamate-D7 (1 mg/1 mL Methanol) Glass ampule: 1 mL 1/5/2015 Mescaline-NB20Me.HC1 (1mgll mL Methanol) Glass ampule: 1 mL 115/2015 Methylone.HCl; bk-MDMA.HCl (1 mg/1 mL Methanol) Methylone-D3.HC1; bk-MDMA-D3.HC1 (0.1 mg/1 mL Methanol) Glass ampule: niL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Methylone-D3.HC1; bk-MDMA-D3.HC1 (0.1 mg/1 mL Methanol) Methylone-D3.HC1; bk-MDMA-D3.HC1 (1 mg/1 mL Methanol) Methylone-D3.HC1; bk-MDMA-D3.HC1 (1 mg/1 mL Methanol) Morphine-D3 (1mg/1 mL Methanol) Lipomed Inc. Nandrolone (1 mg/1 mL Methanol) Lipomed Inc. Nimet:azepan1 (1mg/1 niL Methanol) Lipomed Inc. Norbuprenorphine (0.1 mg/1 niL Methanol) Lipomed Inc. Norbuprenorphine (1 mg/1 mL Methanol) Lipomed Inc. Norbuprenorphine-D3 (O.lmg/1 niL Methanol) Jkt 238001 PO 00000 Frm 00117 Fmt 4701 Sfmt 4725 1 1 1 1 1 Glass ampule: 1 mL Lipomed Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 115/2015 4/8/2013 Morphine-D3 (0.1 mg/1 niL Methanol) 18:45 Mar 24, 2016 4/8/2013 Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Lipomed Inc. VerDate Sep<11>2014 4/8/2013 Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 niL Glass ampule: 1 mL Glass ampule: 1 niL Glass ampule: 1 niL E:\FR\FM\25MRN2.SGM 25MRN2 l/5/2015 115/2015 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 l/5/2015 115/2015 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 EN25MR16.292</GPH> Lipomed Inc. Glass ampule: 1 mL Glass ampule: 1 mL 4/8/2013 17008 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Lipomed Inc. Lipomed Inc. Lipomed Inc. Norbuprenorphine-D3 (1 mg/1 mL Methanol) Nom1eperidine.HCl ; Norpethidine.HCl (1 mg/1 mL Methanol) Normeperidine-D4.HC1 (0.1 mg/1 mL Methanol) Glass ampule: 1 mL 4/8/2013 Glass ampule: 1 mL 4/8/2013 Glass ampule: 1 mL Glass ampule: 1 mL 1/5/2015 Nonneperidine-D4.HC1 (1 mg/1 mL Methanol) Lipomed Inc. Noroxycodone.HCl (lmg/1 mL Methanol) Lipomed Inc. Oxycodone-D6.HCl (0.1 mg/1 mL Methanol) Lipomed Inc. Oxycodone-D6.HCl (1 mg/lmL Methanol) Lipomed Inc. Oxymorphone (1 mg/1 mL Methanol) Lipomed Inc. Ox:ymorphone-D3 (0.1mg/1 mL Methanol) Lipomed Inc. O>.')'morphone-D3 (lmg/1 mL Methanol) Lipomed Inc. Pregabalin (1 mg/1mL Methanol) Lipomed Inc. Propoxyphen-D5.HC1 (0.1 mg/1 mL Methanol) Lipomed Inc. Propo>.')'phen-D5.HCl (1 mg/1 mL Methanol) Lipomed Inc. Pyrovalerone.HCl (1 mg/1 mL Methanol) Lipomed Inc. RCS-4 (0.1 mg/1 mL Methanol) Lipomed Inc. RCS-4 (1mg/1 mL Methanol) Lipomed Inc. S(-)-Cathinone.HCl (1 mg/1 mL Acetonitrile) Glass ampule: 1 mL 1/5/2015 Lipomed Inc. Stanozolol (1mg/1 mL Acetonitrile) Glass ampule: 1 mL 1/5/2015 Lipomed Inc. Temazepam-glucuronide (0.1 mg/1 mL Methanol) Glass ampule: 1 mL 1/5/2015 Lipomed Inc. Thiopental( I mg/1 mL Methanol) Glass ampule: 1 mL 4/8/2013 Lipomed Inc. Trenbolone (1 mg/1 mL Acetonitrile) Glass ampule: 1 mL 1/5/2015 Lipomed Inc. Trenbolone (1 mg/1 mL Acetonitrile) Glass ampule: 1 mL 1/5/2015 Lipomed Inc. Trenbolone acetate (1 mg/1 mL Acetonitrile) Glass ampule: 1 mL 1/5/2015 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00118 Fmt 4701 Sfmt 4725 Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL Glass ampule: mL E:\FR\FM\25MRN2.SGM 1 1 1 1 1 1 1 1 1 1 1 25MRN2 1 1/5/2015 1/5/2015 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 1/5/2015 115/2015 EN25MR16.293</GPH> ebenthall on DSK6SPTVN1PROD with NOTICES2 Lipomed Inc. 17009 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Lipomed Inc. Trenbolone acetate (1 mg/1 mL Acetonitrile) Glass ampule: 1 mL 1/5/2015 Lipomed Inc. Zolpidem-D6.tartrate (0.1 mg/1 mL Methanol) Glass ampule: 1 mL 4/8/2013 Lipomed Inc. Zolpidem-D6.tartrate (1 mg/1 mL Methanol) Lipomed Inc. Zopiclone (1 mg/1 mL Acetonitrile) Lipomed Inc. Zopiclone-D4 (0.1 mg/1 mL Acetonitrile) Glass ampule: 1 mL 4/8/2013 Lipomed Inc. Zopiclone-D4 (1 mg/1 mL Acetonitrile) Glass ampule: 1 mL 4/8/2013 Microgenics Corporation Abbott Phenobarbital Catalog NUlllber: 5P07-21 Box: 6 bottles; 23 mL or8mL each 9/3/2013 Microgenics Corporation Cascadion SM Total Testosterone Calibrator Set Box: 6 vials, 5 mLeach 6/2/2014 Micro genies Corporation Micro genies Corporation Micro genies Corporation Microgenics Corporation Micro genies Corporation Micro genies Corporation Micro genies Corporation Micro genies Corporation Microgenics Corporation Micro genies Corporation ebenthall on DSK6SPTVN1PROD with NOTICES2 Micro genies Corporation Micro genies Corporation VerDate Sep<11>2014 18:45 Mar 24, 2016 Cascadion SM Total Testosterone Control 1 Cascadion SM Total Testosterone Control 2 Cascadion SM Total Testosterone Control 3 Cascadion SM Total Testosterone Internal Standard Reagent DRl Hydrocodone/Hydromorphone Assay Calibrator 100 ng/mL, Catalog Number: 10019837 DRl Hydrocodone/Hydromorphone Assay Calibrator 100 ng/mL, Part Number: 10018079 DRl Hydrocodone/Hydromorphone Assay Calibrator 1000 ng/mL, Part Number: 10018082 Box: 6 vials, 10 mL each Box: 6 vials, 10 mLeach 4/8/2013 4/8/2013 6/2/2014 6/2/2014 Box: 6 vials, 10 mLeach 6/2/2014 Box: 8 bottles, 29 mL each 8/26/2014 Box: 1 bottle, 10 mL 8/18/2014 Box: 1 Bottle, 10 mL Box: 1 Bottle, 10 mL 9/11/2014 9/11/2014 DRl Hydrocodone/Hydromorphone Assay Calibrator 1000 ng/mL, Part Number: 10019840 DRl Hydrocodone/Hydromorphone Assay Calibrator 300 ng/mL, Catalog Number: 10019838 DRl Hydrocodone/Hydromorphone Assay Calibrator 300 ng/mL, Part Number: 10018080 Box: 1 Bottle, 10 mL 8/18/2014 Box: 1 bottle, 10 mL 8/18/2014 Box: 1 Bottle, 10 mL 9/11/2014 DRl Hydrocodone/Hydromorphone Assay Calibrator 500 ng/mL, Part Number: 10018081 Box: 1 Bottle, 10 mL 9/11/2014 DRl Hydrocodone/Hydromorphone Assay Calibrator 500 ng/mL, Part Number: 10019839 DRl Hydrocodone/Hydromorphone Assay Controls (High and Low), Catalog Number: 10019841 DRl Hydrocodone/Hydromorphone Assay Controls (High and Low), Part Number: 10018149 Box: 1 Bottle, 10 mL 8/18/2014 Box: 2 bottles, 10 mL each 8/18/2014 Box: 2 Bottles, 10 mL each 9/11/2014 Jkt 238001 PO 00000 Frm 00119 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.294</GPH> Micro genies Corporation Micro genies Corporation Glass ampule: 1 mL Glass ampule: 1 mL 17010 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Micro genies Corporation Thermo Scientific CEDIA Cocaine Assay Catalog Number: 10016413 Glass vial: 17 mL, Box: 3 vials 8/23/2013 Microgenics Corporation Thermo Scientific CEDIA Opiate Assay Catalog Number: 10016429 Glass vial: 17 mL, Box: 3 vials 8/23/2013 Microgenics Corporation Thenno Scientific Intercept i2he Methamphetamine Oral Fluid Control Set (High and Low), Catalog Number: 10010391 Catalog Number: 10010391 Box: 2 vial; 10 mL each 7/29/2014 Box: 1 vial; 5 mL 7/29/2014 Box: 2 vial; 15 mL each 7/29/2014 Box: 1 vial; 10 mL 7/29/2014 Box: 2 vial; 10 mLeach 7/29/2014 Box: 1 vial; 5 mL 7/29/2014 Ortho Clinical Diagnostics, Inc. VITROS Immunodiagnostics Products Total T4 Reagent Pack Chamber: 18.3 mL 7/29/2014 PerkinElmer, Inc. AlphaLISA Testosterone (100 11M) AL324S 100%DMSO Screw-cap Vial: 210 JlL 5/28/2015 Pierce Bioteclmology, Inc. Cascadion SM Total Testosterone Intemal Standard Reagent, Bulk Solution Glass bottle: 810 L 3/25/2015 Pierce Biotechnology, Inc. Gold Standard, Cascadion SM Total Testosterone Intemal Standard Reagent Ambervial: 30 mL 3/25/2015 Pierce Biotechnology, Inc. Testosterone Stock Solution (500 ng/g) in Metlmnol Glass bottle: 2 L 3/25/2015 Restek Corporation (+/-)-11-nor-9-carba>..'J-delta-9-THC Standard Ampule: 1.3 mL 2/11/2014 Restek Corporation Cannabidiolic Acid (CBDA) Standard Ampule: 1.3 mL 1/28/2014 Restek Corporation Custom Pesticides Standard #1 Glass vial: 1.3 mL 5/22/2013 Restek Corporation Custom Rev Appendix L"\: Kit/ Ampule 2 Ampule: 5.4 mL 7/112013 Restek Corporation Delta-9-THC Standard Ampule: 1.3 mL 2/11/2014 Microgenics Corporation Microgenics Corporation Microgenics Corporation ebenthall on DSK6SPTVN1PROD with NOTICES2 Microgenics Corporation VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00120 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.295</GPH> Thermo Scientific Intercept i2he Methamphetamine Oral Fluid Cutoff Calibrator, Catalog Number: 10010392 Thermo Scientific Intercept i2he Multi-Drug Oral Fluid Control Set A (High and Low), Catalog Number: 10010394 Thermo Scientific Intercept i2he Multi-Drug Oral Fluid Cutoff Calibrator Set A, Catalog Number: 10010395 Thermo Scientific Intercept i2he THC Oral Fluid Control Set (High and Low), Catalog Number: 10010397 Thermo Scientific Intercept i2he THC Oral Fluid Cutoff Calibrator, Catalog Number : 10010398 Micro genies Corporation 17011 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Ampule: 1.3 mL 4/9/2014 Morphine and Hydromorphone Standard Ampule: 1.3 mL 11/15/2013 Siemens Healthcare Diagnostics, Inc. BK Emit Specialty Dmg Calibrator/Control LVL 1 Bulk Container: 10L-50L 6/7/2013 Siemens Healthcare Diagnostics, Inc. BK Emit Specialty Dmg Calibrator/Control LVL2 Bulk Container: 10 L- 50 L 617/2013 Siemens Hea1thcare Diagnostics, Inc. BK Emit Specialty Dmg Calibrator/Control LVL3 Bulk Container: lOL- 50 L 617/2013 Siemens Healthcare Diagnostics, Inc. BK Emit Specialty Dmg Calibrator/Control LVL4 Bulk Container: 10 L- 50 L 6/7/2013 Siemens Healthcare Diagnostics, Inc. BK Emit Specialty Dmg Control Negative Bulk Container: 10 L- 50 L 617/2013 Siemens Healthcare Diagnostics, Inc. BK Emit Specialty Dmg Control Positive Bulk Container: 10 L- 50 L 6/7/2013 Siemens Healthcare Diagnostics, Inc. Dimension Vista TSTP CAL Box of 12 vials, 1 mL each 6/6/2013 Siemens Healthcare Diagnostics, Inc. Dimension Vista TTST CAL Box of 12 vials, 1 mL each 6/6/2013 Siemens Healthcare Diagnostics, Inc. Emit II Plus Specialty Dmg Calibrator/Control Levell Vial: 10 mL 6/7/2013 Siemens Healthcare Diagnostics, Inc. Emit II Plus Specialty Dmg Calibrator/Control Level2 Vial: 10 mL 6/7/2013 Siemens Healthcare Diagnostics, Inc. Emit II Plus Specialty Dmg Calibrator/Control Level3 Vial: 10 mL 6/7/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00121 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.296</GPH> Endoctrine Dismptors Standard #3 Restek Corporation ebenthall on DSK6SPTVN1PROD with NOTICES2 Restek Corporation 17012 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Vial: 10 mL 6/7/2013 Emit II Plus Specialty Drug Control Negative Vial: 10 mL 6/7/2013 Siemens Healthcare Diagnostics, Inc. Emit II Plus Specialty Drug Control Positive Vial: 10 mL 6/7/2013 Siemens Healthcare Diagnostics, Inc. MP BK Emit Specialty Drug Calibrator/Control LVL 1 Bulk Container: 10 L- 50 L 6/7/2013 Siemens Healthcare Diagnostics, Inc. MP BK Emit Specialty Drug Calibrator/Control LVL2 Bnlk Container: 10 L- 50 L 617/2013 Siemens Healthcare Diagnostics, Inc. MP BK Emit Specialty Drug Calibrator/Control LVL3 Bulk Container: 10 L- 50L 617/2013 Siemens Healthcare Diagnostics, Inc. MP BK Emit Specialty Drug Calibrator/Control LVL4 Bulk Container: 10 L- 50 L 6/7/2013 Siemens Healthcare Diagnostics, Inc. MP BK Emit Specialty Drug Control Negative Bulk Container: 10 L- 50 L 6/7/2013 Siemens Healthcare Diagnostics, Inc. MP BK Emit Specialty Drug Control Positive Bulk Container: 10 L- 50 L 6/7/2013 Siemens Healthcare Diagnostics, Inc. MP FC Emit Specialty Drug Calibrator/Control LVL 1 Vial: 15 mL 6/7/2013 Siemens Healthcare Diagnostics, Inc. MP FC Emit Specialty Drug Calibrator/Control LVL2 Vial: 15 mL 6/7/2013 Siemens Healthcare Diagnostics, Inc. MP FC Emit Specialty Drug Calibrator/Control LVL3 Vial: 15 mL 617/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00122 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.297</GPH> Emit II Plus Specialty Drug Calibrator/Control Level4 Siemens Healthcare Diagnostics, Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Siemens Healthcare Diagnostics, Inc. 17013 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Vial: 15 mL 6/7/2013 MP FC Emit Specialty Drug Control Negative Vial: 15 mL 6/7/2013 Siemens Healthcare Diagnostics, Inc. MP FC Emit Specialty Drug Control Positive Vial: 15 mL 617/2013 Siemens Healthcare Diagnostics, Inc. MP Pilot Emit Specialty Drug Calibrator/Control L VL 1 Pilot Container: 4 mL- 200 mL 617/2013 Siemens Healthcare Diagnostics, Inc. MP Pilot Emit Specialty Drug Calibrator/Control L VL 2 Pilot Container: 4 mL- 200 mL 6/7/2013 Siemens Healthcare Diagnostics, Inc. MP Pilot Emit Specialty Drug Calibrator/Control L VL 3 Pilot Container: 4 mL-200mL 6/7/2013 Siemens Healthcare Diagnostics, Inc. MP Pilot Emit Specialty Drug Calibrator/Control L VL 4 Pilot Container: 4 mL- 200 mL 6/7/2013 Siemens Healthcare Diagnostics, Inc. MP Pilot Emit Specialty Drug Control Negative Pilot Container: 4 mL- 200 mL 6/7/2013 Siemens Healthcare Diagnostics, Inc. MP Pilot Emit Specialty Drug Control Positive Pilot Container: 4 mL- 200 mL 617/2013 Siemens Healthcare Diagnostics, Inc. Pilot Emit Specialty Drug Calibrator/Control LVL 1 Pilot Container: 4 mL- 200mL 6/7/2013 Siemens Healthcare Diagnostics, Inc. Pilot Emit Specialty Drug Calibrator/Control LVL2 Pilot Container: 4 mL- 200 mL 617/2013 Siemens Healthcare Diagnostics, Inc. Pilot Emit Specialty Drug Calibrator/Control LVL3 Pilot Container: 4 mL- 200 mL 6/7/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00123 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.298</GPH> MP FC Emit Specialty Drug Calibrator/Control LVL4 Siemens Healthcare Diagnostics, Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Siemens Healthcare Diagnostics, Inc. 17014 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Pilot Container: 4 mL- 200 mL 6/7/2013 Pilot Emit Specialty Drug Control Negative Pilot Container: 4 mL-200mL 6/7/2013 Siemens Healthcare Diagnostics, Inc. Pilot Emit Specialty Drug Control Positive Pilot Container: 4 mL- 200mL 6/7/2013 Siemens Healthcare Diagnostics, Inc. VS TSTP CAL Vial Level A Vial: 1 mL 6/6/2013 Siemens Healthcare Diagnostics, Inc. VS TSTP CAL Vial Level B Vial: 1 mL 6/6/2013 Siemens Healthcare Diagnostics, Inc. VS TSTP CAL Vial Level C Vial: 1 mL 6/6/2013 Siemens Healthcare Diagnostics, Inc. VS TSTP CAL Vial Level D Vial: 1 mL 6/6/2013 Siemens Healthcare Diagnostics, Inc. VS TSTP CAL Vial Level E Vial: 1 mL 6/6/2013 Siemens Healthcare Diagnostics, Inc. VS TSTP CAL Vial Level F Vial: 1 mL 6/6/2013 Siemens Healthcare Diagnostics, Inc. VS TTST CAL Vial Level A Vial: 1 mL 6/6/2013 Siemens Healthcare Diagnostics, Inc. VS TTST CAL Vial Level B Vial: 1 mL 6/6/2013 Siemens Healthcare Diagnostics, Inc. VS TTST CAL Vial Level C Vial: 1 mL 6/6/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00124 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.299</GPH> Pilot Emit Specialty Drug Calibrator/Control LVL4 Siemens Healthcare Diagnostics, Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Siemens Healthcare Diagnostics, Inc. 17015 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices VS TTST CAL Vial Level D Vial: 1 mL 6/6/2013 Siemens Healthcare Diagnostics, Inc. VS TTST CAL Vial Level E Vial: 1 mL 6/6/2013 Siemens Healthcare Diagnostics, Inc. VS TTST CAL Vial Level F Vial: 1 mL 6/6/2013 Sigma-Aldrich, Co. 4-Androstene-3,17-dione-2,3,4-13C3 solution (0.1 mg/mL in methanol) Glass ampule: 2 mL 5/28/2015 Sigma-Aldrich, Co. Dihydrotestosterone-2,3,4-13C3 solution (0.1 mg/mL in methanol) Glass ampule: 2 mL 5/28/2015 Sigma-Aldrich, Co. Testosterone-2,3,4-13C3 solution (0.1 mg/mL in methanol) Glass ampule: 2 mL 5/28/2015 Supelco, Inc. a,a-Dimethylphenethylamine 2000 J.tg/mL in methylene chloride Glass vial: 1 mL 8/15/2013 Supelco, Inc. Chloral Hydrate 1000 J.tg/mL in Acetonitrile Glass ampule: 1 mL 4/8/2013 Supelco, Inc. LS4434-Mix 1_15, 0.019- 2.375 J.tg/mL in Methanol Glass ampule: 1 mL 4/2/2015 Toronto Research Chemicals Inc. L\.1-Testosterone ( 1. 0/mg/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. 10-0xo Morphine (100 J.tg/mL in Methanol) Glass vial: 1 mL 7/11/2014 Toronto Research Chemicals Inc. 17a-Methyl Testosterone (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. 1-Butyl-3-(1-naphthoyl)indole JWH-073 (100 J.tg/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 1-Pentyl-3-(1-naphthoyl)indole JWH 018 (100 in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Che1nicals Inc. 2-(Methylamino)-3 ',4'(methy lenedioxy )valerophenone Hydrochloride (1.0 mg/mL in Methanol) Glass vial: 1 mL 7/11/2014 Toronto Research Chemicals Inc. 2-Methyl Methcathinone Hydrochloride (1 mg/mL in Methanol) Glass vial: 1 mL 7/11/2014 Toronto Research Che1nicals Inc. 2-Naphthyl Pyrovalerone Hydrochloride (1.0 mg/mL in Methanol) Glass vial: 1 mL 7/11/2014 ebenthall on DSK6SPTVN1PROD with NOTICES2 Toronto Research Chemicals Inc. VerDate Sep<11>2014 18:45 Mar 24, 2016 ~tg/mL Jkt 238001 PO 00000 Frm 00125 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.300</GPH> Siemens Healthcare Diagnostics, Inc. 17016 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 1 mL 6/26/2014 3-Fluoroephedrone Hydrochloride (1.0 mg/mL in Methanol) Glass vial: 1 mL 7/11/2014 Toronto Research Chemicals Inc. 4-Fluoroephedrone Hydrochloride (1.0 mg/mL in Methanol) Glass vial: 1 mL 7/11/2014 Toronto Research Chemicals Inc. 6-Acetyl Morphine (100 g /mL in Acetonitrile) Glass vial: 1 mL 7/11/2014 Toronto Research Chemicals Inc. 6-Acetyl Morphine-d3 (100 gg/mL in Acetonitrile) Glass vial: 1 mL 7111/2014 Toronto Research Chemicals Inc. 6~-Naltrexol Glass vial: 1 mL 6/26/2014 Toronto Research Chetnicals Inc. 6~-Naltrexol-d4 Glass vial: 1mL 6/26/2014 Toronto Research Chemicals Inc. Aminorex (1 mg/mL in Acetonitrile) Glass vial: 1 mL 7/11/2014 Toronto Research Chemicals Inc. Amobarbital ( 1.0 mg/mL in Methanol) Glass vial: 1 mL 7/11/2014 Toronto Research Chemicals Inc. Androstanolone (1.0 mg/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Androstanolone (1.0 mg/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Androstenedione (1.0 mg/mL in Acetonitrile) Glass vial: 1mL 6/26/2014 Toronto Research Chemicals Inc. Benzoyl Ecgonine (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chetnicals Inc. Benzoyl Ecgonine (100 gg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Benzoyl Ecgonine-d3 (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Boldenone (1.0 mg/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 (1.0 mg/mL in Methanol) PO 00000 (1.0 mglml in Methanol) Frm 00126 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.301</GPH> 3,4 ,5-Trimethoxyphenethy lamine, Hydrochloride (1.0 mg/mL in Methanol) Toronto Research Chemicals Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Toronto Research Chemicals Inc. 17017 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 1 mL 6/26/2014 Bromazepam (100 J.Lg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Buprenorphine Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Butabarbital (1.0 mg/mL in Methanol) Glass vial: 1 mL 7/11/2014 Toronto Research Chemicals Inc. Butalbital (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Chlordiazepoxide-d5 ( 100 ug/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Clonazepam-d4 (1.0 mg/mL in Methanol) Glass vial: 1 mL 7/11/2014 Toronto Research Chemicals Inc. Cocaine-d3 (1.0 mg/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Cocaine-d3 (100 Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Codeine (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Codeine-d3 (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Delorazepam (1 00 ug/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Desmethyl Diazepam (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Desmethyl Diazepam-d5 (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Desmethyl Pyrovalerone Hydrochloride (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chetnicals Inc. Desmethyl Pyrovalerone-d8 Hydrochloride (100 J.Lg/mL in Methanol) Glass vial: 1mL 6/26/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~-D-Glucuronide ~tg/mL Frm 00127 (100 ug/mL in in Acetonitrile) Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.302</GPH> Bromazepam ( 1 mg/mL in Methanol) Toronto Research Chemicals Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Toronto Research Chemicals Inc. 17018 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 1 mL 6/26/2014 Desornorphine (1.0 rng/rnL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Desornorphine-d3 (100 Jlg/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chetnicals Inc. Diazepam ( 1 rng/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Diethylpropion Hydrochloride (1.0 rng/mL in Methanol) Glass vial: 1 mL 7/11/2014 Toronto Research Chemicals Inc. Dihydrornorphine-d3 (1.0 rng/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Drostanolone (1.0 rng/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Ethyl Morphine (1.0 rng/mL in Methanol) Glass vial: 1 rnL 6/26/2014 Toronto Research Chemicals Inc. Ethylone (1.0 rng/rnL in Methanol) Glass vial: 1 mL 7/11/2014 Toronto Research Chemicals Inc. Ethylone-d5 (100 Jlg/rnL in Methanol) Glass vial: 1 mL 7/1l/2014 Toronto Research Chemicals Inc. Furazabol (1.0 rng/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Heroin (1.0 rng/mL in Acetonitrile) Glass vial: 1 rnL 6/26/2014 Toronto Research Chetnicals Inc. HU 210 (lOOJ.Ig/rnL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Hydrocodone (1.0 rng/rnl in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Hydrocodone-d6 ( 1.0 rng/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chetnicals Inc. Ketarnine Hydrochloride (1.0 rng/rnl in Methanol) Glass vial: 1 mL 6/26/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00128 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.303</GPH> Desornorphine (1.0 rng/mL in Acetonitrile) Toronto Research Chemicals Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Toronto Research Chemicals Inc. 17019 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 1 mL 7/11/2014 Meperidine Hydrochloride (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Mephedrone Hydrochloride (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Mephedrone-d3 Hydrochloride (100 11g/mL in Methanol) Glass vial: 1 mL 7/11/2014 Toronto Research Chemicals Inc. Meprobamate ( 1.0 mg/mL in Methanol) Glass vial: 1 mL 7/11/2014 Toronto Research Chemicals Inc. Meprobamate-d3 (100 11g/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Methcathinone Hydrochloride (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Methylenediox'Y Pyrovalerone Hydrochloride (1 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Methylenediox'Y Pyrovalerone-d8 Hydrochloride (0.5 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Me thy lenediox'Y Pyrovalerone-d8 Hydrochloride (0.5 mg/mL in Methanol) Glass vial: 1 mL 8/29/2014 Toronto Research Chemicals Inc. Methylone Hydrochloride (1.0 mg/mL in Methanol) Glass vial: 1 mL 7/11/2014 Toronto Research Chemicals Inc. Methylone-d3 Hydrochloride (100 11g/mL in Methanol) Glass vial: 1 mL 7/11/2014 Toronto Research Chemicals Inc. Methylphenidate Hydrochloride (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Mibolerone ( 1.0 mg/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Midazolam (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Che1nicals Inc. Morphine (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00129 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.304</GPH> Ketamine-d4 ( 100 11g/mL in Methanol) Toronto Research Chemicals Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Toronto Research Chemicals Inc. 17020 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 1 mL 6/26/2014 Morphine 3-(3-D-Glucuronide (1.0 mg/mL in Methanol w/ 0.05% NaOH) Glass vial: l mL 6/26/2014 Toronto Research Chemicals Inc. Morphine 6-(3-D-Glucuronide (1.0 mg/mL in Water:Methanol 80:20) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Morphine 6-(3-D-Glucuronide (100 Jlg/mL in Methanol:Water) Glass vial: l mL 6/26/2014 Toronto Research Chemicals Inc. Morphine N-Oxide (100 Jlg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Morphine-d3 (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Che1nicals Inc. Morphine-d3 (l 00 Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Morphine-d3 3-(3-D-Glucuronide (100 11g/mL in Methanol w/0.05% NaOH) Glass vial: 1 mL 7/11/2014 Toronto Research Chemicals Inc. Morphine-d3 6-(3-D-Glucuronide (100 gg/mL Methanol:Water 1:1) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Morphine-d6 (1.0 mg/mL in Methanol) Glass vial: 1mL 6/26/2014 Toronto Research Chemicals Inc. Nabilone (1.0 mg/ml in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Naloxone N-Oxide (100 Jlg/mL in 1:1 Acetonitrile and water solution) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Naloxone N-Oxide (100 11g/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Nandrolone (1.0 mg/mL in Acetonitrile) Glass vial: 1mL 6/26/2014 Toronto Research Chemicals Inc. N-Benzylpiperazine Dihydroch1oride (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Che1nicals Inc. Nimetazepam (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~tg/mL Frm 00130 in Methanol) Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.305</GPH> Morphine 3-(3-D-Glucuronide (0.1 mg/mL in Methanol/Water 1:1) Toronto Research Chemicals Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Toronto Research Chemicals Inc. 17021 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 1 mL 6/26/2014 Nitrazepam (1 00 Jlg/ml in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Nitrazepam-d5 (100J1g/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Norbuprenorphine (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Norclostebol (1.0 mg/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Norcocaine Hydrochloride (1.0 mg/mL in Acetonitrile) Glass vial: 1 mL 7/11/2014 Toronto Research Chemicals Inc. Norcocaine-d3 Hydrochloride (100 11g/mL in Acetonitrile) Glass vial: 1 mL 7111/2014 Toronto Research Che1nicals Inc. nor-Flurazepam (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Noroxycodone-d3 (100 Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Oxandrolone (1.0 mg/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Oxazepam (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Oxazepam (100 11g/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Oxazepan1-d5 (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Oxazepan1-d5 (100 Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. 0A)rmorphone-d3 (100 Jlg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Phencyclidine Hydrochloride (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~tg/mL ~tg/mL Frm 00131 in Methanol) in Methanol) Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.306</GPH> Nitrazepam (1.0 mg/ml in Acetonitrile) Toronto Research Chemicals Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Toronto Research Chemicals Inc. 17022 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 1 mL 6/26/2014 Phencyclidine-d5 Hydrochloride (100 Jlg/mL in Methanol) Glass vial: I mL 6/26/2014 Toronto Research Chemicals Inc. Phenobarbital (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Phenobarbital-d5 (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Phenobarbital-d5 (100 Jlg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Pipradrol Hydrochloride (1.0 mg/m1 in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Propoxyphene Hydrochloride (1.0 mg/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chetnicals Inc. Propoxwhene Hydrochloride (100 Jlg/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Pyrovalerone Hydrochloride (1mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chetnicals Inc. rae Amphetamine Hydrochloride (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chetnicals Inc. rae Amphetamine Hydrochloride (100 Jlg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. rae Diethypropion-dlO Hydrochloride (100 Jlg/mL in Methanol) Glass vial: 1 mL 7/11/2014 Toronto Research Chetnicals Inc. rae Methadone Hydrochloride (1 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. rae Methadone-d3 Hydrochloride (1 00 ug/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. rac-Amphetantine-d6 Hydrochloride (100 Jlg/mL in Methanol) Glass vial: 1 mL 7/11/2014 Toronto Research Chemicals Inc. rae-N -Ethy1-4-methy1-Cathinone Hydrochloride (1.0 mg/mL in Methanol) Glass vial: 1 mL 7/11/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00132 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.307</GPH> Phencyclidine-d5 Hydrochloride (1.0 mg/mL in Methanol) Toronto Research Chemicals Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Toronto Research Chemicals Inc. 17023 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 1 mL 6/26/2014 Synthetic Cannabinoid Mixture 2 (1nixture of AM2201, JWH 019, JWH 081, and JWH 122, 100 flg/mL of each component in Acetonitrile) Glass vial: 1 mL 7/ll/2014 Toronto Research Chemicals Inc. Temazepam (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Temazepam (100 flg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Testosterone (1.0 mg/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Testosterone Benzoate (1.0 mg/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Testosterone-d3 (100 flg/mL in 1,2Dimethoxyethane) Glass vial: 1 mL 7/11/2014 Toronto Research Chemicals Inc. Thebaine-N-(methyl-d3) (1.0 mg/ml in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Che1nicals Inc. Tilidine Hydrochloride (1.0 mg/mL in Methanol) Glass vial: 1 mL 7/1112014 Toronto Research Chemicals Inc. Tilidine-d6 Hydrochloride (100 Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Trenbolone (1.0 mg/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Zolpidem (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Zolpidem-d6 (100 ug/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. L'11-Androstenedione (1.0 mg/mL in Acetonitrile) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals, Inc. Buphedrone (1 mg/mL in Methanol, as free base) Glass vial: 1 mL 7/11/2014 USP USP Levomethorphan Reference Standard Amber ampule: 1.2mL 1/19/2015 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00133 Fmt 4701 ~tg/mL in Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.308</GPH> Stanozolol (1.0 mg/mL in Acetonitrile) Toronto Research Chemicals Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Toronto Research Chemicals Inc. Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices ebenthall on DSK6SPTVN1PROD with NOTICES2 The Deputy Assistant Administrator has found that each of the compounds, mixtures, and preparations described in Chart II below is not consistent with the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23. Accordingly, the Deputy Assistant Administrator has VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 determined that the chemical preparations or mixtures generally described in Chart II below and specifically described in the application materials received by the DEA, are not exempt from application of any part of the CSA or from application of any part PO 00000 Frm 00134 Fmt 4701 Sfmt 4703 of the CFR, with regard to the requested exemption pursuant to 21 CFR 1308.23, as of the date that was provided in the determination letters to the individual requesters. E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.309</GPH> 17024 17025 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Chart II Aalto Scientific, Ltd. Glass vial: 3 mL 10/22/2015 Control FD Immunoassay, Level 2 Glass vial: 3 mL 10/22/2015 Control FD Itmnunoassay, Level 3 Glass vial: 3 mL 10/22/2015 Control FD TDM, Level 1 Glass vial: 5 mL 10/22/2015 Control FD TDM, Level 2 Glass vial: 5 mL 10/22/2015 Control FD TDM, Level 3 Glass vial: 5 mL 10/22/2015 Linearity FD Fertility Siemens Centaur, Level A Glass vial: 3 mL 10/22/2015 Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. Linearity FD Fertility Siemens Centaur, Level B Glass vial: 3 mL 10/22/2015 Glass vial: 3 mL 10/22/2015 Linearity FD Fertility Siemens Centaur, Level D Glass vial: 3 mL 10/22/2015 Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. Linearity FD Fertility Siemens Centaur, Level E Glass vial: 3 mL 10/22/2015 Linearity FD Immunoassay, Level A Glass vial: 5 mL 10/22/2015 Linearity FD Immunoassay, Level B Glass vial: 5 mL 10/22/2015 Linearity FD Inununoassay, Level C Glass vial: 5 mL 10/22/2015 Linearity FD Immunoassay, Level D Glass vial: 5 mL 10/22/2015 Linearity FD Inununoassay, Level E Glass vial: 5 mL 10/22/2015 Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. ebenthall on DSK6SPTVN1PROD with NOTICES2 Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. VerDate Sep<11>2014 18:45 Mar 24, 2016 Linearity FD Fertility Siemens Centaur, Level c Jkt 238001 PO 00000 Frm 00135 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.310</GPH> Control FD Immunoassay, Level 1 17026 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. Aalto Scientific, Ltd. Linearity FD TDM Siemens Centaur, Level A Glass vial: 5 mL 10/22/2015 Linearity FD TDM Siemens Centaur, Level B Glass vial: 5 mL 10/22/2015 Linearity FD TDM Siemens Centaur, Level C Glass vial: 5 mL 10/22/2015 Linearity FD TDM Siemens Centaur, Level D Glass vial: 5 mL 10/22/2015 Linearity FD TDM Siemens Centaur, Level E Glass vial: 5 mL 10/22/2015 Linearity FD TDM, Level A Glass vial: 5 mL 10/22/2015 Linearity FD TDM, Level B Glass vial: 5 mL 10/22/2015 Linearity FD TDM, Level C Glass vial: 5 mL 10/22/2015 Linearity FD TDM, Level D Glass vial: 5 mL 10/22/2015 Linearity FD TDM, Level E Glass vial: 5 mL 10/22/2015 Glass ampoule: 1 mL 6/18/2015 Glass ampoule: 1 mL 7/11/2014 Alprazolam (1000 Absolute Standards, Inc. Alprazolam-D5 (1000 ~g/mL in methanol) Glass an1poule: 1 mL 7/11/2014 Absolute Standards, Inc. Chloral hydrate (2000 ~g/mL in acetone) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Fentanyl (1000 Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Fentanyl-D5 (1000 in methanol) Glass an1poule: 1 mL 7/11/2014 Absolute Standards, Inc. Lysergic acid diethylan1ide (LSD) (100 ~tg/mL in acetonitrile) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Lysergic acid diethylamide (LSD) (1000 ~g/mL in acetonitrile) Glass ampoule: 1 mL 7/11/2014 Absolute Standards, Inc. Lysergic acid diethylamide-d3 (LSD) (100 ~tg/mL in acetonitrile) Glass ampoule: 1 mL 7/11/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 ~tg/mL ~g/mL ~tg/mL in methanol) in methanol) in methanol) ~g/mL Frm 00136 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.311</GPH> (- )-~9-THC (Varied Absolute Standards, Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Absolute Standards, Inc. 17027 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampoule: 1 mL 7/11/2014 Medicinal Cannabis PT (Varied Jlg/mL in methanol) Glass ampoule: 1 mL 6/18/2015 Absolute Standards, Inc. Total THC (100 Jlg/mL in methanol) Glass ampoule: 1 mL 6/18/2015 Absolute Standards, Inc. Total THC Medicinal Cannabis Calibration (100 Jlg/mL in methanol) Glass ampoule: 1 mL 6/18/2015 Absolute Standards, Inc. Total THC Medicinal Cannabis PT (Varied Jlg/mL in methanol) Glass ampoule: 1 mL 6/18/2015 Biochemical Diagnostics, Inc. l-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3tetramethylcyclopropyl)methanone (UR144/XLRll) Bulk Solution Bottle: 1 mL- 500 mL 8/29/2014 Biochemical Diagnostics, Inc. 1-Pentyl-1H-indol-3-yl)(2,2,3,3tetran1ethylcyclopropyl)methanone (UR-144) Bulk Solution Bottle: 1 mL- 500 mL 8/29/2014 Biochemical Diagnostics, Inc. 3,4-Methylendioxy-N-Methylcathinone (Metl1ylone) Bulk Solution Bottle: 1 mL- 500 mL 9/2/2014 Biochemical Diagnostics, Inc. 3,4-Methylenedioxy-N-Methylcathinone (Methylone) Bulk Solution Bottle: 1 mL- 500 mL 8/29/2014 Biochemical Diagnostics, Inc. 4-Methyl-N-Methycathinone (Mephedrone) Bulk Solution Bottle: 1 mL- 500 mL 8/29/2014 Biochemical Diagnostics, Inc. 4-Metlw 1-N -Methycatlrinone (Mephedrone) Bulk Solution Bottle: 1 mL- 500 mL 9/2/2014 Biochemical Diagnostics, Inc. Benzoylecgonine Bulk Solution Bottle: 1 mL- 500 mL 9/2/2014 Biochenrical Diagnostics, Inc. Butylone Bulk Solution Bottle: 1 mL- 500 mL 8/29/2014 Biochenrical Diagnostics, Inc. Carisoprodol Bulk Solution Bottle: 1 mL- 500 mL 9/2/2014 Biochenrical Diagnostics, Inc. Cocaine Bulk Solution Bottle: 1 mL- 500 mL 9/2/2014 Biochemical Diagnostics, Inc. Codeine Bulk Solution Bottle: 1 mL- 500 mL 9/2/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00137 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.312</GPH> Lysergic acid diethylamide-d3 (LSD) (1000 Jlg/mL in acetonitrile) Absolute Standards, Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Absolute Standards, Inc. 17028 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Biochemical Diagnostics, Inc. d-Amphetamine Bulk Solution Bottle: 1 mL- 500 mL Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC182 Glass vials: 500 mL-2L Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC207 Glass vials: 1 mL200mL 12/30/2013 Biochemical Diagnostics, Inc. Dctectabuse Custom Liquid Control Urine, MC207 Glass vials: 1 mL200mL 2/24/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC207 Glass vials: 1 mLlOOmL 4/14/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC23l Glass vials: 1 mL100mL 4/16/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC232 Glass vials: 1mLlOOmL 4/16/2014 Biochemical Diagnostics, Inc. Detectabuse Custom Liquid Control Urine, MC233 Glass vials: 1 mLlOOmL 4/25/2014 Biochemical Diagnostics, Inc. d-Methamphetamine Bulk Solution Bottle: 1 mL- 500 mL 9/2/2014 Biochemical Diagnostics, Inc. d-Propoxyphene Bulk Solution Bottle: 1 mL- 500 mL 9/2/2014 Biochemical Diagnostics, Inc. Fentanyl Bulk Solution Bottle: 1 mL- 500 mL 9/2/2014 Glass bottle or polypropylene and polyethylene container: 1 mL 100mL Glass bottle or polypropylene and polyethylene container: 1 mL lOOmL 9/2/2014 4/22/2013 Heroin Bulk Solution ( 1 mL - 1L) Biochemical Diagnostics, Inc. Heroin Bulk Solution ( 1 mL- 1 L) Biochemical Diagnostics, Inc. Hydrocodone Bulk Solution Bottle: 1 mL- 500 mL 9/2/2014 Biochemical Diagnostics, Inc. Hydromorphone Bulk Solution Bottle: 1 mL- 500 mL 9/2/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00138 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 8/12/2014 7/3/2014 EN25MR16.313</GPH> ebenthall on DSK6SPTVN1PROD with NOTICES2 Biochemical Diagnostics, Inc. 17029 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Bottle: 1 rnL- 500 mL 9/2/2014 1-Benzylpiperazine Bulk Solution Bottle: 1 mL- 500 rnL 8/29/2014 Biochemical Diagnostics, Inc. MDA Bulk Solution Bottle: 1 rnL- 500 rnL 9/2/2014 Biochemical Diagnostics, Inc. MDEA Bulk Solution Bottle: 1 mL- 500 mL 9/2/2014 Biochemical Diagnostics, Inc. MDMA Bulk Solution Bottle: 1 rnL- 500 rnL 9/2/2014 Biochemical Diagnostics, Inc. Mescaline Bulk Solution Bottle: 1 rnL- 500 rnL 8/29/2014 Biochemical Diagnostics, Inc. Methadone Bulk Solution Bottle: 1 rnL- 500 mL 9/2/2014 Biochemical Diagnostics, Inc. Metl1aqualone Bulk Solution Bottle: 1 rnL- 500 mL 9/2/2014 Biochemical Diagnostics, Inc. Methcathinone Bulk Solution Bottle: 1 mL- 500 rnL 8/29/2014 Biochemical Diagnostics, Inc. Morphine Bulk Solution Bottle: 1 rnL- 500 rnL 9/2/2014 Biochemical Diagnostics, Inc. Oxazepam Bulk Solution Bottle: 1 rnL- 500 rnL 9/2/2014 Biochemical Diagnostics, Inc. Pentylone Bulk Solution Bottle: 1 mL- 500 rnL 8/29/2014 Biochemical Diagnostics, Inc. Phencyclidine Bulk Solution Bottle: 1 rnL- 500 mL 9/2/2014 Biochemical Diagnostics, Inc. Secobarbital Bulk Solution Bottle: 1 rnL- 500 rnL 9/2/2014 Biochemical Diagnostics, Inc. Tapentadol Bulk Solution Glass/plastic bottle: 1 mL- 1 L 5/6/2013 Biochemical Diagnostics, Inc. Tapentadol Bulk Solution Glass/plastic bottle: 1 rnL- 1 L 5/31/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00139 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.314</GPH> Ketamine Bulk Solution Biochemical Diagnostics, Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 Biochemical Diagnostics, Inc. 17030 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Bottle: 1 mL- 500 mL 9/2/2014 Plastic bottle: 1 L 9/12/2013 Plastic bottle: 1 L 9/12/2013 Benzoylecgonine Anhydrous [Spike Solution] Flask: 10 mL 5/19/2013 Dextropropoxyphene HCl [Spike Solution] Flask: 50 mL 5/19/2013 d-Methamphetamine HCl [Spike Solution] Flask: 50 mL 5/19/2013 Methadone HCl [Spike Solution] Flask: 50 mL 5/19/2013 Methaqualone [Spike Solution] Flask: 50 mL 5/19/2013 Morphine HCl [Spike Solution] Flask: 50 mL 5/19/2013 Oxazepam [Spike Solution] Flask: 50 mL 5/19/2013 Secobaibital [Spike Solution] Flask: 10 mL 5/19/2013 Cayman Chemical Company Alprazolam CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Alprazolam CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Alprazolam CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 4/30/2015 Cayman Chemical Company Alprazolam-d5 (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Alprazolam-d5 CRM; 1 mg/mL in Methanol Glass an1pule: 1 mL 9/19/2014 Cayman Chemical Company Alprazolam-d5 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Buprenorphine (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Buprenorphine-d4 (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Bionostics, Inc. Bionostics, Inc. Bio-Rad Laboratories Bio-Rad Laboratories Bio-Rad Laboratories Bio-Rad Laboratories Bio-Rad Laboratories ebenthall on DSK6SPTVN1PROD with NOTICES2 Bio-Rad Laboratories Bio-Rad Laboratories Bio-Rad Laboratories VerDate Sep<11>2014 18:45 Mar 24, 2016 Tramadol Bulk Solution IN PROCESS MATERIAL DC PRO Whole Blood Control IN PROCESS MATERIAL DC Whole Blood Control Jkt 238001 PO 00000 Frm 00140 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.315</GPH> Biochemical Diagnostics, Inc. 17031 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass vial: 400 pL 5/2/2014 Callllabichromene (exempt preparation); 25 mg in 1 mL Methanol Glass vial: 1 mL 5/2/2014 Cayman Chemical Company Callllabichromene (exempt preparation); 5 mg in 200 pL Methanol Glass vial: 200 pL 5/2/2014 Cayman Chemical Company Cam1abigerol (exempt preparation); 10 mg in 400 pL Methanol Glass vial: 400 ~tL 5/2/2014 Cayman Chemical Company Callllabigerol (exempt preparation); 25 mg in 1 mL Methanol Glass vial: 1 mL 5/2/2014 Cayman Chemical Company Catmabigerol (exempt preparation); 5 mg in 200 pL Methanol Glass vial: 200 pL 5/2/2014 Cayman Chemical Company Callllabinol (exempt preparation); 10 mg in 400 pL Methatlol Glass vial: 400 pL 5/2/2014 Cayman Chemical Company Catmabinol (exempt preparation); 25 mg in1 mL Methm1ol Glass vial: 1 mL 5/2/2014 Cayman Chemical Company Catmabinol (exempt preparation); 5 mg in200 pL Methanol Glass vial: 200 pL 5/2/2014 Cayman Chemical Company Clonazepan1 CRM; 1 mg/mL in Acetonitrile Glass atnpule: 2 mL 12/2/2014 Cayman Chemical Compatly C1onazepatn CRM; 1 mg/mL in Acetonitrile Glass atnpule: 1 mL 12/2/2014 Cayman Chetnical Company Clonazepatn CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 mL 4/30/2015 Cayman Chemical Company Clonazepatn CRM; 1 mg/mL in Methat1ol Glass an1pule: 2 mL 9/19/2014 Cayman Chemical Company Clonazepan1 CRM; 1 mg/mL in Methanol Glass atnpule: 1 mL 9/19/2014 Cayman Chemical Company Clonazepatn CRM; 100 pg/mL in Methanol Glass an1pule: 2 mL 9/19/2014 Cayman Chemical Company Clonazepatn-d4 (exempt preparation); 1 mg in 1 mL Methm1ol Glass atnpule: 1 mL 9/22/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00141 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.316</GPH> Cannabichromene (exempt preparation); 10 mg in400 ~tL Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 17032 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 9/19/2014 Clonazepam-d4 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Clonazepam-d4 CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Diazepam CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Diazepam-d3 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Fentanyl (hydrochloride) CRM CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Fentanyl (hydrochloride) CRM CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Caytmn Chemical Company Fentanyl (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 4/30/2015 Cayman Chemical Company Fentanyl (hydrochloride) CRM; 100 in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Fentanyl (hydrochloride); 1 mg in 1 mL Methanol- Glass vial: 3 mL 12/20/2013 Caytmn Chemical Company Fentanyl (hydrochloride); 100 Jlg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Fentanyl (hydrochloride); 500 11g in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayiik'ln Chemical Company Fentanyl-d3 (HCl) (exempt preparation); 1mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Caytmn Chemical Company Fentanyl-d3 (HCl) (exempt preparation); 100 ~tg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Caytmn Chemical Company Fentanyl-d3 (hydrochloride) CRM CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Fentanyl-d3 (hydrochloride) CRM CRM; 100 Jlg/mL in Methanol Glass ampule: 2 mL 1/27/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00142 Fmt 4701 ~tg/mL Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.317</GPH> Clonazepam-d4 CRM; 1 mg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 17033 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 1 mL 1/27/2014 Fentanyl-d3 (hydrochloride); 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Fentanyl-d3 (hydrochloride); 100 Jlg in 0.1 mLMethanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Fentany1-d3 (hydrochloride); 500 Jlg in 0.5 mLMethanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Flunitrazepam CRM; 1 mg/mL in Acetonitrile Glass ampule: 2 mL 12/2/2014 Cayman Chemical Company Flunitrazepam CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 mL 12/2/2014 Cayman Chemical Company Flunitrazepam CRM; 1 mg/mL in Acetonitrile Glass an1pule: 1 mL 4/30/2015 Cayman Chemical Company Flunitrazepam CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Flunitrazepam CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Flunitrazepam-d3 (exempt preparation); 1mg in 1 mL Methanol Glass ampule: 1 mL 9/22/2014 Cayman Chemical Company Flunitrazepam-d3 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chetnical Company Flunitrazepam-d3 CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Hydromorphone-d3 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Lorazepam CRM; 1 mg/mL in Acetonitrile Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Lorazepam CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Lorazepam CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 mL 4/30/2015 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00143 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.318</GPH> Fentanyl-d3 (hydrochloride) CRM; 1 mg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 17034 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 9/19/2014 Lorazepam-d4 CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 mL 9/19/2014 Caynum Chemical Company Lysergic acid diethylamide CRM; 1 mg/mL in Acetonitrile Glass ampule: 1 mL 1127/2014 Cayman Chemical Company Lysergic acid diethylamide CRM; 1 mg/mL in Acetonitrile Glass ampule: 2 mL 1127/2014 Cayman Chemical Company Lysergic acid diethylamide CRM; 100 11g/mL in Acetonitrile Glass ampule: 1 mL 1/27/2014 Cayman Chetnical Company Lysergic acid diethylamide CRM; 100 11g/mL in Acetonitrile Glass ampule: 2 mL 1127/2014 Cayman Chemical Company Lysergic acid diethylamide; 1mg in1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Lysergic acid diethylamide; 100 11g in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Lysergic acid diethylan1ide; 500 11g in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Opiate Mixture CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chemical Company Oxymorphone CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1127/2014 Cayman Chetnical Company Oxymorphone CRM; 1mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company O>..)'morphone-d3 (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Oxymorphone-d3 CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company 0>..)'morphone-d3 CRM; 1 mg/mL in Methanol Glass an1pule: l mL 9/19/2014 Caytnan Chemical Company Sufentanil (citrate) CRM; 1mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00144 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.319</GPH> Lorazepam-d4 CRM; 1 mg/mL in Acetonitrile Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 17035 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Glass ampule: 2 mL 9/19/2014 Sufentanil (citrate) CRM; 100 J.lg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Sufentanil (citrate) CRM; 100 J.lg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Sufentanil (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Sufentanil (hydrochloride) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Sufentanil (hydrochloride) CRM; 100 J.lg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Sufentanil (hydrochloride) CRM; 100 in Methanol ~tg/mL Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Sufentanil (hydrochloride); 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Sufentanil (hydrochloride); 100 J.lg in O.lmL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Sufentanil (hydrochloride); 500 J.lg in 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Sufentanil citrate CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Sufentanil citrate CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayllk'ln Chemical Company Sufentanil citrate CRM; 100 Methanol in Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Sufentanil citrate CRM; 100 J.lg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Sufentanil citrate; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Sufentanil citrate; 100 J.lg in 0.1 mL Methanol Glass vial: 3 mL 12/20/2013 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00145 ~tg/mL Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.320</GPH> Sufentanil (citrate) CRM; 1 mg/mL in Methanol Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Cayman Chemical Company 17036 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Cayman Chemical Company Sufentanil citrate; 500 Cayman Chemical Company ~gin Sufentanil CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 1127/2014 Sufentanil CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Sufentanil CRM; 100 ~Lg/mL in Methanol Glass ampule: 2 mL 1/27/2014 Cayman Chemical Company Sufentanil CRM; 100 ~g/mL in Methanol Glass ampule: 1 mL 1/27/2014 Cayman Chemical Company Sufentanil; 1 mg in 1 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Sufentanil; 100 ~gin 0.1mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Sufentanil; 500 ~gin 0.5 mL Methanol Glass vial: 3 mL 12/20/2013 Cayman Chemical Company Sufentanil-d3 (citrate) CRM; 1 mg/mL in Methanol Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Sufentanil-d3 (citrate) CRM; 1 mg/mL in Methanol Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Sufentanil-d3 (citrate) CRM; 100 Methanol ~g/mL in Glass ampule: 2 mL 9/19/2014 Cayman Chemical Company Sufentanil-d3 (citrate) CRM; 100 Methanol ~g/mL in Glass ampule: 1 mL 9/19/2014 Cayman Chemical Company Sufentanil-d3 citrate (exempt preparation); 1 mg in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Sufentanil-d3 citrate (exempt preparation); 100 ~g in 1 mL Methanol Glass vial: 1 mL 9/22/2014 Cayman Chemical Company Tetrahydrocmmabivarin (exempt preparation); 10 mg in 400 pL Methanol Glass vial: 400 pL 5/2/2014 Cayman Chemical Compa11y Tetral1ydrocmmabivarin (exempt preparation); 25 mg in 1 mL Methanol Glass vial: 1 mL 5/2/2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00146 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.321</GPH> 12/20/2013 Cayman Chemical Company ebenthall on DSK6SPTVN1PROD with NOTICES2 Glass vial: 3 mL VerDate Sep<11>2014 0.5 mL Methanol 17037 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices Cayman Chemical Company Tetrahydrocannabivarin (exempt preparation); 5 mg in 200 pL Methanol Glass vial: 200 pL 5/2/2014 Cayman Chemical Company ~9-Tetrahydrocannabinol (exempt preparation); 10 mg in400 pL Methanol Glass vial: 400 pL 5/2/2014 Cayman Chemical Company ~9-Tetrahydrocam1abinol (exempt preparation); 25 mg in 1 mL Methanol Glass vial: 1 mL 5/2/2014 ~9-Tetrahydrocannabinol (exempt preparation); 5 mg in 200 JlL Methanol Glass vial: 200 pL 5/2/2014 Cayman Chemical Company Celanese Ltd. Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cerilliant Corporation Cliniqa Corporation Acetaldehyde 6-beta-Naltrexol-3-beta-D-glucuronide (1 mg/mL) Tmck: 85 tons Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Acetyl fentanyl (1.0 mg/mL) Acetylfentanyl-13C6 (0.1 mg/mL) Remifentanil HCl (1.0 mg/mL) THC Cannabinoids Mixture-3 (1.0 mg/mL) Glass ampule: 1 mL Glass ampule: 1 mL 5/20/2013 4/14/2015 7/17/2015 7/17/2015 4/3/2014 10/7/2014 Plastic jug: 1 Gallon 4/15/2014 TDM Control Level 3 Plastic jug: 1 Gallon 4/15/2014 HDL Cholesterol Gel Kit: 48 gels 9/10/2014 Honeywell Specialty Materials LUMILUX Red CD 325 Plastic bottle: 5 g 9/16/2015 !so Sciences, LLC Testosterone-[2H5], 5000 Jlg/mL in methanol Amber ampule: 1 mL 9/17/2015 Glass vial: 1 mL 6/23/2014 Glass vial: 1mL 6/23/2014 Glass vial: 1 mL 6/23/2014 Glass vial: 1 mL 6/23/2014 Glass vial: 1 mL 6/23/2014 Glass vial: 1 mL 6/23/2014 Glass vial: 1 mL 6/23/2014 Glass ampule: 1 mL 6/8/2015 Cliniqa Corporation Helena Laboratories LGCLimited LGCLimited LGC Limited LGCLimited LGCLimited ebenthall on DSK6SPTVN1PROD with NOTICES2 LGCLimited LGCLimited LGC Standards VerDate Sep<11>2014 18:45 Mar 24, 2016 (-)-delta-9-Tetrahydrocaimabinol-C3 (THCV) 1.0 mg/mL in Methanol (-)-delta9-THC (Dronabinol) 0.1mg/mL in Methanol (-)-Delta-9-THC (Dronabinol) 5.0 mg/mL in Methanol Ca111labidiol carboxylic acid (CBDA) 1.0 mg/mL in Methanol Cammbigerol (CBG) 1.0 mg/mL in Methanol LSD (Lysergic Acid Diethylamide) 0.01 mg/mL in Acetonitrile THCA-A (Tetrahydrocannabinolic acid A) 1.0 mg/mL in Methanol LAMPA (Lysergic Acid N-Methyl-Npropylamide) 1.0 mg/mL in Acetonitrile Jkt 238001 PO 00000 Frm 00147 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.322</GPH> TDM Control Level 2 17038 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices LGC Standards Lipomed Inc. Lipomed Inc. Lorazepam-D4 1.0 mg/mL in Acetonitrile (-)-11-Nor-D9-THC-carboxylic acid (1 mg/I mL methanol) (±)-11-Nor- ~9-THC-carboxylic acid (1 mg/1 mL methanol) Lipomed Inc. Cannabidiol-D3 (0.1 mg/1 mL methanol) Lipomed Inc. Cannabidiol-D3 (1 mg/1 mL methanol) Lipomed Inc. Cannabinol-D3 (0.1 mg/1 mL methanol) Lipomed Inc. Catmabinol-D3 (1 mg/1 mL methanol) Lipomed Inc. Clonazepam-D4 (1 mg/1 mL methanol) Lipomed Inc. Lipomed Inc. Lipomed Inc. Lipomed Inc. Lipomed Inc. Lipomed Inc. d,l-11-HydrOA'Y-D9-THC-CD3 (0.1 mg/1 mL methanol) d,l-11-Hydroxy-D9-THC-CD3 (1 mg/1 mL methanol) d,l-11-Nor-L\9-THC-carbOA'Ylic acid-D9 (0.1 mg/1 mL methanol) d,l-11-Nor-L\9-THC-carboxylic acid-D9 (1 mg/1 mL methanol) d,l-11-Nor-~9- THC-carbOA'Ylic acid-D3 (0.1 mg/1 mL methanol) d,l-11-Nor-~9-THC-carboxylic acid-D3 (1 mg/1 mL methanol) Glass ampule: 1 mL Glass ampule: 1 mL Glass an1pule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Glass an1pule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Glass ampule: 1 mL Glass an1pule: 1 mL Glass an1pule: 1 mL Glass atnpule: 1 mL Glass container: 22.4g 6/8/2015 4/8/2013 4/8/2013 1/5/2015 115/2015 4/8/2013 4/8/2013 1/5/2015 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 Fentanyl.citrate (1 mg/1 mL methanol) Lipomed Inc. Fentanyl.citrate (1 mg/1 mL methanol) Lipomed Inc. Fentanyl-D5 (0.1 mg/1 mL methanol) Lipomed Inc. Fentanyl-D5 (1 mg/1 mL methanol) Lipomed Inc. THCA-A [(-)-trans- ~9-THC acid A] (1 mg/1 mL methanol) Microgenics Corporation Sodium Plus Buffer pH 8.6 Toronto Research Chemicals Inc. Alfentanil Hydrochloride (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Alfentanil-d3 Hydrochloride (1.0 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 Toronto Research Chemicals Inc. Alprazolam (1 mg/mL in Methanol) Glass vial: 1 mL 6/26/2014 VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 PO 00000 Frm 00148 Fmt 4701 Sfmt 4725 E:\FR\FM\25MRN2.SGM 25MRN2 4/8/2013 4/8/2013 4/8/2013 4/8/2013 4/8/2013 7/27/2015 EN25MR16.323</GPH> ebenthall on DSK6SPTVN1PROD with NOTICES2 Lipomed Inc. ebenthall on DSK6SPTVN1PROD with NOTICES2 BILLING CODE 4410–09–C Scope of Approval The exemptions are applicable only to the precise preparation or mixture described in the application submitted to DEA in the form(s) listed in this order and only for those sections of the CSA and the CFR that are specifically identified. In accordance with 21 CFR 1308.24(h), any change in the quantitative or qualitative composition of the preparation or mixture, or change in the trade name or other designation of the preparation or mixture after the date of application requires a new application. In accordance with 21 CFR 1308.24(g), the DEA may prescribe requirements other than those set forth in 21 CFR 1308.24 (b) through (e) on a case-by-case basis for materials exempted in bulk quantities. Accordingly, in order to limit opportunity for diversion from the larger bulk quantities, the DEA has determined that each of the exempted bulk products listed in this order may only be used in-house by the manufacturer, and may not be distributed for any purpose, or transported to other facilities. Additional exempt chemical preparation requests received between April 1, 2013, and December 31, 2015, and not otherwise referenced in this order may remain under consideration until the DEA receives additional information required, in accordance VerDate Sep<11>2014 20:35 Mar 24, 2016 Jkt 238001 with 21 CFR 1308.23(d), as detailed in separate correspondence to individual requesters. The DEA’s order on such requests will be communicated to the public in a future Federal Register publication. The DEA also notes that these exemptions are limited to exemption from only those sections of the CSA and the CFR that are specifically identified in 21 CFR 1308.24(a). All other requirements of the CSA and the CFR apply, including registration as an importer as required by 21 U.S.C. 957. Chemical Preparations Containing Newly Controlled Substances The statutory authority for exempt chemical preparations is based on the control status of substances contained within a preparation, the intended administration of a preparation, and the packaged form of a preparation. The DEA conducts a case-by-case analysis of each application for exemption to determine whether exemption of a preparation from certain provisions of the CSA is appropriate pursuant to the specified statutory and regulatory requirements. Most exempt chemical preparations have remained effective until the holder of a specific exempt chemical preparation specifically requested that the exemption be terminated. The CSA allows for modifications to the controlled substances schedules to add, remove, or change the schedule of PO 00000 Frm 00149 Fmt 4701 Sfmt 4703 17039 substances thus resulting in periodic modifications to the control status of various substances. 21 U.S.C. 811(a). Since the CSA was enacted in 1970, the DEA has on several occasions added to, removed from, or modified the schedules of controlled substances in accordance with the CSA. Such changes may result in the non-compliance of exempt chemical preparations with current statutes or regulations if chemical preparations that have already obtained exempt status contain newly controlled substances. For example, although an exempt chemical preparation may continue to be packaged in the same manner as when it was approved, non-controlled substances in the preparation may become controlled, thus prompting the need for a new application for exemption of the chemical preparation to ensure continued compliance. Other preparations that previously contained no controlled substances may contain newly controlled substances and thus would require an application for exemption. The DEA reviews applications for chemical preparation exemptions based on the statutes and regulations that are in place at the time of the application, including the control status of substances included in the preparation. The DEA must remain vigilant to ensure that exempt chemical preparations remain consistent with the standards set E:\FR\FM\25MRN2.SGM 25MRN2 EN25MR16.324</GPH> Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices 17040 Federal Register / Vol. 81, No. 58 / Friday, March 25, 2016 / Notices forth in the CSA and its implementing regulations. As such, the DEA reminds the public that any chemical preparation, regardless of whether it was previously exempt, that contains a newly controlled substance will require a new application for exemption pursuant to 21 U.S.C. 811(g)(3)(B) and 21 CFR 1308.23–1308.24. ebenthall on DSK6SPTVN1PROD with NOTICES2 Opportunity for Comment In accordance with 21 CFR 1308.23, any interested person may submit written comments on or objections to any chemical preparation in this order that has been approved or denied as VerDate Sep<11>2014 18:45 Mar 24, 2016 Jkt 238001 exempt. If any comments or objections raise significant issues regarding any finding of fact or conclusion of law upon which this order is based, the Deputy Assistant Administrator will immediately suspend the effectiveness of any applicable part of this order until he may reconsider the application in light of the comments and objections filed. Approved Exempt Chemical Preparations Are Posted on DEA’s Web Site A list of all current exemptions, including those listed in this order, is PO 00000 Frm 00150 Fmt 4701 Sfmt 9990 available on the DEA’s Web site at https://www.DEAdiversion.usdoj.gov/ schedules/exempt/exempt_chemlist.pdf. The dates of applications of all current exemptions are posted for easy reference. Dated: March 16, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016–06624 Filed 3–24–16; 8:45 am] BILLING CODE 4410–09–P E:\FR\FM\25MRN2.SGM 25MRN2

Agencies

[Federal Register Volume 81, Number 58 (Friday, March 25, 2016)]
[Notices]
[Pages 16891-17040]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-06624]



[[Page 16891]]

Vol. 81

Friday,

No. 58

March 25, 2016

Part III

Book 3 of 3 Books

Pages 16891-17058





Department of Justice





-----------------------------------------------------------------------



Drug Enforcement Administration



-----------------------------------------------------------------------



Exempt Chemical Preparations Under the Controlled Substances Act; 
Notice

Federal Register / Vol. 81 , No. 58 / Friday, March 25, 2016 / 
Notices

[[Page 16892]]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-372]


Exempt Chemical Preparations Under the Controlled Substances Act

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: Notice of order with opportunity for comment.

-----------------------------------------------------------------------

SUMMARY: The applications for exempt chemical preparations received by 
the Drug Enforcement Administration (DEA) between April 1, 2013, and 
December 31, 2015, as listed below, were accepted for filing and have 
been approved or denied as indicated.

DATES: Interested persons may file written comments on this order in 
accordance with 21 CFR 1308.23(e). Electronic comments must be 
submitted, and written comments must be postmarked, on or before May 
24, 2016. Commenters should be aware that the electronic Federal Docket 
Management System will not accept comments after 11:59 p.m. Eastern 
Time on the last day of the comment period.

ADDRESSES: To ensure proper handling of comments, please reference 
``Docket No. DEA-372'' on all correspondence, including any 
attachments. The Drug Enforcement Administration (DEA) encourages that 
all comments be submitted through the Federal eRulemaking Portal, which 
provides the ability to type short comments directly into the comment 
field on the Web page or to attach a file for lengthier comments. 
Please go to https://www.regulations.gov and follow the online 
instructions at that site for submitting comments. Upon completion of 
your submission you will receive a Comment Tracking Number for your 
comment. Please be aware that submitted comments are not 
instantaneously available for public view on Regulations.gov. If you 
have received a comment tracking number, your comment has been 
successfully submitted and there is no need to resubmit the same 
comment. Paper comments that duplicate the electronic submission are 
not necessary and are discouraged. Should you wish to mail a comment in 
lieu of an electronic comment, it should be sent via regular or express 
mail to: Drug Enforcement Administration, Attention: DEA Federal 
Register Representative/ODW, 8701 Morrissette Drive, Springfield, 
Virginia 22152.

FOR FURTHER INFORMATION CONTACT: Barbara J. Boockholdt, Office of 
Diversion Control, Drug Enforcement Administration; Mailing Address: 
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 
598-6812.

SUPPLEMENTARY INFORMATION:

Posting of Public Comments

    Please note that all comments received are considered part of the 
public record and made available for public inspection online at https://www.regulations.gov and in the DEA's public docket. Such information 
includes personal identifying information (such as your name, address, 
etc.) voluntarily submitted by the commenter.
    If you want to submit personal identifying information (such as 
your name, address, etc.) as part of your comment, but do not want it 
to be posted online or made available in the public docket, you must 
include the phrase ``PERSONAL IDENTIFYING INFORMATION'' in the first 
paragraph of your comment. You must also place all the personal 
identifying information you do not want posted online or made available 
in the public docket in the first paragraph of your comment and 
identify what information you want redacted.
    If you want to submit confidential business information as part of 
your comment, but do not want it to be posted online or made available 
in the public docket, you must include the phrase ``CONFIDENTIAL 
BUSINESS INFORMATION'' in the first paragraph of your comment. You must 
also prominently identify confidential business information to be 
redacted within the comment.
    Comments containing personal identifying information and 
confidential business information identified as directed above will 
generally be made publicly available in redacted form. If a comment has 
so much confidential business information that it cannot be effectively 
redacted, all or part of that comment may not be made publicly 
available. Comments posted to https://www.regulations.gov may include 
any personal identifying information (such as name, address, and phone 
number) included in the text of your electronic submission that is not 
identified as directed above as confidential.
    An electronic copy of this document is available at https://www.regulations.gov for easy reference.

Legal Authority

    The Drug Enforcement Administration (DEA) implements and enforces 
titles II and III of the Comprehensive Drug Abuse Prevention and 
Control Act of 1970, as amended. Titles II and III are referred to as 
the ``Controlled Substances Act'' and the ``Controlled Substances 
Import and Export Act,'' respectively, and are collectively referred to 
as the ``Controlled Substances Act'' or the ``CSA'' for purpose of this 
action. 21 U.S.C. 801-971. The DEA published the implementing 
regulations for these statutes in title 21 of the Code of Federal 
Regulations (CFR), chapter II.
    The CSA and its implementing regulations are designed to prevent, 
detect, and eliminate the diversion of controlled substances and listed 
chemicals into the illicit market while ensuring an adequate supply is 
available for the legitimate medical, scientific, research, and 
industrial needs of the United States. Controlled substances have the 
potential for abuse and dependence and are controlled to protect the 
public health and safety.
    Section 201 of the CSA (21 U.S.C. 811) authorizes the Attorney 
General, by regulation, to exempt from certain provisions of the CSA 
certain compounds, mixtures, or preparations containing a controlled 
substance, if she finds that such compounds, mixtures, or preparations 
meet the requirements detailed in 21 U.S.C. 811(g)(3)(B).\1\ DEA 
regulations 21 CFR 1308.23 and 1308.24 further detail the criteria by 
which the DEA Deputy Assistant Administrator may exempt a chemical 
preparation or mixture from certain provisions of the CSA. The Deputy 
Assistant Administrator may, pursuant to 21 CFR 1308.23(f), modify or 
revoke the criteria by which exemptions are granted and modify the 
scope of exemptions at any time.
---------------------------------------------------------------------------

    \1\ This authority has been delegated from the Attorney General 
to the Administrator of the DEA by 28 CFR 0.100, and subsequently 
redelegated to the Deputy Assistant Administrator pursuant to 
section 7 of 28 CFR 0.104, appendix to subpart R.
---------------------------------------------------------------------------

Exempt Chemical Preparation Applications Submitted Between April 1, 
2013, and September 17, 2015

    The Deputy Assistant Administrator received applications between 
April 1, 2013, and September 17, 2015, requesting exempt chemical 
preparation status detailed in 21 CFR 1308.23. Pursuant to the criteria 
stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23, the Deputy 
Assistant Administrator has found that each of the compounds, mixtures, 
and preparations described in Chart I below is intended for laboratory, 
industrial, educational, or special research purposes and not for 
general administration to a human being or animal and either: (1) 
Contains no narcotic controlled substance and is packaged in such a 
form or concentration that the packaged

[[Page 16893]]

quantity does not present any significant potential for abuse; or (2) 
contains either a narcotic or non-narcotic controlled substance and one 
or more adulterating or denaturing agents in such a manner, 
combination, quantity, proportion, or concentration that the 
preparation or mixture does not present any potential for abuse; if the 
preparation or mixture contains a narcotic controlled substance, it 
must be formulated in such a manner that it incorporates methods of 
denaturing or other means so that the preparation or mixture is not 
liable to be abused or have ill effects if abused, and so that the 
narcotic substance cannot in practice be removed.
    Accordingly, pursuant to 21 U.S.C. 811(g)(3)(B), and in accordance 
with 21 CFR 1308.23 and 21 CFR 1308.24, the Deputy Assistant 
Administrator has determined that each of the chemical preparations or 
mixtures generally described in Chart I below and specifically 
described in the application materials received by the DEA, are exempt, 
to the extent described in 21 CFR 1308.24, from application of sections 
302, 303, 305, 306, 307, 308, 309, 1002, 1003, and 1004 (21 U.S.C. 822-
823, 825-829, and 952-954) of the CSA, and 21 CFR 1301.74, as of the 
date that was provided in the approval letters to the individual 
requesters.
BILLING CODE 4410-09-P

[[Page 16894]]

[GRAPHIC] [TIFF OMITTED] TN25MR16.179


[[Page 16895]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.180


[[Page 16896]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.181


[[Page 16897]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.182


[[Page 16898]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.183


[[Page 16899]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.184


[[Page 16900]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.185


[[Page 16901]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.186


[[Page 16902]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.187


[[Page 16903]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.188


[[Page 16904]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.189


[[Page 16905]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.190


[[Page 16906]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.191


[[Page 16907]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.192


[[Page 16908]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.193


[[Page 16909]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.194


[[Page 16910]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.195


[[Page 16911]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.196


[[Page 16912]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.197


[[Page 16913]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.198


[[Page 16914]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.199


[[Page 16915]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.200


[[Page 16916]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.201


[[Page 16917]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.202


[[Page 16918]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.203


[[Page 16919]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.204


[[Page 16920]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.205


[[Page 16921]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.206


[[Page 16922]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.207


[[Page 16923]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.208


[[Page 16924]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.209


[[Page 16925]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.210


[[Page 16926]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.211


[[Page 16927]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.212


[[Page 16928]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.213


[[Page 16929]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.214


[[Page 16930]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.215


[[Page 16931]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.216


[[Page 16932]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.217


[[Page 16933]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.218


[[Page 16934]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.219


[[Page 16935]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.220


[[Page 16936]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.221


[[Page 16937]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.222


[[Page 16938]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.223


[[Page 16939]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.224


[[Page 16940]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.225


[[Page 16941]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.226


[[Page 16942]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.227


[[Page 16943]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.228


[[Page 16944]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.229


[[Page 16945]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.230


[[Page 16946]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.231


[[Page 16947]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.232


[[Page 16948]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.233


[[Page 16949]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.234


[[Page 16950]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.235


[[Page 16951]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.236


[[Page 16952]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.237


[[Page 16953]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.238


[[Page 16954]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.239


[[Page 16955]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.240


[[Page 16956]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.241


[[Page 16957]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.242


[[Page 16958]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.243


[[Page 16959]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.244


[[Page 16960]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.245


[[Page 16961]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.246


[[Page 16962]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.247


[[Page 16963]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.248


[[Page 16964]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.249


[[Page 16965]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.250


[[Page 16966]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.251


[[Page 16967]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.252


[[Page 16968]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.253


[[Page 16969]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.254


[[Page 16970]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.255


[[Page 16971]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.256


[[Page 16972]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.257


[[Page 16973]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.258


[[Page 16974]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.259


[[Page 16975]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.260


[[Page 16976]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.261


[[Page 16977]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.262


[[Page 16978]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.263


[[Page 16979]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.264


[[Page 16980]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.265


[[Page 16981]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.266


[[Page 16982]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.267


[[Page 16983]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.268


[[Page 16984]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.269


[[Page 16985]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.270


[[Page 16986]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.271


[[Page 16987]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.272


[[Page 16988]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.273


[[Page 16989]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.274


[[Page 16990]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.275


[[Page 16991]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.276


[[Page 16992]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.277


[[Page 16993]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.278


[[Page 16994]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.279


[[Page 16995]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.280


[[Page 16996]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.281


[[Page 16997]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.282


[[Page 16998]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.283


[[Page 16999]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.284


[[Page 17000]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.285


[[Page 17001]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.286


[[Page 17002]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.287


[[Page 17003]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.288


[[Page 17004]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.289


[[Page 17005]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.290


[[Page 17006]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.291


[[Page 17007]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.292


[[Page 17008]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.293


[[Page 17009]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.294


[[Page 17010]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.295


[[Page 17011]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.296


[[Page 17012]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.297


[[Page 17013]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.298


[[Page 17014]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.299


[[Page 17015]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.300


[[Page 17016]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.301


[[Page 17017]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.302


[[Page 17018]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.303


[[Page 17019]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.304


[[Page 17020]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.305


[[Page 17021]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.306


[[Page 17022]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.307


[[Page 17023]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.308


[[Page 17024]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.309

    The Deputy Assistant Administrator has found that each of the 
compounds, mixtures, and preparations described in Chart II below is 
not consistent with the criteria stated in 21 U.S.C. 811(g)(3)(B) and 
in 21 CFR 1308.23. Accordingly, the Deputy Assistant Administrator has 
determined that the chemical preparations or mixtures generally 
described in Chart II below and specifically described in the 
application materials received by the DEA, are not exempt from 
application of any part of the CSA or from application of any part of 
the CFR, with regard to the requested exemption pursuant to 21 CFR 
1308.23, as of the date that was provided in the determination letters 
to the individual requesters.

[[Page 17025]]

[GRAPHIC] [TIFF OMITTED] TN25MR16.310


[[Page 17026]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.311


[[Page 17027]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.312


[[Page 17028]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.313


[[Page 17029]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.314


[[Page 17030]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.315


[[Page 17031]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.316


[[Page 17032]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.317


[[Page 17033]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.318


[[Page 17034]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.319


[[Page 17035]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.320


[[Page 17036]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.321


[[Page 17037]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.322


[[Page 17038]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.323


[[Page 17039]]


[GRAPHIC] [TIFF OMITTED] TN25MR16.324

BILLING CODE 4410-09-C

Scope of Approval

    The exemptions are applicable only to the precise preparation or 
mixture described in the application submitted to DEA in the form(s) 
listed in this order and only for those sections of the CSA and the CFR 
that are specifically identified. In accordance with 21 CFR 1308.24(h), 
any change in the quantitative or qualitative composition of the 
preparation or mixture, or change in the trade name or other 
designation of the preparation or mixture after the date of application 
requires a new application. In accordance with 21 CFR 1308.24(g), the 
DEA may prescribe requirements other than those set forth in 21 CFR 
1308.24 (b) through (e) on a case-by-case basis for materials exempted 
in bulk quantities. Accordingly, in order to limit opportunity for 
diversion from the larger bulk quantities, the DEA has determined that 
each of the exempted bulk products listed in this order may only be 
used in-house by the manufacturer, and may not be distributed for any 
purpose, or transported to other facilities.
    Additional exempt chemical preparation requests received between 
April 1, 2013, and December 31, 2015, and not otherwise referenced in 
this order may remain under consideration until the DEA receives 
additional information required, in accordance with 21 CFR 1308.23(d), 
as detailed in separate correspondence to individual requesters. The 
DEA's order on such requests will be communicated to the public in a 
future Federal Register publication.
    The DEA also notes that these exemptions are limited to exemption 
from only those sections of the CSA and the CFR that are specifically 
identified in 21 CFR 1308.24(a). All other requirements of the CSA and 
the CFR apply, including registration as an importer as required by 21 
U.S.C. 957.

Chemical Preparations Containing Newly Controlled Substances

    The statutory authority for exempt chemical preparations is based 
on the control status of substances contained within a preparation, the 
intended administration of a preparation, and the packaged form of a 
preparation. The DEA conducts a case-by-case analysis of each 
application for exemption to determine whether exemption of a 
preparation from certain provisions of the CSA is appropriate pursuant 
to the specified statutory and regulatory requirements.
    Most exempt chemical preparations have remained effective until the 
holder of a specific exempt chemical preparation specifically requested 
that the exemption be terminated. The CSA allows for modifications to 
the controlled substances schedules to add, remove, or change the 
schedule of substances thus resulting in periodic modifications to the 
control status of various substances. 21 U.S.C. 811(a). Since the CSA 
was enacted in 1970, the DEA has on several occasions added to, removed 
from, or modified the schedules of controlled substances in accordance 
with the CSA. Such changes may result in the non-compliance of exempt 
chemical preparations with current statutes or regulations if chemical 
preparations that have already obtained exempt status contain newly 
controlled substances. For example, although an exempt chemical 
preparation may continue to be packaged in the same manner as when it 
was approved, non-controlled substances in the preparation may become 
controlled, thus prompting the need for a new application for exemption 
of the chemical preparation to ensure continued compliance. Other 
preparations that previously contained no controlled substances may 
contain newly controlled substances and thus would require an 
application for exemption.
    The DEA reviews applications for chemical preparation exemptions 
based on the statutes and regulations that are in place at the time of 
the application, including the control status of substances included in 
the preparation. The DEA must remain vigilant to ensure that exempt 
chemical preparations remain consistent with the standards set

[[Page 17040]]

forth in the CSA and its implementing regulations. As such, the DEA 
reminds the public that any chemical preparation, regardless of whether 
it was previously exempt, that contains a newly controlled substance 
will require a new application for exemption pursuant to 21 U.S.C. 
811(g)(3)(B) and 21 CFR 1308.23-1308.24.

Opportunity for Comment

    In accordance with 21 CFR 1308.23, any interested person may submit 
written comments on or objections to any chemical preparation in this 
order that has been approved or denied as exempt. If any comments or 
objections raise significant issues regarding any finding of fact or 
conclusion of law upon which this order is based, the Deputy Assistant 
Administrator will immediately suspend the effectiveness of any 
applicable part of this order until he may reconsider the application 
in light of the comments and objections filed.

Approved Exempt Chemical Preparations Are Posted on DEA's Web Site

    A list of all current exemptions, including those listed in this 
order, is available on the DEA's Web site at https://www.DEAdiversion.usdoj.gov/schedules/exempt/exempt_chemlist.pdf. The 
dates of applications of all current exemptions are posted for easy 
reference.

    Dated: March 16, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-06624 Filed 3-24-16; 8:45 am]
 BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.